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It’s my tail, 
and I’ll chase it if I want to. 
 
Oceansize, 2010.  
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Abstract 
 
Hosts and infections can interact in potentially subtle and under-
appreciated ways. These interactions are reciprocal and there is 
evidence that identical processes govern host defence and parasite 
pathogenicity. I demonstrate the benefits of approaching host and 
microbe in the same way by studying how costs and benefits of 
resistance in Tenebrio molitor and the opportunistic pathogen 
Staphylococcus aureus determine parasite persistence, pathogenicity, 
and collateral immunological self-damage.  
 
Focusing first on bacteria, I divergently selected bacteria derived from 
one ancestral clone for resistance to an array of antimicrobial peptides 
(AMPs) to measure the genetic costs of evolving resistance to these 
immunological stressors, which has rarely been observed and was 
thought to be highly costly. Costs of resisting AMPs were comparable to 
those of resisting antibiotics against which resistance is common in 
environmental isolates, suggesting that intrinsic costs do not constrain 
natural AMP resistance. However the response to selection from AMPs 
in combination was much weaker, suggesting that the multiplicity of 
AMPs in antimicrobial immunity slows resistance evolution.  
 
AMP-resistant bacteria showed significantly elevated resistance to T. 
molitor's immune response. My results therefore suggest that proposed 
medical use of these compounds could mediate pathogenesis. 
 
I consider why autotoxic immunity has been conserved, and suggest 
autopathology is a secondary effect of a requirement for immune 
defence to remain potent against diverse infections. I found 
morphological self-damage after simulated infection, but fitness effects 
were unclear. I show that infected T. molitor transcribe numerous 
reactive enzymes that are predicted to damage self-tissue.  
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As a body of work these studies demonstrate that applying the same 
conceptual approach to hosts and their parasites can improve 
understanding of host-parasite coevolution. Costs of resistance can be 
classified identically in hosts and microparasites, likely generating 
identical consequences.  
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Glossary 
 
Term Description 
AMP(s) Antimicrobial peptide(s). Small peptides 
synthesised by the innate immune system, with in 
vitro antimicrobial activity, and under development 
as new antibiotic drugs. Also referred to elsewhere 
as ribosomal AMPs (rAMPs) and cationic ribosomal 
AMPs (crAMPs). 
Autopathology Self-damage.  
Immunopathology a) An autopathological trait that is also associated 
with parasite killing.  
b) The proportion of post-infection fitness loss that 
can be directly attributed to collateral damage from 
endogenous immunological processes 
Inoculum Exogenous biological material introduced into a 
host’s tissues. 
Parasite A functional classification for a symbiont that 
invades host tissues and gains energetic resources 
from a larger host. They do not necessarily cause 
pernicious harm to a host (see ‘pathogen’) 
Pathogen A sub-class of parasites, which gain additional 
fitness by causing pernicious damage to the host 
through activation of virulence factors, in addition to 
consuming a host’s resources. 
Pathology a) The phenomenon of damage to a host after 
infection 
b) The proportion of host fitness loss that can be 
directly attributed to activation of a pathogen’s 
virulence factors. 
Pathogenicity The property of pathology 
PO Phenoloxidase, an oxidative enzyme commonly 
assayed as a metric of ‘immunocompetence’ in 
! 11 
invertebrates. 
pro-PO Pro-phenoloxidase, the inactive precursor to PO. 
Selected culture A bacterial culture after selection from a given 
stressor. 
Symbiont Any non-self organism living in a host's tissues, 
including the full range of functional interactions 
between mutualism and pathogen. 
Tolerance The condition of a host’s immune system permitting 
coexistence with a parasite.  
Virulence The sum of host damage caused by expression of 
immunopathology and parasite pathology 
Virulence factor A parasite trait that enhances that parasite’s fitness 
by damaging its host, e.g. secreted toxins that 
compromise the immune response by damaging 
host tissues. 
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Chapter One 
 
Introduction 
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1.1. The conceptual framework of this thesis 
 
This thesis aims to develop a more integrative understanding of how 
hosts and parasites resist one another, and to identify shared benefits 
and costs that determine these traits. There has been widespread recent 
recognition of the subtleties of how immunity evolves, which emphasizes 
that resisting a parasite may not always be the ideal strategy for a host. 
A reciprocal case is also made, arguing that there are some situations in 
which costs to a parasite of resisting host defence are too great for this 
strategy to be optimal. This is achieved by measuring costs of resistance 
in both a model host and model parasite. The approach is to try to 
understand the mechanistic bases of infection and immunity from an 
evolutionary biology perspective, and knowledge of the economic 
principles of modern evolutionary theory is assumed in the reader. 
 
The body of the thesis is structured into two main parts, split over four 
chapters. Chapters 2 and 3 detail experiments regarding the costs and 
benefits to bacteria of resisting components of host immunity. Chapters 
4 and 5 respectively aim to measure the costs to hosts of induced 
resistance to an infection; and to elucidate the mechanisms that might 
induce these costs of resistance.  By studying the costs of resistance in 
both host and parasite, these experiments are intended as a case study 
in the advantages of applying a unifying conceptual framework to both 
components of the system. For continuity and comparability, the 
mealworm beetle Tenebrio molitor is used as a model host throughout, 
and the gram-positive opportunistically pathogenic bacterium 
Staphylococcus aureus is used as model parasite. 
 
1.2. The power of parasites  
 
Hosts and parasites impose powerful selection on one other (Frank, 
2002; Dittmer and Kanost, 2010; Prasain et al., 2012). This selection is 
ancient and ubiquitous: any cellular host species from protozoa to 
! 15 
primates can be infected, and there is a greater diversity of parasites 
than any other functional group of organisms (Leclerc et al., 2006; 
Schmid-Hempel, 2011). The complicated and often fascinating effects of 
parasitism are thought to range between traits and processes as diverse 
as sex, speciation, lekking, and human body hair (Folstad and Karter, 
1992; Kirkness et al., 2010; Brockhurst, 2011; Dean and Siva-Jothy, 
2011). 
 
Hosts have responded to selection from parasites by evolving 
sophisticated immune systems. The dominant paradigm in 
immunological research has long been to understand how and why 
hosts kill their parasites. However there has been a recent recognition 
that immune systems can behave in subtle and previously under-
appreciated ways.  
 
1.3. The sophistication of immunity 
 
It has recently been recognised that there are two basic ways for a host 
to survive infection, by either resisting or tolerating infection (Lazzaro 
and Rolff, 2011). Resistance responses can be defined as mechanisms 
to reduce fitness of a parasite, killing it or externalising it from host 
tissues. This is the traditional view of animal immunity, and the focus of 
this thesis is to find common features of resistance responses in hosts 
and microbes. The second route to immunity is common between 
parasites and other symbionts inhabiting the host, which is to tolerate 
infection by controlling and minimising the damage caused by the 
symbiont. Resistance and tolerance are defined by Raberg et al., (2007); 
and Rowntree et al., (2011b), who base their definitions on animal and 
plant systems respectively, but converge in their conclusions.  
 
Implicitly, resistance responses must harm parasites by killing, or 
terminally damaging cells, or blocking access to resources. Resistance 
is well defined, and its biological mediators are well understood. The 
classical view of immunity was that hosts should always resist infection 
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as strongly as possible, by avoiding parasitism or eradicating parasites 
after they have entered host tissue. As the mediators of resistance are 
well understood on a molecular and biochemical level, they are 
discussed later in this introduction, with specific respect to insect 
systems. On the other hand, the chemical mediators of tolerance are not 
clear, and there is scope to develop the phenomena that have to date 
been termed tolerance. Epidemiology-centric definitions of tolerance 
(e.g. Boots, 2008; Best et al., 2010) consider tolerance as any means of 
isolating the host from the effect of harm caused by the parasite, for 
example by detoxification; and resistance as direct control of the 
parasite by killing, externalising it from host tissue, or preventing growth. 
However reducing a parasite's metabolism does not necessarily render it 
inviable, and may simply delay the parasite's growth until the host dies 
or relaxes its tolerant control of the parasite. In this case slowing growth 
delays but does not reduce parasite fitness, and is therefore a tolerance 
mechanism. 
 
1.4. The evolutionary ecology of resistance 
 
The costs and benefits of resistance responses are clear: the host gains 
the benefit of reduced future parasitism and damage from the parasite, 
at the cost of evolving and activating resistance responses. Classic life-
history theory predicts that trade-offs and therefore costs must operate 
on immunological resistance, because natural selection has not 
favoured universally perfect immunity (Siva-Jothy et al., 2005). These 
principles are well-established theoretically, supported empirically, and 
are the fundamental basis of evolutionary immunology (Sheldon and 
Verhulst, 1996; Graham et al., 2010). Costs of resistance can be 
classified as the costs of evolving an immune system, and the costs of 
initiating an immune response (Schmid-Hempel, 2011). Costs of 
evolving resistance responses can be sub-categorised as genetic and 
physiological; and costs of activating an immune response are sub-
categorised as genetic, physiological and auto-reactive. Each class of 
costs is briefly discussed below, with examples. To maintain consistency 
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with the source of these definitions (Schmid-Hempel, 2011) these 
classes of cost are termed costs of immunity, but they are implicitly costs 
of resistance: 
 
• Genetic costs of evolving immunity are described by negative 
genetic correlations between the ability to survive an infection and 
other life-history components, which has often been described 
between parasite resistance and fecundity. For example, 
Biomphalaria glabrata snails selected for parasite resistance are 
less fecund than susceptible lines (Webster and Woolhouse, 
1999); and, conversely, sexual competitiveness is negatively 
related to immune function and resistance to bacterial infection in 
male Drosophila melanogaster (McKean and Nunney, 2008; 
McKean et al., 2008). Recent work has shown that antiviral 
defence and growth rate are negatively related in a moth (Boots, 
2011). 
 
• Physiological costs of evolving immunity are caused by 
maintaining immunological machinery to ward off potential 
infection. For example, constitutive expression of resistance traits 
to infer prophylactic resistance to potential parasites from the 
environment (e.g. Gross et al., 2008) will come at an energetic 
cost. As evidence of such costs, (Schmid-Hempel, 2011) cites 
examples of regulation of wild mammalian immune-related genes 
in response to seasonal variation in the risk of parasitism.  
 
• Genetic costs of activating an immune response are similar to the 
life-history trade-offs caused by evolving immunity, with the 
essential difference that they are inducible upon activation of the 
immune system, rather than being constitutively expressed as 
'overheads'. For example, fever caused by a simulated bacterial 
infection leads to a greater risk of predation in crickets (Otti et al., 
2012). Interestingly this trade-off may be bi-directional, for 
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instance copulation interferes with subsequent immunity in 
damselflies and beetles (Siva-Jothy et al., 1998; Rolff and Siva-
Jothy, 2002). 
 
• Physiological costs of activating an immune response are the 
costs of using deploying mediators of immunity. Numerous 
negative relationships between immunity and fecundity have also 
been shown on this level. (Moret and Schmid-Hempel, 2000) 
showed that stimulating an immune response by using sterile, 
non-pathological material caused a dramatic reduction in the 
lifespan of bumblebee workers, as a consequence of the 
energetic cost of immunity. There are also strong negative 
relationships between immunity and indicators of general 
condition, such as anorexia and body fat content (Rolff and 
Reynolds, 2009). 
 
• Auto-reactive costs of activating an immune response are of 
particular relevance to this thesis, specifically in Chapter 4. These 
costs can be considered a sub-class of the physiological costs of 
activating an immune response, but with a more specific outcome 
in which the active immune system causes collateral damage to 
the host's own tissues (Long and Boots, 2011). The clearest 
example of this phenomenon is detailed by (Sadd and Siva-Jothy, 
2006), who showed a decline in essential physiological function of 
Tenebrio molitor resulting from the immune system attacking self-
tissue. A more recent study connects this process in early life with 
reduced adult mortality (Pursall and Rolff, 2011). In the case of T. 
molitor it is thought that these effects are mediated by the 
cytotoxic intermediates of the phenoloxidase (PO) system (Nappi 
and Ottaviani, 2000; Christensen et al., 2005). In plants, parasitic 
attack often results in dramatic occlusion and death of host 
tissues (Cameron et al., 2006). In malaria-infected mice, inhibiting 
interleukin signaling strongly improved host survival and 
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decreased parasite density independent of parasite genotype, 
demonstrating powerful auto-pathology associated with this 
signaling pathway (Long et al., 2008). These studies demonstrate 
that the phenomena of host sickness and death, termed 
virulence, are the sum of parasite and host pathologies (Graham 
et al., 2010). 
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Figure 1.4.1. Costs of immunity/resistance (From Schmid-Hempel, 
2011) 
 
Costs of immunity are the trade-offs involved with the evolution and 
maintenance or deployment of immune traits. Costs of evolution and 
maintenance are standing costs associated with having a certain trait at 
the expense of another (genetic), and maintaining its machinery 
(physiological). Costs of deployment relate to use of a trait, and can also 
manifest as a negative correlation with another trait (genetic), costs of 
using the trait (physiological) or host self-damage caused by the immune 
system (self-reactivity). The net costs of traits are environment-
dependent. 
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for any other trait, the defence machinery evolves and 
thereby attains a certain degree of perfection at the det-
riment of another fi tness-relevant function of the organ-
ism. Furthermore, once the machinery is in plac , it has 
to be maintained, even if it is not used. Both require-
ments can be considered a cost of possessing and keep-
ing an immune-defence machinery in ready state; these 
can be considered costs of having evolved an immune 
defence. For this reason, evolution and maintenance are 
grouped together in  Figure  5.3 , but sometimes these two 
costs are considered separate from each other. On the 
other hand, once an infection has occurred, the machin-
ery is activated and used to generate an immune 
response. This again comes at a cost to the organism, 
such as a reduction in the performance of another func-
tion due to competing demands on resources. These 
kinds of cost can be considered costs of deployment. 
 The costs are implemented in di! erent ways—either 
genetically hard-wired, or at the physiological level. Note 
that genetic costs are ultimately also produced by physi-
ological proce ses. Hence, the di! erence refers to 
whether or not the costs are fi xed by the genotype, or 
whether they can be altered at the physiological level 
(. . . and, again, real cases are somewhere in-between). 
Costs entrenched in the genetic makeup of a population 
are a constraint for a given individual and its genotype. 
Any changes a! ecting this cost can only occur by the 
process of selection and evolution. Such costs are visible 
as negative genetic covariances between di! erent traits. 
For example, some genotypes might be able to mount a 
strong immune response when challenged, yet they have 
low fecundity when no infection occurs; other genotypes 
might show the reverse pattern instead ( McKean et al. 
 2008 ). Across the population of genotypes, immune 
Cost of immunity
Evolution and Maintenance Deployment
PhysiologicalGenetic PhysiologicalGenetic
Immediate cost
(reduction of
other function)
Immediate cost
(reduction of
other function)
(Negative) genetic
covariance with
other function
(Negative) genetic
covariance with
other function
Environment
Self-reactivity
Immediate cost
by self-damage
 Figure 5.3 Costs of immune defences. Costs can be classifi ed according to cause (evolution, maintenance, deployment) or 
according to implementation (genetic, physiological). For example, the immune defence ‘machinery’ must evolve in the fi rst 
place. This can cause genetic costs because an increased response capacity can only evolve at the price of a reduced 
performance in another fi tness component, e.g. when there is a negative genetic covariance with reduced fecundity. 
The machinery can also cause physiological costs of maintenance, even when not used. When the system is activated in case of 
an infection (deployment), additional costs emerge. These can again be genetic costs, when using the defence inevitably 
reduces another fi tness component (e.g. predator avoidance). Activation can also induce physiological costs, e.g. energy 
consumption that is not available for host loco otion. Further ore, the costs are a! ected by the enviro me t. Self-reactivity 
is, strictly speaking, a physiological cost too. However, it is perceived distinct enough to warrant an own category. Physiological 
costs are plastic (the individual can ‘decide’), whereas genetic costs are constrained by the genotype. 
0001214949.INDD   106 9/27/2010   11:03:58 PM
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These are the principles that have guided the evolution of immunity, and 
the trade-offs inherent in host management of symbiotic organisms of all 
descriptions. Although there are clear benefits to resistance, there are 
numerous associated costs and negative feedbacks, evidenced by the 
fact that hosts are not immune to all parasites.  
 
1.5. The evolutionary ecology of tolerance 
 
Although parasite tolerance has been observed in both animal and plant 
systems, there is no clear suggestion of why it should evolve. This thesis 
experimentally parameterises costs of resistance responses, so there is 
value in considering whether these costs could be related to tolerance. 
Theory (Stowe et al., 2000) suggests that resistance and tolerance are 
negatively correlated, which has received some support in animal and 
plant systems (but see also examples in Koskela et al., 2002; 
Rodenburg et al., 2006; Raberg et al., 2007; Ayres and Schneider, 2008; 
Stjernman et al., 2008; Vale et al., 2011; Rowntree et al., 2011a). 
Assuming this negative correlation, then the costs and benefits of each 
strategy must be related, and each is a stable strategy when the other is 
not. Since the expression of resistant phenotypes is determined by 
condition (Fellous and Lazzaro, 2010; Boots, 2011), it seems likely that 
the optimality of tolerance is determined by the relationship between 
condition and costs of resistance. This is discussed further in Chapter 4.  
 
1.6. A natural history of insect immunity 
 
The experiments in Chapters 3, 4 and 5 use the mealworm beetle 
Tenebrio molitor as a model host, so the mechanistic bases of insect 
immunity merit some introduction. Although the mechanisms described 
are general, specific mention is made of T. molitor to introduce the 
immune system of this host. 
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The arthropod immune system consists of cellular and humoral 
components, which can be sub-classified as constitutive or induced 
(Nappi and Ottaviani, 2000). “Cellular immunity” refers to haemocytes, 
which phagocytose or encapsulate parasites (Strand, 2008), and are 
responsible for coagulation and wound healing (Haine et al., 2007). 
“Humoral” components comprise soluble proteins such as antimicrobial 
peptides (AMPs) (Bulet et al., 2004) and lysozymes; and a range of 
reactive cytotoxins e.g. reactive oxygen species (ROS), quinones and 
lectins (Siva-Jothy et al., 2005). The specifics of these components are 
discussed below. 
 
1.6.1. Haemocytes 
 
The functional significance of haemocytes is clear (see Rosales, 2011 
for review). Upon inoculation with foreign microbes, phagocytes rapidly 
surround the alien matter, isolating them from the haemocoel (Lavine 
and Strand, 2002). Parasites are therefore rapidly externalised from the 
haemocoel. After phagocytosis, haemocytes aggregate on other tissues, 
forming ‘nodules’ (Gillespie and et al., 1997). Larger foreign bodies – 
such as parasitoids, nylon filament or polystyrene beads - are 
encapsulated by a layer of haemocytes (Siva-Jothy, 2000). After 
encapsulation or nodulation, haemocytes enter a program of cell death 
and melanise (Gillespie and et al., 1997). Pathogens are thus rapidly 
removed from circulation, starved of oxygen and nutrients, and 
bombarded with the toxic products of melanisation.  
 
Genetic ablation of haemocytes has shown them to play a pivotal role in 
Drosophila resistance to S. aureus infection (Defaye et al., 2009). 
Parasites are nearly always removed by haemocytes (Lavine and 
Strand, 2002), so their function is under strong positive selection, 
leading to, for instance, the evolution of 'hyperphagocytes' in Manduca 
sexta (Dean et al., 2004). It is thought that the action of haemocytes is 
responsible for a large proportion of the clearance of infectious bacteria 
from the haemocoel of T. molitor (Haine et al., 2008a). Furthermore, 
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they play a role in clearing recalcitrant infection and are the agents of 
immunological ‘priming’ against a previously cleared parasite in 
Drosophila (Pham et al., 2007).  
 
Immunological haemocyte function is tightly integrated with other 
immune effectors (Nehme et al., 2011). The externalisation of both 
micro- and macro-parasites is dependent on oxidative enzymes involved 
in melanin production (Zhao et al., 2007; Jiang, 2008), and they produce 
soluble antimicrobial peptides (Lavine et al., 2005). 
 
1.6.2. Cytotoxins and oxidative enzymes 
 
A crucial constitutive immune defence is the proteolytic casecade of 
tyrosinase reactions resulting in the eventual production of 
phenoloxidase (PO) and melanin, known as the PO cascade 
(Sugumaran, 2002; Laughton et al., 2011a). The precursor compound 
proPO (Nigam et al., 1997) is activated by stimuli indicating infection, 
including mechanical wounding, detection of pathogen-associated 
molecular patterns (PAMPs) (Cerenius et al., 2008; 2010); or disruption 
of the basement membrane (Brennan et al., 2007). The PO cascade is 
often assayed as a proxy for general immune activity and 
“immunocompetence” (Mucklow and Ebert, 2003; Lee et al., 2008), 
although the associated phenotypes are probably the sum of the 
activities of a diverse range of oxidative enzymes (Dittmer and Kanost, 
2010; Prasain et al., 2012) 
 
PO is involved in melanin and sclerotin production (Sugumaran, 2002), 
and is thus pivotal in externalising phagocytosed or encapsulated 
parasites. PO has also been implicated in producing compounds that aid 
phagocytosis (Nigam et al., 1997; Cerenius et al., 2008; 2010). Killing is 
probably caused by production of toxic intermediates such as lectins, 
quinones and reactive oxygen species (ROS) (Christensen et al., 2005; 
Zhao et al., 2007; Jiang, 2008). This hypothesis is supported by the 
finding that PO-deficient Drosophila mutants are not 
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immunocompromised relative to wild-type strains (Leclerc et al., 2006) 
suggesting that toxicity is mediated by up-stream compounds. However 
this need not invalidate measurement of PO as a proxy for the 
production of these compounds and therefore immune activity.  
 
The PO cascade and activity of other oxidative enzymes such as 
laccases and multicopper oxidases are known to be autopathological 
(An and Kanost, 2010; Dittmer and Kanost, 2010; Prasain et al., 2012). 
Sadd and Siva-Jothy, (2006) showed a mechanistic link in T. molitor 
between the induction of phenoloxidase activity by nylon implant, and 
the melanisation and impairment of a fundamental physiological function 
(malpighian tubule activity). This is likely mediated by the release of toxic 
by-products into the open insect haemocoel. Despite some ongoing 
debate caused by sometimes equivocal functional evidence for a role of 
PO in antimicrobial defence - which quite often comes from a small 
selection of research groups working on Drosophila - there is a strong 
evolutionary argument that these self-damaging processes would be 
strongly selected against unless they had a direct or pleiotropic role in 
immunity. On this basis, the antimicrobial and autopathological roles of 
melanin are central to the arguments presented in Chapters 4 and 5. 
 
1.6.3. Antimicrobial peptides 
 
Antimicrobial peptides (AMPs) are components of the induced immune 
response. They are present at low concentrations in unwounded insects, 
but their production by the insect fat body and haemocytes is greatly up-
regulated after inoculation with microbes or pathogen-associated 
molecular patterns (Iwanaga and Lee, 2005; Lavine et al., 2005; Haine 
et al., 2008b). AMPs can be detected in the haemolymph of Drosophila 
as quickly as two hours post-infection (Meister et al., 1997; Lehrer and 
Ganz, 1999). Typically, AMPs are composed by fewer than 100 amino 
acid residues (Huang, 2000), with molecular masses below 25-30kDa. 
They are hydrophobic and cationic (Zasloff, 2002), and demonstrate 
amphipathic structures crucial to their bactericidal action. Structurally, 
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AMPs consist of !-helices, "-sheets, or combinations of the two (Bulet et 
al., 1999). The diversity of AMPs is so great that any classification by 
any system other than structure is difficult (Zasloff, 2002). AMPs have 
been extensively studied in Drosophila, in which they have been shown 
to be powerful predictors of resistance to infection, and wild-type fitness 
can be restored in AMP-deficient mutants by re-expression of just one 
AMP (Tzou et al., 2002). There is published data on five AMPs from T. 
molitor, and unpublished transcriptomic data predicts the existence of an 
additional two (P. Johnston, Pers. Comm.). 
 
AMPs damage microorganisms in two ways. The cationically-charged 
AMPs exploit the uniquely negative charges on the outer cell 
membranes of microorganisms, then disrupt the membrane structure 
and lyse the cell (The Shai-Matsuzaki-Huang model) (Boman, 1995; 
Bulet et al, 1999; Zasloff, 2002; Ganz, 2003; Zanetti, 2005).  Others 
penetrate the bacterial cell membrane and act on intracellular structures 
(Brogden, 2005). By acting on highly conserved features of microbial 
structures, AMPs exhibit extraordinarily broad-spectrum activity (Zanetti, 
2005). Eukaryote cell membranes do not attract AMPs, in contrast to 
those of prokaryotes, so AMPs are not toxic to hosts. 
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Figure 1.6.3.1. Examples of amphipathic AMP structure. 
The amphipathic structures of AMPs are fundamental for their tertiary structure and bactericidal activity. This Figure shows the 
positions of basic, positive-charged amino acids (red); and green, hydrophobic amino acids (green). Figure from (Zasloff, 
2002)
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Whilst conservation of homologs is rare across higher taxa, there is 
frequent analogy: for example tenecin 1 (from T. molitor) and holotricin 1 
(from a scarabid beetle) show 60% sequence homology, disulphide 
bridges on homologous amino acids, and are both effective against 
gram-negatives but not gram-positives (Moon et al., 1994b; Lee et al., 
1995) (Figure 1.6.3.2). On a broader scale, analogues of peptides 
originally identified in the moth Hyalophoria cecropia (cecropins) have 
been found in animals as evolutionarily distant as vertebrates (Moore et 
al, 1996); but defensin family peptides show a greater molecular 
distance within dipterans than between odonates and arachnids (Bulet et 
al, 1999). Figure 1.6.3.3. (from Altincicek et al., 2008a) shows the 
molecular conservation of AMP protein sequence across insect orders. 
Based on the contrast between genomic evolution and AMP evolution in 
Drosophila, Juneja & Lazzaro (in Rolff and Reynolds, 2009) suggest that 
the lack of peptide evolution within Drosophila, contrasted with genomic 
evolution across higher taxonomic levels, implies that AMPs are 
effective in specific ecologies, but adaptation is required in different 
environments. The extraordinary functional and structural conservation 
of AMPs (Figures 1.6.3.2. & 1.6.3.3) suggests an important adaptive role 
for these immune effectors.  
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Figure 1.6.3.2. Amino acid sequence conservation between beetle antimicrobial peptides, from (Lee et al., 1995) 
Holotricin-1, from the scarabid beetle Holotrichia diomphalia, and tenecin-1, from the tenebrionid Tenebrio molitor, show 60% 
conservation of amino acid sequence (shared residues are starred), disulphide bridges to identical residues (shown by large 
brackets), and identical spectra of microbicidal activity. 
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Figure 1.6.3.3. Molecular conservation of defensins across insect 
orders and higher taxa, from (Altincicek et al., 2008a)) 
Antimicrobial peptides are highly conserved across taxa. A shows 
amino acid conservation of defensins within the beetle Tribolium 
castaneum; compared to the confamilial beetle Tenebrio molitor, the 
honeybee Apis mellifera, the kissing bug Triatoma brasiliensis, the 
fruitfly Drosophila melanogaster, the ant Formica aquilonia, the firebrat 
Thermobia domestica, the moth Galleria melonella, and the dragonfly 
Aeschna cyanea. A also demonstrates how these insect defensins 
compare to defensins from organisms in separate kingdoms, including 
the plant Raphanus sativus, and the fungus Pseudoplectania nigrella. B 
shows clustering of defensins by species. The scale bar represents 
amino acid substitutions per site. 
expression is induced in several pathological and stressful
conditions and LPS shows a time- and dose-dependent effect
on apoD expression in human cells that correlates with an
increase in proliferation [44]. At the pro oter level, NF-kB,
AP-1, and APRE-3 proved to be the elements implicated in
this LPS response. However, apart from the involvement of
apoD in lipid metabolism, its binding activity for progesterone
and arachidonic acid plays a role in cancer development and
neurological diseases. In agreement, insect lipocalins were
found to bind a variety of lipophilic molecules (endo-
genous and exogenous compounds) and to be involved in
e.g. cryptic coloration, olfaction, pheromone transport,
enzyme synthesis of prostaglandins, nerve cell guidance
(apoD homolog Lazarillo), or retinoic acid binding [45]. This
suggests that potential lipophilic hormones may be involved
in insect immunity by transcriptional regulation of important
genes by e.g. nuclear receptors.
3.6. Quantitative real-time RT-PCR analysis of
immune-induced genes in Tribolium
To confirm and precisely determine expression levels of
identified immune-induced genes we performed quantita-
tive real-time RT-PCR. We compared RNA from untreated
Tribolium beetles with RNA samples from animals that were
wounded with sterile saline or LPS, respectively. In addition,
we analyzed mRNA levels from mild heat-shocked beetles in
order to directly compare the induction levels of immune
and stress-responsive genes. We examined the expression of
two house-keeping genes, four potential antimicrobial
effector genes, and seven potential stress-responsive genes.
The latter ones include apoD, Hsp 68, Hsp 27, cytochrome
P450, and hypoxia-inducible gene 1 (HIG), and additionally
thor and hypoxia-inducible factor 1 a (HIF). Thor is a
member of the eIF4E-binding proteins (4E-BPs) and an
ARTICLE IN PRESS
Fig. 4 Three defensin genes exist in Tribolium. (A) The predicted mature defensin sequences from T. castaneum defensins
(Tribolium-Defensin1, XP_967194; Tribolium-Defensin2, XP_968237; Tribolium-Defensin3, XP_973575) were aligned to defensin
sequences from the hemipteran Triatoma brasiliensi (UniProt: Q4VSI0), the coleopteran Tenebrio molitor (UniProt: Q27023), the
hymenopterans Apis mellifera (Defensin, NP_001011638; Royalisin, NP_001011616) and Formica aquilonia (UniProt: Q5BU36), the
dipteran D. melanogaster (Defensin, UniProt: P36192; Drosomycin, NP_523901), the dragonfly Aeschna cyanea (UniProt: P80154),
the apterygote insect Ther obia domestica (EMBL-Bank: AM495104), the lepidopteran Galleria mellonella (AAM46728), the plant
Raphanus sativus (AAA69541), and the fungus Pseudoplectania nigrella (UniProt: Q53I06). (B) A Bayesian protein tree was
generated and we found that the three Tribolium defensins (indicated by gray shading) grouped tog th r with the insect-type
defensins, whereas the Aeschna defensin and Galleria gallerimycin grouped with the fungal defensin, and Drosophila drosomycin
with the plant defensin. These findings reveal the presence of three defensin subfamilies in insects. The scale bar epres nts the
substitutions per site.
B. Altincicek et al.592
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There is scope for interesting work on the evolution of resistance with 
particular respect to AMPs in T. molitor. Haine and colleagues (Haine et 
al., 2008a) found that inoculating T. molitor with a high dose of 
Staphylococcus aureus led to a low level of persistent infection for up to 
four weeks after initial infection (but see Appendix 2). Beetles 
coincidentally up-regulated humoral antimicrobial activity, measured as 
the bactericidal activity of crude haemolymph samples, which the 
authors proposed was likely mediated by AMPs. These data 
complemented earlier work that showed a long-lasting induction of 
antimicrobial activity after inoculation with a range of microbial elicitors 
(Haine et al., 2008b). Haine et al. (2008a) proposed that this 
phenomenon of long-lasting immunity serves to control persistent 
bacteria that have evolved resistance to constitutive defences, rather 
than as a prophylactic defence against reinfection from environmental 
bacteria. There is an argument that this distinction is unnecessary, 
because defending against a new infection from environmental bacteria 
or secondary infection from persistent cells living in vivo is 
fundamentally the same process, but that need not violate the notion 
that long-lasting immunity defends against the haemocoel being re-
invaded with bacteria. Chapter 3 shows results from an experiment on 
the dynamic interplay between T. molitor's long-lasting immune 
response and AMP-resistant S. aureus. Chapter 4 contains data that 
suggest an additional reason for hosts to invest in long-lasting induced 
humoral immune responses. 
 
1.6.4. Other responses to infection 
 
Specific mention has been made of the role in insects of haemocyte-
mediated defence, cytotoxic and oxidative resistance mechanisms, and 
antimicrobial peptides; because these are the best-understood and 
arguably most potent defence mechanisms, and moreover because they 
are most pertinent to the data presented in Chapters 2-5. It is worth 
noting that there is a great diversity of other parasite resistance 
mechanisms in insects. The ecology and evolution of the full diversity of 
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insect defence is reviewed by (Rolff and Siva-Jothy, 2003; Siva-Jothy et 
al., 2005), and thorough mechanistic accounts of the immunological 
transcriptomes of two coleopterans are provided by (Altincicek et al., 
2008a; Vogel et al., 2011a) 
 
1.7. The evolution of bacterial resistance 
 
Microparasites derive many benefits from living in a host, such as the 
provision of effectively infinite resources, and a stable physiological 
environment. To be able to colonise hosts, would-be parasites must 
have means to avoid being killed by the immune system. This section 
will discuss the mechanisms by which infectious bacteria resist being 
killed by immune effectors. In particular, I focus on AMPs and S. aureus, 
since they are the main components of the study system used in 
Chapters 2 & 3. A case is made that costs of resistance to the immune 
system can be studied in the same evolutionary ecology framework as 
costs of host resistance to parasites. Just as hosts can avoid or fight 
infection, so can bacteria directly resist and subvert host immunity, or 
evade and tolerate it. 
 
1.7.1. Bacterial resistance to (and tolerance of) host immunity 
 
Well-established theory stipulates that parasite damage to a host - 
referred to hereafter as "virulence" (as discussed by Alizon et al., 2009), 
or "pathology" to build cohesion with endogenous host damage 
(autopathology) - should only evolve if it enhances parasite fitness by 
increasing transmission rates (Anderson and May, 1982). Therefore, 
pathogen "virulence factors" might be more accurately termed "survival 
factors", although correlation between the molecular basis of traits that 
might be expected to confer virulence do not always correlate with 
disease (e.g. Tong et al., 2012). However a number of toxins secreted 
by pathogenic microorganisms are known to kill host cells responsible 
for antimicrobial immunity. A full review of secreted microbial toxins 
could be a thesis in itself, and a topical example is sufficiently 
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explanatory: Staphylococcal phenol-soluble modulins (PSMs) are small 
!-helical peptides secreted by inter- and intra-cellular infectious S. 
aureus, which attract and destroy mammalian neutrophils in a manner 
analogous to the action of AMPs on bacteria, thereby resisting a primary 
immune effector (Wang et al., 2007). However, PSMs also activate 
inflammatory responses, which may explain why their expression is 
tightly linked to bacterial cell densities by quorum-sensing, and therefore 
the probability of alerting the immune system to their presence (Wang et 
al., 2007). The " subclass of PSMs have also been shown to promote 
dissemination of cells from biofilms - protective agglomerations of cells 
bound in extracellular proteins, and a common microbial survival 
phenotype (Lewis, 2005) - thereby aiding colonisation of new regions of 
the host. Such secreted toxins are arguably the best-studied factors 
contributing to microbial survival in hosts, and since their expression is 
energetically costly and pleiotropic (Jarraud et al., 2002) their 
expression is associated with an inducible physiological cost of resisting 
the host. The loss of these exotoxins and their cell-bound counterparts 
from microbial genomes when they lose adaptive value is strongly 
suggestive of genetic evolutionary costs. For example, during host 
specialisation to horses, the pathogen Streptococcus equi equi has lost 
many of the exoproteins used by its ancestor S. equi zooepidermicus to 
infect a broader range of hosts (Kadioglu et al., 2008; Holden et al., 
2009),  
 
Other infectious phenotypes are subtler in their contribution to microbial 
fitness. The immune response can be avoided either passively or 
actively (Boman and Hultmark, 1987). Passive resistance tends to 
involve antigenic modification to avoid alerting the immune system of 
the microbe's presence. Spiroplasma poulsonii, for example, lacks cell 
walls and therefore does not present many of the antigens that would 
ordinarily stimulate an immune response (Hurst et al., 2003). Active 
resistance responses tend to be associated with more pathological 
infection. Biofilms have commonly been considered a stress response 
and a survival phenotype, although considering that the bountiful and 
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stress-free conditions found in laboratory culture tubes are fairly rare in 
nature, it seems more likely that bacteria are more commonly found in 
biofilm-like states in nature than as exponentially growing plankton. 
Biofilms are associated with elevated resistance to stressors including 
antibiotics and salinity (Lewis, 2001; 2005). They have been estimated 
to be responsible for 60% of human infections (National Institutes of 
Health, USA, in Lewis (2001)) and are commonly associated with 
chronic human infections after surgery or on prostheses and implants 
(Otto, 2008). Biofilms aid in resistance to the immune system by 
surrounding living cells from the host with an outer layer of dead cellular 
material and an excreted protein matrix (Costerton et al., 2003), which 
defends against phagocytes and soluble antimicrobial proteins and 
peptides (Foschiatti et al., 2009). Cells within biofilms are often in a 
physiological "persistence" state, where low metabolism allows 
individual cells to survive in stasis for a long time without dividing, 
immune to the effects of any stressor whose function is proportional to 
microbial growth rate (Balaban, 2004). Persisters seem to have evolved 
as specialised survival cells, but little is known about the conditions 
required to activate this phenotypic switch (Keren et al., 2004). The net 
result of biofilm formation is effectively a bacterial fortress in which 
besieged cells can long persist in the face of a potent immune response. 
As they isolate infection from the immune system, these processes are 
ecologically comparable to host tolerance of parasites.  
 
Bacterial resistance to AMPs is the main focus of Chapters 2 and 3, and 
is discussed further in these two Chapters. Bacterial resistance to AMPs 
has rarely been observed (Gillespie and et al., 1997; Hancock, 2000). 
However AMP resistance is not impossible (reviewed in Yeaman and 
Yount, 2003), and it can evolve in response to an individual peptide after 
only a few hundred generations under selection (Perron et al., 2006; 
Habets and Brockhurst, 2012). There are also data on some of the 
mechanisms of AMP resistance, discussed further in Chapter 2. The 
dichotomy between the evolutionary potential for AMP resistance and its 
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apparent rarity raises a perplexing question: why has AMP resistance 
not been commonly observed?  
 
It is conceivable that the mechanisms by which AMPs exert their 
bactericidal effect prevent resistance. AMPs exploit the inherent 
properties of prokaryotic cell membranes, and so some have proposed 
that evolutionary change to avoid this force would be highly costly 
(Zasloff, 2002), particularly when infectious cells are faced by multiple 
and various molecules exerting this stress on cells. The costs of 
evolution of such fundamental traits would render resistant mutants 
weak competitors in an infection, in a similar fashion to the costs of cell 
wall and membrane evolution to vancomycin-resistant mutants (Weigel, 
2003; Chambers and DeLeo, 2009). Others suggest that the 
deployment of multiple peptides accounts for the lack of natural 
resistance (Moon et al., 1994a; Lee et al., 1995; Rolff and Reynolds, 
2009), because simultaneously evolving resistance to diverse peptides 
which each disrupt fundamental cytostructure is unlikely. However, it is 
important to emphasise that observations of rare AMP resistance are 
based largely on in vitro studies, and certain bacteria may be resistant 
to AMPs from natural hosts in ways that would not be revealed by lab 
study.  
 
 
The multi-pronged assault exerted by a panel of AMPs may provide 
scope for further bactericidal benefits. (Bulet et al., 1999) suggest that 
multiple AMPs may interact synergistically. By way of analogy, models 
of antibiotic resistance evolution (Chait and Craney, 2007; Hegreness et 
al., 2008; Fischbach, 2011) suggest that the direction of functional 
interactions between antibiotics affect the resistance outcome. This 
prediction is borne out by data: of 119 isolates of drug resistant 
Burkholderia cepacia exposed to 10 to 15 antibiotics, 50% were 
resistant to individual antibiotic administration, 8% resisted two-drug 
combinations, but 0% could resist three-drug combinations (Aaron et al., 
2000). Complementarily, antagonistic epistatic effects have been shown 
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by experimental evolution of streptomycin resistance in a rifampicin-
resistant strain of Pseudomonas flourescens, in which the controls 
performed better than combination-selected lines (Ward et al., 2009). 
Considering that AMPs tend to act only on one class (e.g. gram-
positive) of parasite, Bulet et al’s (1999) hypothesis is an intriguing 
suggestion: the window of opportunity for resistance evolution is 
diminished if the sum of a system’s bactericidal action is greater than its 
parts. Alternatively, if a pair of AMPs act antagonistically, evolving 
resistance to one will remove the suppressive effect on the other and 
thus help to prevent resistance to the immune system (Chait and 
Craney, 2007). In either case, investigating bactericidal action of 
peptides in isolation and combination may help elucidate the 
circumstances under which AMP resistance evolves. This issue is 
addressed experimentally in Chapter 2. 
 
There is a potentially important applied biomedical angle to 
understanding the constraints on natural AMP resistance. The apparent 
stability of bacterial susceptibility to AMPs has generated strong interest 
in their potential as a novel class of therapeutic antibiotics or 
immunomodulatory drugs (Reddy et al., 2004; Wuerth and Hancock, 
2011). The basic premise of this proposal is that if AMP resistance has 
rarely been observed, then there must be strong intrinsic factors 
constraining natural AMP resistance, and so they can be co-opted as 
powerful "resistance proof' clinical antibiotics. However there are 
potential dangers to using AMPs clinically. AMP resistance may be rare, 
but their bactericidal action is just one component of complicated and 
finely-tuned immune responses, and their use out of this context could 
select resistant strains. As AMP protein motifs are conserved, 
resistance to one AMP could in principle select for broad cross-
resistance to many others, endowing resistant strains with defences 
against host immunity (Bell and Gouyon, 2003; Buckling and 
Brockhurst, 2005). Such cross-resistance has recently been shown in 
vitro, between S. aureus artificially selected for resistance to an AMP 
developed as a therapeutic antibiotic (pexiganan) and a human 
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cathelicidin (Habets and Brockhurst, 2012). Chapter 3 goes further, by 
testing the interaction between AMP-resistant cultures and immunity in a 
living host. 
 
1.7.2. Evolutionary responses to antibiotics as a model of 
resistance evolution 
 
Antibiotics are without a doubt one of the most important public health 
interventions in human history. Unfortunately, in just over seventy years 
since their introduction, their effectiveness has rapidly waned (Davies & 
Davies, 2010). A high-profile clinical problem of recent years is the 
increasing prevalence of antibiotic-resistant bacteria (Peterson and 
Dalhoff, 2004), and particularly ‘superbugs’ such as methicillin resistant 
Staphylococcus aureus (MRSA) (Enright et al., 2002). The emergence 
of antibiotic resistance surprised few evolutionary biologists (Margolis 
and Levin, 2008), since the rapid evolution of ubiquitous and easily 
transferred resistance genes is quite predictable in response to strong 
selection from solitary chemical stressors, on organisms with rapid 
generation times and capacity for horizontal gene transfer (Maisnier-
Patin and Andersson, 2004; Martinez, 2008).  
 
The rapid emergence of antibiotic resistance is arguably the largest 
experimental evolution experiment in history, albeit accidental and 
unfortunate. Nevertheless, it is an excellent model of the way that 
populations adapt to environmental chemical stresses, particularly when 
the populations are microbial and the stresses chemical. Consequently 
there is value in understanding how antibiotics have selected resistant 
bacteria, as a model of resistance evolution that can potentially be 
applied to host-microbe associations. 
 
The most commonly studied way for bacteria to evolve resistance is 
through the acquisition of resistance genes, since this causes most 
clinically significant resistant infections (e.g. Fricke et al., 2008). 
Resistance genes could in principle arise through spontaneous 
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mutation, but the molecular complexity of many antibiotics means that 
this is highly unlikely (Wright, 2007). A far more commonplace means of 
acquiring resistance is through horizontal transfer of resistance genes 
(Martinez, 2008). Genes for antibiotic resistance are more ancient than 
the divergence between gram-positive and gram-negative bacteria (Hall 
and Barlow, 2004), and the compounds they produce are too 
complicated to have arisen since the advent of clinical antibiotics 
(Wright, 2007). Furthermore, since resistance is frequently mediated by 
plasmid DNA (Kruse and Sørum, 1994), genes for resistance are easily 
horizontally transferred. 
 
In common with evolved responses to immune systems, microbial 
resistance to antibiotic stress can be active or passive. There are 
however numerous genetic and physiological costs (Levin et al., 2000), 
which typically manifest as compromised growth rate or greater 
sensitivity to environmental stress (Weigel, 2003; Chambers and DeLeo, 
2009).  However, these costs can be ameliorated by compensatory 
mutations, which are rapidly fixed in populations (Maisnier-Patin et al., 
2002; 2005). Antibiotic tolerance can also evolve, expressed as a 
microbe's non-heritable ability to survive under antibiotic stress, but 
remaining sensitive to it (Levin and Rozen, 2006). The theory and cost 
structure from ecological immunology (Schmid-Hempel, 2011) can once 
again be applied to this antibiotic-microbe model. Conversely, findings 
from studies concerned with antibiotic resistance can be hypothetically 
applied to the evolution of infection and immunity. For example, 
bacterial 'charity work' by a few mutants leading to population-wide 
antibiotic resistance (Lee et al., 2010) may be also occur in infectious 
bacteria. 
 
1.8. Summary and perspective 
 
The framework of evolutionary immunology is well defined, and although 
the picture of the evolutionary costs of parasite resistance is not 
complete, its broad strokes are fairly clear. Costs can manifest both in 
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the evolution and maintenance of parasite resistance in terms of the use 
and maintenance of traits, or genetically determined life history trade-
offs. This framework can also be explicitly and integratively applied to 
parasites in terms of the way they deal with host immunity. With specific 
reference to bacteria, there is abundant evidence that the cost 
framework determining how bacteria deal with stress from antibiotics 
and immune systems is the same as that which determines how 
immune systems resist parasites. Additionally, although the evolutionary 
drivers of tolerance are unknown and there is room for disagreement 
over its proper definition, this phenomenon is clearly common to both 
hosts and parasites: hosts tolerate parasites, and parasites tolerate host 
immunity. These parallels demonstrate the merit of applying the same 
evolutionary framework to both host and parasite as one intrinsically 
connected symbiotic unit, facilitating a richer and broader understanding 
of how they coevolve and selectively sculpt each other as part of their 
biotic environment. 
 
The remainder of this thesis aims to use this proposed integrative 
framework by examining the costs and benefits of resistance in a host-
microbe association, using the mealworm beetle Tenebrio molitor as a 
host, and the opportunistic pathogen Staphylococcus aureus as a 
parasite and pathogen. Chapter 2 describes an experiment to 
parameterise the genetic costs to S. aureus of evolving resistance to 
antimicrobial peptides. Chapter 3 follows 2 by using these resistant 
cultures as model parasites, to test whether genetic costs of resistance 
are traded against benefits of increased host persistence. There is a 
secondary but important applied biomedical angle to the experiments in 
Chapter 3, due to the potential for the pathogenic interactions it 
highlights should AMPs be developed as therapeutic drugs. The focus 
of the latter half of the thesis switches to T. molitor resistance to S. 
aureus. Chapter 4 is concerned with how costs of antimicrobial 
resistance, particularly autopathological immunity, could modify an 
individual's optimal immune strategy over time after infection. This is 
achieved through an experiment that attempts to measure the costs of 
! 39 
immunopathology relative to the costs of infection. Based on Chapter 4, 
Chapter 5 focuses on the transcriptomics of T. molitor's resistance to S. 
aureus, to qualitatively assess the mechanisms used to fight the 
infection and how immunopathological they might be. These studies 
demonstrate reciprocal and parallel processes operating in host-microbe 
resistance and microbe-immunity resistance. The general discussion 
discusses the common conceptual threads in each Chapter, and what 
they likely mean for the coevolution of host-microbe interactions, be they 
resistant, tolerant, or mutualistic.  
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Chapter Two 
 
Comparative experimental evolution 
of antimicrobial peptide resistance in 
Staphylococcus aureus 
 
 
 
 
 
 
 
 
 
  
! 41 
2.1. Abstract 
 
Antimicrobial peptide (AMP) resistance has been demonstrated in 
experimental studies, but has rarely been observed in environmental 
bacterial isolates. By contrast, antibiotic resistance is extremely 
common in environmental bacteria. Since the selection imposed by 
antibiotics and AMPs is thought to be the same, why is there this 
disparity in resistance? I propose that it could be driven by different 
costs associated with AMP and antibiotic resistance, by the multiplicity 
and diversity of AMPs in immune responses, or by weak selection in the 
wild. This study uses an experimental evolution experiment to select for 
resistance to antibiotics and to preparations of single and combined 
AMPs, allowing comparison of the associated fitness costs in a fully 
controlled framework. The results of this experiment suggest that costs 
of resistance to single AMPs are in the same range of the costs of 
antibiotic resistance. The evolutionary response to selection from a 
combination of AMPs was weaker, which suggests that natural patterns 
of AMP resistance are constrained by the multiplicity of AMPs that hosts 
transcribe to fight infection. 
 
2.2. Introduction 
 
2.2.1. The AMP resistance paradox 
 
Antimicrobial peptide (AMP) resistance has rarely been observed in 
environmental isolates of bacteria (Hancock, 2000; Loose et al., 2006). 
However, resistance to these molecules is possible (Yeaman and 
Yount, 2003). AMPs are ancient, occur in phyla spanning prokaryotes 
through to humans, and are commonly produced by infected hosts as 
part of an immune response (Zasloff, 2002; Reddy et al., 2004; Pränting 
et al., 2008). As such, AMPs are ancient and commonplace stressors of 
parasitic microorganisms. The rarity of AMP resistance contrasts starkly 
to the rapid and widespread evolution of resistance to antibiotics that 
has taken place over the last century. Ice-core data suggest that in 
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addition to being highly evolvable, antibiotic resistance is at least tens of 
thousands of years old (Miteva et al., 2004; D’Costa et al., 2011), in 
accordance with the observation that bacteria have been historically 
exposed to compounds that are now used as antibiotics, which are 
naturally produced by environmental microbes (Martinez, 2008). 
Analogously, the observation of AMPs in all taxonomic kingdoms 
suggests that microbes have been selected by these compounds for 
millennia, and bacteria exhibit similar phenotypes when stressed by 
AMPs and antibiotics (Zasloff, 2002; Bulet et al., 2004). So, the rarity of 
natural AMP resistance is a puzzling evolutionary paradox: why have 
bacteria, notorious for their speed and flexibility in evolving responses to 
environmental stresses, not commonly evolved AMP resistance?  
 
This paradox is a fascinating problem for immunologists (and drug 
designers, as discussed in Chapter 3), since it may reveal how the 
immune system limits the in vitro emergence of resistant bacteria (Haine 
et al., 2008a). The most common initial hypothesis was that bacteria 
simply cannot evolve AMP resistance, because of the way that AMPs 
disrupt prokaryote cell membranes: it was thought that evolving 
resistance would involve enormous fundamental change to cell 
structure, and that these changes would be great enough to render 
resistant cells unviable (Zasloff, 2002). This idea has since been 
debunked by experimental evolution of AMP resistance (Perron et al., 
2006). AMP resistance has been selected in numerous subsequent 
studies (Pränting et al., 2008; Sun et al., 2009; Pränting and Andersson, 
2010; Habets and Brockhurst, 2012), and its mechanisms are beginning 
to become clear based on some few resistant environmental isolates 
(see Peschel and Sahl, 2006 for review). It is now known that AMP 
resistance can be mediated by four basic mechanisms (Fig 2.1.1). 
Additional to these physiological resistance mechanisms, there is 
evidence that pathogenic gram-negative bacteria can actively down-
regulate host AMP expression (reviewed in Gruenheid and Le Moual, 
2012).  
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Figure 2.1.1. Mechanisms of bacterial resistance to antimicrobial 
peptides (AMPs) (from Peschel and Sahl, 2006) 
AMP resistance can be mediated by a) extracellular cleavage of the 
AMP, b) inactivation of the AMP by binding it to another compound, c) 
active extrusion of AMPs by membrane-bound pumps after the AMP 
breaches the cell membrane, d) reducing the net anionic charge of the 
membrane to reduce its attractiveness to cationically-charged AMPs. 
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Hepcidin-related CAMP
A vertebrate peptide with 
antimicrobial and iron-
metabolism-regulating 
hormone-like activities.
Cryptdin
An α-defensin produced by 
Paneth cells in the small 
intestine of mice.
CAMP-like structures and activities, contain lanthio-
nine amino acids with intra molecular thioether bridges 
that are even more stable than disulphide bridges47,48.
However, despite the virtues of disulphide bridges and 
the structural stabilization they afford, linear CAMPs 
have not disappeared during the course of evolution 
and it can therefore be assumed that certain activities of 
CAMPs, such as the interaction with dedicated receptors, 
might have favoured the development of more flexible 
peptides such as LL-37.
In addition to disulphide bridges, the introduction 
of proline residues and the amidation of the protease-
 susceptible C termini might render CAMPs more pro-
tease resistant. The concomitant production of CAMPs 
and protease inhibitory proteins, such as secretory 
leukocyte proteinase inhibitor (SLPI) and elafin, could 
represent another intriguing host strategy to circumvent 
microbial proteolysis of CAMPs49, although it has not yet 
been demonstrated that these molecules have the capac-
ity to inhibit microbial proteases. Interestingly both SLPI 
and elafin also have antimicrobial activity.
Eluding bacterial CAMP-specific resistance
As proteases have limited activity against defensins 
and other CAMPs, several bacterial pathogens have 
evolved additional strategies to interfere with the activ-
ity of these molecules. Many of these mechanisms are 
specific for certain peptides, relying on recognition and 
extracellular capturing or active extrusion of CAMPs 
from the bacterial membrane. S. aureus produces the 
exoprotein staphylokinase, which, in addition to its 
fibrinolytic activity, can bind and inactivate α-defensins 
from human neutrophils50. Staphylokinase contributes 
to resistance to defensin-mediated bacterial killing and 
also to virulence in experimental infections. S. pyogenes 
produces two secreted proteins streptococcal inhibitors 
of complement (SIC)51 and the cell-wall-anchored M1 
protein22 that bind LL-37 and other CAMPs with high 
affinity and therefore prevent them from accessing the 
bacterial cytoplasmic membrane. In addition, CAMPs, 
including protegrins and LL-37 are substrates for the 
MtrCDE multiple drug resistance exporter of Neisseria 
gonorrhoeae52 and Neisseria meningitidis53.
Although the structural requirements for most 
of these CAMP-capturing or CAMP-extruding mol-
ecules have not yet been elucidated in detail, it is clear 
that they depend on the direct recognition of certain 
CAMP sequences or structural motifs. As such, minor 
alterations in CAMP sequence would compromise the 
ability of these molecules to recognize their cognate 
antimicrobial peptides. Accordingly, the SIC proteins of 
S. pyogenes mediate resistance to the human β-defensins, 
human β-defensin 2 (hBD2) and human β-defensin 3 
(hBD3), but not to human β-defensin 1 (hBD1)54. The 
MtrCDE drug exporter expels protegrin 1 but tachy-
plesin 1, which is quite similar to the protegrins, and 
neutrophil defensins are not substrates for MtrCDE52. 
Notably, only a small number of amino-acid positions 
in most CAMP sequences are essential for antimicrobial 
activity — many other residues can be exchanged without 
loss of function. Many vertebrate species produce large 
collections of related CAMPs with small sequence altera-
tions, probably arising from repeated gene duplication 
and mutation events. The presence of five different genes 
for hepcidin-related CAMPs in the flounder 55 versus only 
one gene in humans56, and the presence of 26 Paneth 
cell α-defensins (cryptdins) in mice versus only two in 
humans57,58, represents typical examples of the expansion 
of a particular CAMP. The human genome encodes at 
least 10 β-defensin genes; however, only some of these 
have been characterized in detail7,8,58, and the actual 
number of β-defensin genes remains unknown59. The 23 
genes encoding different murine CRS peptides, the gene 
products of which can form a large set of different hetero-
dimers, are another example of a host-derived ‘broad-
spectrum antimicrobial combination therapy’ for limiting 
infections45. Various CRS heterodimers have been shown 
to have different activity spectra against microorganisms, 
underscoring the value of having diverse collections of 
CAMP variants for defence purposes. It can be assumed 
that the simultaneous presence of many antimicrobial 
peptide variants makes it considerably more difficult for 
microorganisms to develop CAMP resistance.
Figure 2 | Bacterial cationic antimicrobial pep ide 
(CAMP)-re istance mechanisms. a | CAMPs with a 
simple linear or α-helical structure such as LL-37 are 
susceptible to proteolysis and are targeted by several 
microbial proteases. b | CAMPs can be prevented from 
reaching the bacterial cell membrane by bacterial secreted 
proteins, for example Streptococcus pyogenes 
streptococcal inhibitors of complement (SIC) proteins, and 
Staphylococcus aureus staphylokinase. c | Some CAMPs can 
be actively extruded from bacterial cells, for example by 
the MtrCDE multiple drug resistance exporter in Neisseria 
gonorrhoeae and Neisseria meningitidis. d | Some bacteria 
can also reduce the net anionic charge of the bacterial cell 
envelope, reducing its affinity for CAMPs.
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As the question of whether or not AMP resistance can evolve has been 
affirmatively answered several times, its rarity becomes more puzzling. 
Understanding what governs natural patterns of AMP resistance could 
reveal whether innate immune systems have means to subvert microbial 
evolution. The notion of a high intrinsic cost of AMP resistance has been 
frequently proposed (e.g. Hancock, 2001; Bulet et al., 2004), although it 
is not supported by extrapolation from experimental evidence (Habets 
and Brockhurst, 2012). Using a simple mathematical model, Bell and 
Gouyon (2003) demonstrate that the probability of resistance to a 
heterogeneously-distributed environmental stressor is determined by the 
frequency of exposure to the stressor, and the associated costs of 
resistance. This argument is predicated on costs of resistance, 
environmental heterogeneity, and the assumption that the compound or 
process in question stresses the initially susceptible population. This 
model is supported by recent surveys, which have shown that antibiotic-
resistant clinical isolates tend to bear few costs of resistance, 
suggesting that only the most competitive strains survive, and so costs 
of resistance are a truly limiting factor in microbial resistance evolution 
(Ward et al., 2009). To properly address why AMP resistance is rare, 
the validity of these arguments with specific reference to AMPs needs to 
be evaluated. Thorough consideration of Bell & Gouyon’s model 
generates a number of explanations other than the ‘high cost’ argument, 
which can be categorised as consequences of the multiplicity of immune 
defences, or as issues associated with the strength of selection for AMP 
resistance. These hypotheses are discussed in detail below. 
 
2.2.2. Multiple effectors and the probability of resistance evolution 
 
Animals transcribe a broad panel of AMPs after subcutaneous infection 
(reviewed in Bulet et al., 2004). This is a nonsensical strategy if one 
alone is sufficient. The deployment of multiple, varied and interacting 
immune effectors may limit the opportunity for bacteria to adapt against 
them: the probability of evolving resistance to a suite of stressors with 
different mechanisms should be inversely proportional to the number of 
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stressors. These effects could be exaggerated if the stressors interact 
functionally, or if their distributions vary spatially or temporally. Such 
effects have been modeled and to an extent empirically demonstrated 
for antibiotic regimes, (Yeh et al., 2006; Hegreness et al., 2008; Michel 
et al., 2008; Torella et al., 2010; Fischbach, 2011), the principles of 
which can be easily applied to immunological processes. Antagonistic 
epistasis between resistance loci has been shown in multidrug-resistant 
Pseudomonas aeruginosa (Ward et al., 2009). These studies all point 
towards a difficult evolutionary balancing act for infectious microbes 
faced with a diverse panel of immune effectors: bear the cost of 
susceptibility, or evolve resistance at the cost of weaker 
competitiveness?  
 
2.2.3. How strong is selection for AMP resistance in nature? 
 
An even more parsimonious explanation for the scarcity of AMP 
resistance is that natural selection for it is actually quite weak. This 
argument is predicated on the proposition that our understanding of the 
immunological functions of AMPs is incomplete, for which three cases 
are made below. The arguments are that microbial strategies other than 
resistance are likely to be more efficient; that relatively few bacteria are 
exposed to immunological AMPs; and that AMPs may not be 
bactericidal in vivo. 
 
2.2.3.1 – The virtues of and evidence for alternative strategies to 
AMP resistance 
 
Strategies other than resistance may be more straightforward solutions 
for microbes under stress from AMPs: tolerance may be less costly than 
resistance. In principle, phenotypically plastic responses are a more 
elegant way to deal with stress than evolved resistance, assuming that 
the trade-offs involved in evolved resistance are greater than the costs 
of plastic tolerance of the stressor. For example, biofilms are a common 
phenotype of stressed bacteria. Bacteria in biofilms are better able to 
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survive antibiotics, hypersalinity and unpredictable temperature than 
planktonic cells are (reviewed by Lewis, 2001; 2005). Biofilms have also 
been shown to improve the ability of constituent cells to survive AMPs 
(Otto, 2008; Foschiatti et al., 2009; Wang et al., 2011). It is even 
conceivable that the physical structure of a biofilm is not required to 
mediate these tolerance effects, and that they are mediated by the 
physiology of the cells that form them (Balaban, 2004). For example, 
small colony variants (SCVs), which are commonly associated with 
bacteria derived from biofilms or anoxic tissue, are more tolerant of AMP 
stress (Kahl et al., 1998; Sadowska et al., 2002; Besier et al., 2007). 
Bacteria can sense AMPs (Li et al., 2007), which may have evolved to 
modulate induction of tolerant phenotypes. If the physiologies 
associated with such phenotypes are commonly switched on in 
response to AMP stress, then bacteria have in-built mechanisms that 
minimise their stress and therefore mitigate effects of selection from 
AMPs. 
 
2.2.3.2. The strength of selection from constitutive and induced 
defences 
 
AMPs are often constitutively expressed in dermal tissues as a 
prophylactic defence against infection, e.g. defensins in mammal skin 
(Kulkarni et al., 2011). AMPs are not usually constitutively expressed in 
internal body tissues, but rather transcribed after infection is detected or 
dermal tissues are breached (Bulet et al., 2004; Zasloff, 2009). 
Consequently, infectious bacteria are exposed to constitutive defences 
before AMPs, which diminish the size of the viable population of 
infectious cells before it is exposed to AMPs. Therefore, there is a 
reduced probability of the presence of mutant alleles that could aid AMP 
resistance. For example, in invertebrates, inoculated bacteria are 
exposed to oxidative enzymes, phagocytes and numerous other lethal 
immune effectors for up to several hours before AMPs are detectable 
(Haine et al., 2008a). If AMPs merely prevent secondary infection by the 
few persistent cells that remain after constitutive defences have done 
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their work, only a small subset of the initial inoculum will be exposed to 
them.  
 
2.2.3.3. Do AMPs have a clear role in immunity? 
 
Our understanding of AMPs’ bactericidal functions is based on in vitro 
tests. If these in vitro functions are not mirrored in vivo, then the rarity of 
AMP resistance could be explained as a consequence of this 
misunderstanding, and AMPs may not in fact select for resistance at all. 
The essence of what we believe to be the role of AMPs is based on the 
observation that they interact with prokaryote cell membranes, and kill 
these cells above a certain concentration. However this does not 
necessarily mean that AMPs are killers of infection in vivo, since 
interactions with membranes are crucial in a broad range of molecular 
and cellular processes other than killing. Concentration-dependent in 
vitro lethality of AMPs may be a secondary consequence of the 
interaction with cell membranes and physiologically unrealistic AMP 
titers in in vitro assays. Inference about the functions of AMPs based on 
immunodeficient subjects (e.g. Drosophila (Tzou et al., 2002); and 
human children (Gruenheid and Le Moual, 2012)) should be made 
cautiously, because results are confounded by compromised function of 
other immunological systems. 
 
There is some reason to suspect that the in vivo role of AMPs is not 
entirely properly understood, or at least that they serve dual functions. 
They are known to have roles in intercellular signaling in metazoans, for 
instance in iron regulation and responses to inflammatory compounds in 
humans (Collins et al., 2008; Amatngalim et al., 2010). The 
immunomodulatory effects of AMPs have been extensively reviewed by 
Hancock and colleagues (Easton et al., 2009; Yeung et al., 2011). 
Immunomodulation by AMPs may be a conserved feature, and “AMPs” 
produced by microbes may serve similar functions in microbial 
communication, in common with other compounds of microbial origin 
that are now used as antibiotics (Martinez, 2008). It is even possible that 
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such small peptides are involved in communication with hosts, as 
recently demonstrated in Pseudomonas (Jarosz et al., 2011). 
Accordingly, correlational studies show that human deficiency in AMP 
production is associated with a diminished ability to manage gut 
microbiota (Gruenheid and Le Moual, 2012). Since AMPs have putative 
roles in metabolic regulation as well as in membrane poration (Brogden, 
2005), a role in intercellular communication is easily conceivable.  
 
There is recent exciting evidence suggesting a real role of AMPs in 
communication on an important ecological level. Sitophilus weevils are 
dependent on just one AMP to manage a bacterial symbiosis (Login et 
al., 2011). In plants, Sinorhizobium-Medicago symbiosis is dependent 
on just one bacterial gene to allow the bacteria to resist the defensins 
that the plant uses to protect against other infections, and thereby 
inhabit the host’s roots (Haag et al., 2011). These results suggest that, 
rather than just being broad-spectrum antimicrobials, AMPs can also be 
exquisitely specific tools to manage interspecific associations. If these 
are general phenomena and occur in other organisms, then the lack of 
expected resistance to AMPs could be explained by a misunderstanding 
of their true function, and selection for AMP resistance is weak. 
 
2.2.4. Role of the present study 
 
The remainder of this chapter details an experiment designed to test two 
of the hypotheses detailed above through a comparative experimental 
evolution experiment. Bacteria derived from one original S. aureus clone 
are selected in parallel by a range of AMPs and antibiotics, and the 
response to selection is compared, to see if AMP resistance is more 
costly to bacteria than antibiotic resistance. One treatment group is 
selected by a 50:50 combination of two of the other AMPs, testing 
whether the combination is greater than the sum of its parts in terms of 
slowing resistance evolution. This allows parameterization and 
comparison of the fitness of these selected cultures. Since the 
frequency of exposure and intensity of stress was controlled, the 
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emergence of resistance is determined by cost or functional 
interactions.  
 
 
2.3. Materials and methods 
  
2.3.1 Bacteria and stressor selection 
 
All bacteria were derived from one ancestral colony of S. aureus (JLA 
513, SH1000 background; sourced from Simon Foster, University of 
Sheffield). This strain is tetracycline resistant, controlled by a 
chromosomal intergenic resistance cassette. This cassette does not 
affect transcription of surrounding genes or growth in nonselective 
medium (G. McVicker, Pers. Comm; Shaw et al., 2006) This label is 
useful in subsequent animal infection experiments (Chapter 3), and 
allowed a “belt-and-braces” approach to controlling contamination. 
 
Five antimicrobial stressors were chosen as selective agents. 
Streptomycin sulphate (Sigma-Aldrich S9137-25G) is an antibiotic in 
clinical usage, with a history of use stretching back to the 1940s (D'Arcy 
Hart, 1999). In nature it is produced by Streptomyces griseus – a 
widespread soil bacteria – so S. aureus is likely to have a history of low-
level association with streptomycin. In contrast, Vancomycin (Sigma-
Aldrich V1130-1G) is an antibiotic which has only been in widespread 
since the 1980s, and environmental isolates of vancomycin-resistant S. 
aureus are less (albeit increasingly) common than streptomycin-
resistant isolates (Weigel, 2003). Streptomycin and vancomycin were 
respectively used as ‘soft selection’ and ‘hard selection’ treatment 
controls.  
 
Pexiganan was included as a stressor because it is the only AMP 
currently commercially available as an antibiotic. Several grams of 
pexiganan acetate were generously supplied by Michael Zasloff 
(Georgetown University, USA). The synthetic AMPs melittin and 
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iseganan were also used as stressors. Melittin was purchased from a 
commercial supplier (Sigma-Aldrich M2272), and expressed iseganan 
(expression protocol and data unpublished) was generously supplied by 
Wojciech Kamysz (University of Gdansk, Poland). Pexiganan and 
melittin were additionally combined in a 1:1 ratio, constituting a fourth 
treatment (“pgml”) to test the effect of combinations of AMPs on 
bacterial evolution.  
 
2.3.2. Pre-selection MIC50 determination 
 
The concentration of each stressor sufficient to inhibit 50% population 
growth was determined by a protocol based on that of (Perron et al., 
2006), who modified the United States’ National Committee for Clinical 
Laboratory Standards broth macrodilution susceptibility assay 
guidelines. A single colony from the tetracycline-resistant SH1000 S. 
aureus clone JLA 513 (source: S. Foster, University of Sheffield) was 
inoculated into 5ml Müller-Hinton broth containing tetracycline at 5 #g 
ml-1 and amphotericin-B at 5.6 #g ml-1 [these conditions will henceforth 
be referred to as ‘standard growth medium’], and grown for 48 hours at 
30oC in a shaking incubator at 120rpm. A sub-culture was then started 
by inoculating 500#l of this culture into 4.5ml of fresh medium and 
grown to exponential phase. 
 
A concentration gradient of each antimicrobial stressor ranging from 64 
#g ml-1 to 0.125 #g ml-1 in standard growth medium was constructed by 
two-fold serial dilution in 96-well microtitre plates in 100#l solution per 
well, with an additional series of unsupplemented controls on each 
plate. 10#l of the previously sub-cultured bacteria was added to each 
well, giving an OD595 of 0.046. Optical density at 595nm (OD595) was 
measured immediately after inoculation and again once every hour for 
up to seven hours.  
 
Maximal growth rates (#) data from these data were used to estimate 
the concentration of each stressor causing 50% inhibition of maximum 
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growth (MIC50) with the R package Grofit. The intensity of selection 
imposed by each stressor was therefore standardised. 
 
2.3.3. Selection protocol. 
 
Selection protocols were based on those of Perron et al. (2006), in 
which opportunities for growth and evolution are standardized between 
treatments, whilst providing time for evolution of varied trajectories. 
 
Before selection began, a single colony of S. aureus JLA 513 was 
inoculated into standard growth medium, and grown for 24 hours at 
30oC in a shaking incubator at 120rpm. 50#l of this culture was then 
sub-cultured into 5ml standard growth medium and cultured under the 
same conditions. This process was repeated daily for 10 days to allow 
random mutation and accumulation of genetic diversity.  
 
The ten-day serial culture was used to establish parallel selection lines 
that were exposed to each microbial stressor, and unselected controls. 
5#l samples (c. 2.8 x 107 colony forming units) of this bacterial culture 
were inoculated into 500#l preparations of standard growth medium, 
containing stressors at the estimated MIC50 for each respective 
treatment. Five parallel replicate cultures were established in each 
treatment. Unselected control cultures which were grown in 500#l 
standard growth medium. A further five dummy cultures containing 
500#l standard growth medium were supplemented with 5#l sterile 
water as a sterility control. Once the sub-cultured selection lines were 
established, the parental culture was frozen at -90 oC in a 1:1 ratio with 
sterile glycerol, for future revival and comparison (Chapter 3), in which it 
is referred to as the Ancestor strain. 
 
These cultures were grown for 24h in a shaking incubator at 30 oC, 
before 5#l was inoculated into a fresh 500#l of growth medium identical 
to the previous day for each respective treatment, i.e. standard growth 
medium plus stressor. Optical densities at 595nm (OD595) of 100#l of the 
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24-hour cultures were determined in a 96-well plate reader (Molecular 
Devices Versamax). Co-ordinates for each culture on the plate were 
randomised daily. This procedure was repeated daily for 28 days. On 
days 7, 14 and 21 the concentration of antimicrobial compound in each 
respective treatment was doubled, in accordance with the protocol 
developed by Perron et al (2006). Consequently each stressor was 
suspended at its MIC50 during week 1, 2xMIC50 (week two), 4x MIC50 
(week three), and 8x MIC50 (week four). Each 24-hour culture was 
frozen daily at -90 oC in 50% sterile glycerol.  
 
Contamination was checked for bi-daily by either serial dilution of each 
culture in PBS and plating with beads, or by spreading a sample onto a 
plate with a sterile inoculation loop. In either case samples were plated 
LB containing 1.5% agar. Any colonies displaying abnormal colour or 
morphology were checked on Mannitol Salt Phenol Red Agar. These 
protocols revealed no contamination through the course of the 
experiment. 
 
An incubator error meant that all lines, including unselected controls, 
dwindled between day 14 and day 21 at the first attempt. To revive the 
cultures from day 14, 10#l of an aliquot of a day 13 glycerol stock was 
sub-cultured into day 7-14 growth media, respective to each treatment. 
After 24h, these cultures were pelleted and re-suspended in standard 
growth medium to within 0.02 of the 24h OD of the original day 14 
cultures. 5#l of each of these re-suspended cultures was then sub-
cultured into day 15 stressor conditions and the selection protocol 
resumed as per normal. The data presented from day 15 onwards are 
from these restarted cultures. 
 
2.3.4. Dose-response assays 
 
The multiple levels of replication in this assay necessitate clear 
definitions of the working terms. The five biological replicate cultures in 
each treatment are referred to as populations, since after time growing 
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in serial passage they are unlikely to be monoclonal. Growth was 
assayed across 11 different concentrations (two-fold dilutions of 64-
0.125#g ml-1 plus unsupplemented medium at the end of weeks one and 
two, and the same with an additional 128 #g ml-1 level in weeks three 
and 4) of their respective selective stressor, each of which is referred to 
as a test concentration. Each population/test concentration combination 
was technically replicated three times.  
 
These assays were conducted in 96-well microtitre plates, in common 
with the initial MIC50 determination assay. 50#l of all surviving 
populations were sub-cultured into 5ml unsupplemented standard 
growth medium at the end of days 7, 14, 21 and 28. Standard (i.e. rather 
than selective) growth medium was used for these sub-cultures to relax 
selection and provide opportunity for expression of plastic phenotypic 
mechanisms of resistance to be down-regulated prior to the assay, 
increasing confidence in the assay’s detection of heritable traits. These 
cultures were incubated at 30oC, shaking at 120 rpm, until late 
exponential phase.  
 
10#l of each 18-hour culture was added to its full range of technically 
replicated test concentrations. OD595 was determined every hour for six 
hours as per the initial MIC50 assay. 
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Figure 2.3.3. Schematic of the protocol for resistance selection and 
dose-response assay.  
The original culture was grown by serial passage (10 days) to generate 
the ancestor. The ancestor was split between 7 treatments, containing 5 
replicate populations. These cultures were serially cultured in their 
respective stressors, starting at MIC50. Stressor concentration was 
doubled weekly. Dose-response assays were performed weekly (3 
replicate plates per treatment). On each plate, each population was 
exposed to a two-fold 128 – 0.125 #g ml-1 dilution series of its stressor. 
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2.3.5. Data analysis 
 
Data were exported from Softmax Pro as text files and manually 
assembled into data frames in Microsoft Excel for Mac (version 14.1.4). 
All analyses were conducted in R (version 2.14.1). 
 
2.3.5.1. r0 calculation 
 
Instantaneous intrinsic growth rates of each culture (i.e. three technical 
replicates/12 test concentrations/ 5 biological replicates/treatment/week) 
were calculated by logging the input OD data to calculate r0!, where ! 
represents an unknown constant, according to the logic detailed in box 
2.3.5.1 (see Appendix 1 for further information): 
 
  Box 2.3.5.1: calculating instantaneous r0!!"#!$!%!&'!()*!+!%!,-./0!,1/)!/(21!3456,1!2748/!2()!9/!:7..(4-:/*!(:;!! !"!" ! !"!! !!!! !!"!"! ! !"!
! !"#$%!" ! !!!! !!"!"! ! !"!!+5!/<,/)*!,1-:!,5!,1/!*(,(!-)!,1/!=4/:/),!:,7*>0!-)2?7*-)3! !(:!()!7)@)56)!25):,(),;!! !" ! !!!! !"#!!" ! !!!"#$!!! !"#!"! ! !!!!! !!"!"! ! !!"! !!
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Slight variation in the starting ODs of cultures entering the dose-
response assay and the technical impracticality of controlling the growth 
dynamics of up to 40 independent serial cultures meant that parametric 
models fitted to r0! data would likely have varied r2 values. Therefore, 
the R library Grofit (Kahm et al., 2010) was used to fit smoothed splines 
to logged OD data in a similar analysis to that described in 2.3.2. Grofit 
fits splines by implementing the R function smooth.spline(), for which the 
user determines smoothing values. 0%, 25%, 50%, 75% and 100% 
smoothing of these splines was tested on the week 1 dataset, which 
revealed that 50% spline smoothing provided fits to the data that were 
smoothed but still sensitive to departures from linearity. Each growth 
curve was bootstrapped 100 times using Grofit’s inbuilt bootstrapping 
features to increase the confidence of these spline fits. 
 
As input OD595 values ranged between 0 and 1, calculated r0! values 
(log OD595) were negative. Grofit requires positive input data, so splines 
were fitted to logOD+10: this process increased all y-intercepts to >0 but 
maintained slopes.  
 
Grofit’s implementation of the smooth.spline() R function fits splines 
determined as a sequence of cubic polynomials. The Grofit library takes 
the first derivative of this sequence and determines its maximum (M. 
Kahm, Pers. Comm.). This equals the maximum slope during the 6-hour 
assay, during which each culture should reach exponential phase. 
Consequently the outputs from the Grofit analysis were the max 
instantaneous r0! x three technical replicates x 12 test concentrations x 
five biological replicates x five treatments x four weeks (see Figure 
2.3.3). These values were plotted with smooth geometric fits to each 
biological replicate by their respective test concentration, per treatment, 
per week, using the R library ggplot2 (Wickham, 2009). 0 #g ml-1 cannot 
be presented on the log scale used in this figure and so are presented 
separately in Figure 2.4.2. 
 
! 57 
These analyses produced dose-response curves by treatment and 
week, showing the range of stressor concentrations in which each 
selection line is growing well or badly. This allows an assessment of the 
trade-offs that each treatment group was subject to as the intensity of 
selection increased over the course of their evolution, for example an 
improvement of growth at high concentrations of stressor associated 
with deteriorating growth rate at low concentrations.  
 
Absolute minimum inhibitory concentrations (MIC) provide a measure of 
a population's absolute resistance to a stressor. These values were 
calculated conservatively. There was some error in the assay, evidenced 
by negative growth values in certain treatments. To account for this 
error, the maximum negative growth value over the entire course of the 
4-week experiment (-0.07) was taken as an estimate of the maximum 
potential error. On this basis growth values in the range 0 - 0.07 can be 
explained as error: any cultures showing growth rates <0.07 were 
therefore counted as inhibited. The lowest concentration of stressor from 
the inhibited subset was taken as the MIC. In some treatments inhibition 
was not observed in the range of stressor concentrations used in the 
assay, i.e. the MIC was greater than assayed for - such results are 
reported accordingly. This procedure was applied to each population, 
per week (including week 0). The statistical modes of MIC values were 
calculated per treatment per week. Fold-change of modal MIC over 
week 0 MIC was then calculated. 
 
Change in the concentration of stressor in which a population shows 
maximum growth (maxG) provides a measure of the population's 
adaptation to that environment. As for MIC, these values were calculated 
for each population per week, followed by fold-change of the statistical 
mode relative to week 0. 
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2.3.4.2. Uninhibited growth analyses 
 
A linear model was fitted to r0! values (means of technical replicates) of 
selected cultures growing in unsupplemented standard growth media in 
the dose-response assay. Week 0 data were excluded from this analysis 
because all cultures grew by serial passage in uninhibited S.G.M. 
between days -10 and 0, increases in growth rate between week 0 and 
week 1 are largely systemic and independent of treatment. Cultures 
showing r0! values <0.005 were excluded as noise from dead cultures 
generated by inaccuracies in initial OD595 measurement. A linear model 
with an interaction between week and treatment provided the best fit to 
the data (R2 = 0.82) 
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2.4. Results 
 
2.4.1. Initial MIC50  
 
Pre-selection MIC50 estimates and the maximum stressor 
concentrations in which strains survived are presented in Table 2.4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.4.1. Estimates of antimicrobial concentration inhibiting 
50% growth of the target population (MIC50) 
Stressor MIC50 before 
selection (#g ml-1) 
Maximum tolerated 
stressor concentration 
(#g ml-1) 
Iseganan 3 24 
Melittin 1 8 
Pexiganan 6 18** 
PGML 5 10* 
Streptomycin 3 24 
Vancomycin 1 2* 
*Extinct at week 3; **Functionally extinct at week 3. 
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The data in Table 2.4.1 show that iseganan-, melittin- and streptomycin-
selected S. aureus survived in up to 800% MIC50. PGML- and 
vancomycin-selected cultures grew up to 200% MIC50, and pexiganan-
selected cultures maintained functional populations up to 400% MIC50 
(see 2.4.4. for more discussion of Pexiganan-selected cultures) 
 
2.4.2. Evolution of dose-response curves 
 
Dose-response curves evolved in a strongly treatment-dependent 
fashion, indicating that selection from different stressors acted on 
different traits (Fig. 2.4.1). Table 2.4.2 summarises minimum inhibitory 
concentration (MIC) and concentration in which maximum growth was 
observed (maxG), extrapolated from the dose-response data.  
 
There was some consistency within some treatments over the 
progression of the experiment but not between them, and changes in y-
intercepts of dose-response curves and inflection points after the end of 
week 1 were not linear. These results show that selection from different 
stressors acts on distinct physiological traits. Treatments are discussed 
by case below. 
 
All cultures evolved greater r0 values across the full range of test 
concentrations (Fig. 2.4.1). This change was most pronounced between 
week 0 (selection day -10) and the end of week 1, likely as a 
consequence of the initial 10 days of uninhibited serial passage before 
selection began, which is predicted to select for fast growth. 
Streptomycin-selected cultures showed the strongest response to 
selection, and were almost completely indifferent to streptomycin 
concentration by the end of week 1. This pattern was consistent 
throughout the remainder of the experiment.  
 
After the initial universal increase in r0 at the end of week 1, dose-
response y-intercepts decreased at the end of week 2 across all 
treatments except streptomycin. Melittin-selected cultures showed an 
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increased r0 at 8#g ml-1 at the end of week 2, consistent with a tradeoff 
between resistance and fitness in low-stress environments. However 
there was little apparent increase in resistance in other treatments at this 
point.  
 
Vancomycin- and pgml-selected cultures were not viable in the selection 
protocol beyond the end of week 2, and went extinct at the beginning of 
week 3. Extinction was confirmed by plating. Pexiganan-selected 
cultures showed a strong depression of r0 across all test concentrations 
at the end of week 3, in conjunction with a depressed OD in the main 
selection cultures. The low density of cells in the selection culture is 
likely to negatively affect the output of the dose-response assay (see 
Appendix 1), so these data from the end of week 4 are not shown for 
pexiganan-selected cultures. 
 
Melittin and iseganan-selected cultures showed further increases in r0 at 
higher (A8 #g ml-1) concentrations of their stressors at the end of week 4. 
Indeed, iseganan-selected cultures showed an almost flat dose-
response, similar to that of streptomycin-selected cultures. This was 
associated with a recovery of r0 at low concentrations of stressor, to 
levels approximating those at the end of week 1. 
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 Figure 2.4.1. Evolution of dose-responses during selection from antimicrobial stressors 
S. aureus cultures under standardised weekly-increasing selection from antimicrobial stressors were sub-cultured into 
unsupplemented media until late exponential phase and then grown for six hours in a dilution series of the stressor against which 
it had been selected. Optical density (595nm) was measured hourly, and used to calculate r0 of cultures at each concentration, 
from which dose-response curves are constructed. Dose-response assays were repeated weekly until cultures became 
functionally extinct or had been selected for four weeks. Some input cultures (iseganan-selected, week 3; and pgml-selected, 
week 2; pexiganan-selected, week 3) did not grow or barely grew before the assay. 
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Table 2.4.2. Evolution of S. aureus resistance to AMPs and antibiotics: Fold-change in modal minimum 
inhibitory concentration (MIC) & and concentration showing maximum growth (maxG) (both !g ml-1) relative 
to week 0, under increasing selection from antimicrobial stressors, starting at MIC50. Grey blocking denotes 
functional extinction.  
* assay over range 0.125 - 64 !g ml-1.** assay over range 0.125 - 128 !g ml-1. 
 Weekly fold change (modal values) over day -10 
 W1 W2 W3 W4 
Treatment MIC* maxG* MIC* maxG* MIC** maxG** MIC** maxG** 
Iseganan 8 0.5 8 2 4 2 >16 16 
Melittin 2 0.25 4 0.5 8 1 4 0.5 
Pexiganan 8 0.5 8 0.63     
PGML 2 0.32 4 0.5     
Streptomycin >8 1 >8 1 >16 2 >16 32 
Vancomycin >64 0.5 32 1     
 High     Low 
Selection 
intensity 
        
 MIC50 2 x MIC50 4 x MIC50 8 x MIC50 
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Table 2.4.2 summarises fold-change of MIC and maxG values 
extrapolated from the data presented in Figure 2.4.1. Consistent with 
Figure 2.4.1, the data in the table show a marked increase in resistance 
(MIC) across all treatments, particularly in the first week of selection. 
There is no evidence of a negative relationship between these 
parameters. 
 
2.4.3 – Evolution of r0 in stress-free environments 
 
r0 in stress-free conditions (“r0max”) was strongly related to the 
interaction between treatment and week of selection (Linear model: F-
ratio=23.04, df=18,72, p<0.0001, adjusted r2=0.82) (Fig 2.3.2). An 
increasing background of selection corresponded to a depression of 
r0max across treatments for most of the selection protocol, apart from in 
week 4 when the surviving cultures (iseganan, melittin and streptomycin) 
showed a marginal recovery of r0max. Pexiganan-selected cultures 
maintained the same r0max throughout weeks one and two, but this was 
strongly depressed in week 3, prior to extinction. Conversely, 
streptomycin-selected cultures showed a slight depression of growth 
rate in the first week relative to the other cultures, but there was little 
change in this trait through the remainder of the experiment. The r0max 
of PGML and vancomycin-selected declined in week 2, before extinction 
in week 3. 
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Figure 2.4.2 – Uninhibited r0! values (population means) by week 
S. aureus cultures under standardised weekly-increasing selection from 
antimicrobial stressors were sub-cultured into unsupplemented media 
until late exponential phase. They were then sub-cultured into 
unsupplemented media again, optical density (595nm) was measured 
hourly for six hours, and the subsequent data were used to calculate r0. 
This assay was repeated weekly until the cultures under selection 
became functionally extinct, or until four weeks had passed. 
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2.4.4 – Population size 
 
There are few universal trends in the daily 24h ODs of cultures between 
treatments, but ODs were consistent within treatments (Fig 2.4.3). 24h 
ODs were consistently equivalent across all treatments in week 1 apart 
from pgml selected cultures, in which populations were smaller. There 
was a steady systematic decline of 24h ODs in vancomycin- and 
pexiganan-selected cultures during the first few days of week 2. 
Pexiganan populations remained depressed, but vancomycin-selected 
populations recovered on day 9, suggesting simultaneous evolutionary 
innovation in vancomycin-selected cultures. Pgml-selected lines showed 
consistently low population size through this second week.  
 
Unfortunately, the incubator fault described in 2.4.2 led to slower growth 
of all populations on day 15, despite the attempt to normalise OD to day 
14 levels, suggesting that culture physiology had not fully recovered 
from freezing by day 15, despite showing apparently strong growth 
before re-suspension. However, plating after day 15 revealed the 
continued presence of viable cells in all cultures, albeit at lower densities 
in some. This is particularly significant for vancomycin- and pgml-
selected cultures, because it suggests that eventual extinction in the 
middle of week three was a genuine phenomenon caused by slow 
growth, consequent of an inability to evolve responses to their stressors 
(i.e. rather than an interactive effect of recovering from freezing and 
exposure to more concentrated stressor).  
 
Figure 2.4.4 shows extinction of cultures by day under selection, 
determined by the absence of viable cells when they were scraped onto 
agar. These data demonstrate the greater difficulty faced by pgml-
selected cultures than other cultures (notably pexiganan and melittin) in 
overcoming increased intensity of selection. The sudden demise of 
vancomycin-selected lines between days 16 and 18 also suggests an 
upper limit of the ability of cultures in this selection protocol to evolve 
resistance to this particular stressor. The persistence of some viable 
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cells in two pexiganan-selected lines was confirmed by plating, and 
these cells were cultured up to the end of week 4. However undetectably 
low densities, as determined photometrically, meant that they were 
considered functionally extinct in comparison to other cultures by the 
end of week 3. The remaining three pexiganan-selected cultures 
persisted at very low densities, but were not considered extinct because 
their ODs were consistently above those of sterile SGM. 
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Figure 2.4.3. Daily 24h OD595 (means, threshold OD = 0.05) of 
selected cultures 
Optical Density (595nm) of S. aureus cultures under standardised 
weekly-increasing selection from a range of antimicrobial stressors was 
measured daily when the culture was sub-cultured into the following 
day’s media. There were five replicates per treatment, the ODs of which 
were averaged if they were >0.05. Cultures of ODs <0.05 are considered 
functionally extinct. 
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Figure 2.4.4. Functional Extinctions during the AMP/antibiotic 
selection protocol 
S. aureus were serially cultured under standardised weekly-increasing 
selection from a range of antimicrobial stressors for up to four weeks. 
There were five replicates per treatment. Cultures selected by some 
stressors (Vancomycin and pgml) became totally extinct, confirmed by a 
lack of growth after plating on agar. Some persisted at extremely low 
densities in medium (measured photometrically) but displayed some 
growth after plating, which were considered functionally extinct. 
Surviving lines are compressed into the line at the top of the figure.  
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2.5 - Discussion 
 
This experiment was designed to measure the costs of resistance to 
AMPs individually and in combination, by measuring performance in 
terms of growth and viability during selection, and comparing these 
metrics to cultures under selection from antibiotics. Taken together, 
these results are consistent with the theoretical predictions of how 
bacteria should perform under selection. Crucially, there were no 
categorical differences in how AMP-selected and antibiotic-selected S. 
aureus performed under selection, either in terms of fitness or their 
ability to evolve a response to a stressor. The responses to single AMPs 
are in the range set by vancomycin and streptomycin, showing that S. 
aureus adapted to grow in AMPs suffer no greater costs than those that 
must be borne by viable natural isolates. Therefore, this experiment 
shows that there is no fundamental difference between the costs of 
resistance to AMPs and antibiotics. The weaker response to a 
combination of AMPs indicates that additional costs of resistance to 
multiple stressors and interactions between component stressors 
constrain the emergence of AMP resistance in natural infections. 
 
2.5.1 – Trade-offs in resistance evolution 
 
A strong trade-off between general fitness and resistance to stressors 
should be manifested as a negative relationship between MIC and maxG 
over time. However, Table 2.4.2 suggests the absence of such a 
relationship in these data. This suggests that intrinsic trade-offs do not 
constrain resistance to individual AMPs in this experiment. However the 
data do not show the predicted trade-off for vancomycin- or 
streptomycin-selected bacteria either, so this conclusion should be 
treated cautiously. 
 
There are two apparent trajectories for bacteria under selection in this 
protocol. Cultures in treatments that did not go extinct (iseganan, 
melittin, streptomycin) showed a slight depression of r0max (a proxy of 
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fitness) but survived the duration of the experiment, and even appear to 
show some compensatory evolution of r0max in the final week of the 
experiment. This suggestion corresponds with the ability of bacteria 
under selection from these stressors to evolve in terms of dose-
response: Fig 2.4.1 suggests that, over the course of the whole 
experiment, dose-response evolved most in iseganan-, melittin- and 
streptomycin-selected cultures, although the changes were not 
necessarily synchronous. In evolutionary terms this means that these 
cultures show the greatest shift in their performance in varied 
environments, and can grow better at higher concentrations of their 
selective stressor at the cost of weaker growth at lower concentrations. 
 
Interestingly, streptomycin-selected cultures showed both the quickest 
response to selection in terms of dose-response  - which was almost flat 
by the end of week 1 – a concurrent depression of r0max, and a 
reasonably stable r0max thereafter. The ancestor uses a rapid efflux 
pump to resist tetracycline (A. Williams & S. Foster, Pers Comm; Hillen 
and Berens, 1994), which could possibly have simply been modified and 
used to export streptomycin. On the other hand, iseganan and melittin-
selected cultures took longer to evolve resistance to their stressors, and 
a more gradual depression of r0max over the course of weeks 1 to 3. 
This is consistent with the theoretical prediction that responses to 
selection should be proportional to cost (Levin et al., 2000; Andersson, 
2006). 
 
The second trajectory witnessed in this experiment is an inability to 
adapt to the environment, hallmarked by a decline in r0max over time, 
decreased OD in selection cultures, and eventual extinction. This pattern 
is displayed by pexiganan-, pgml- and vancomycin-selected cultures. 
The decreasing r0max could be a consequence of two processes. First, 
the cultures may simply be highly stressed after their prolonged 
exposure to AMPs or antibiotics. A second possibility is that that the 
apparent decrease in r0max over time is semi-artefactual, and is in fact 
a consequence of variation in numbers of starting bacteria entering the 
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dose-response assay resulting in varied maximal rates of change in the 
assay. However, for reasons explained in Appendix 1, although this 
issue could compromise the absolute precision of the results, it does not 
completely invalidate the conclusion. The decreases in r0max are 
corroborated by their correspondence with falling OD and extinction in 
the selection cultures themselves. Although there is some (limited) 
potential for the dose-response and r0max values to show low fitness as 
an artefact of low population size in the selection cultures, low 
population size in the selection cultures is itself caused by low fitness. 
 
Pgml- and vancomycin-selected cultures were the quickest to show 
compromised fitness and to go extinct. This is particularly remarkable for 
the pgml-selected lines, because it took another week for any 
pexiganan-selected cultures to go extinct, and melittin-selected cultures 
survived the duration of the experiment. This meets the theoretical 
prediction that the evolution of resistance is not favoured by this 
combination treatment (Aaron et al., 2000; Fischbach, 2011). This study 
is the first to show such a pattern using AMPs. It would be interesting to 
see what the nature of the interaction between pexiganan and melittin is 
through killing-curve and checkerboard assays, to test the theoretical 
notion that the pace of evolution of resistance to combinations of 
stressors should be associated with functional interactions (Hegreness 
et al., 2008; Michel et al., 2008; Yeh et al., 2009; Torella et al., 2010). 
 
It is interesting that pexiganan-selected cultures went extinct in this 
protocol, but not in the recently published work of Habets & Brockhurst 
(Habets and Brockhurst, 2012). This suggests an upper limit of S. 
aureus’ ability to evolve pexiganan resistance in this experimental 
protocol. The difference between this result and those of Habets & 
Brockhurst may be a function of differences in minimum population size 
(5!l and 40!l of 24h culture were transferred in each experiment, 
respectively) altering the probability of beneficial mutants arising and 
remaining in the population. Also, this experiment differs from Habets & 
Brockhurst’s insofar as it was concerned with the dynamics of resistance 
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evolution rather than the potential for it, which manifested in differences 
in experimental protocols, and a less forgiving selection regime in the 
present study for any cultures that did not quickly evolve. Habets & 
Brockhurst selected S. aureus for pexiganan resistance to test for cross-
resistance: this experiment was concerned with how the bacteria behave 
during selection. 
 
2.5.2 – No difference between antibiotics and AMPs 
 
The most critical trend in the data from this experiment is the lack of any 
apparent difference in the performance of S. aureus under selection 
from streptomycin, vancomycin, or the panel of AMPs. Streptomycin and 
vancomycin-selected bacteria performed as predicted: S. aureus 
struggled to grow in concentrated vancomycin, but rapidly evolved to 
grow in high concentrations of streptomycin. By incorporating antibiotics 
into the selection protocol, this study is the first to measure the costs of 
AMP resistance in a fully parameterised fitness framework. If 
streptomycin and vancomycin are accepted as extremes of the selection 
that S. aureus can be exposed to from antibiotics, then the AMPs used 
in this study select for the same range of responses as antibiotics. 
Critically, although S. aureus’ resistance to pexiganan and vancomycin 
did not increase hugely in this experiment, they have been demonstrated 
previously in other studies or environmental isolates. Therefore, this 
study has shown no difference in the ability of bacteria to evolve 
resistance to AMPs or antibiotics in vitro. 
 
These findings have two broad implications, concerning the evolution of 
immunity and the potential to use AMPs as drugs. First, it excludes the 
hypothesis that the rarity of AMP resistance in natural isolates is 
regulated by the intrinsic properties of AMP-microbe interactions 
(Hancock and Diamond, 2000; Hancock, 2001; Zasloff, 2002). On this 
basis, other properties of immune systems or AMP-microbe ecology 
must constrain microbial resistance. The lack of any factorial difference 
in the costs of AMP resistance in this study suggest that cost is not 
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necessarily a limiting factor, consistent with previous work (Pränting et 
al., 2008). Indeed, the comparison of pgml-selected S. aureus to 
pexiganan- and melittin-selected cultures suggests that the 
simultaneous action of numerous different immunological stressors 
constrains resistance evolution. This study is the first proof-of-principle 
experimental evidence of this process. Assuming that AMPs are 
bactericidal, analogous selective processes are likely in vivo when 
multiple host AMPs are synthesised after infection. In this case, plastic 
phenotypic responses to immunological stress in an infection are likely 
to be more facile than evolved resistance, and thereby dampen the 
effects of selection from AMPs on bacteria (Kahl et al., 1998; Lewis, 
2001; Sadowska et al., 2002; Lewis, 2005; Moisan et al., 2006; Cai et 
al., 2009) 
 
As well as the evolutionary ecology implications of these results, there is 
an important applied aspect. AMPs are currently under development as 
a new class of clinical antibiotics, based on the now discredited 
judgment that AMPs are somehow resistance-proof. If AMP resistance 
confers cross-resistance, then it might also be effective in helping 
infectious bacteria to evade the effects of AMPs when they are used in 
an immune response. Use of AMPs as therapeutic antibiotics might 
therefore select for more persistent and harmful pathogens. Experiments 
to test whether this is so are described in Chapter 3. 
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Chapter Three 
 
The ecology of antimicrobial peptide-
resistant Staphylococcus aureus in 
Tenebrio molitor 
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“There may be a danger!It is not difficult to make microbes resistant 
to penicillin in the laboratory by exposing them to concentrations not 
sufficient to kill them, and the same thing has occasionally happened 
in the body. 
 
!there is the danger that the ignorant man may easily underdose 
himself and by exposing his microbes to non-lethal quantities of the 
drug make them resistant. Here is a hypothetical illustration. Mr. X. 
has a sore throat. He buys some penicillin and gives himself, not 
enough to kill the streptococci but enough to educate them to resist 
penicillin. He then infects his wife. Mrs. X gets pneumonia and is 
treated with penicillin. As the streptococci are now resistant to 
penicillin the treatment fails. Mrs. X dies. Who is primarily responsible 
for Mrs. X’s death? Why, Mr. X whose negligent use of penicillin 
changed the nature of the microbe. Moral: If you use penicillin, use 
enough” 
 
Alexander Fleming, 
Nobel Prize lecture. 
December 11th, 1945 
 
“The evolution of resistance to any antibiotic makes it less useful in 
treating disease!it also deprives any organism that produces it of 
part of its antibacterial armoury. This would not normally be a matter 
for concern; but in the case of antimicrobial peptides, we ourselves 
are the producers. The evolution of resistance to human antimicrobial 
peptides, therefore, may have much more serious consequences 
than the evolution of resistance to conventional antibiotics, because 
our ability to resist infection might be permanently compromised.” 
 
Graham Bell & Pierre-Henri Gouyon, 2003. 
Arming the enemy: the evolution of resistance to self-proteins. 
Microbiology 149, 1367-1375 
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3.1. Abstract 
 
Antimicrobial peptides (AMPs) have been proposed as a solution to the 
increasing ineffectiveness of conventional antibiotics, because AMP 
resistance has rarely been observed in natural systems. However if 
using AMPs in a clinical setting selects for resistance and cross-
resistance to other AMPs, then AMP therapy could coincidentally select 
for bacteria that are more resistant to AMPs deployed as part of immune 
responses. To test these ideas in an animal model, AMP-resistant, 
antibiotic-resistant and unselected Staphylococcus aureus generated in 
experiments described in Chapter 2 were inoculated into Tenebrio 
molitor. There were treatment-specific effects on beetle survival and 
long-term persistence of infection, but these effects were not necessarily 
related to AMP resistance of the cultures. However all but one of the 
AMP-resistant bacterial populations were significantly better at surviving 
the first 24 hours after inoculation into beetles than control strains. 
These results suggest that putative AMP therapies should be used with 
extreme caution, and confirm that AMPs are important effectors of innate 
immunity. Complementary to in-vitro data (Chapter 2), these data show 
that AMP-resistant S. aureus are not less fit in a host than their 
unselected ancestors, suggesting that intrinsic cost does not constrain 
natural AMP resistance. 
 
3.2. Introduction 
 
The evolutionary constraints on antimicrobial peptide (AMP) resistance 
have been extensively discussed in Chapter 2, focusing mainly on costs 
of this trait. This chapter addresses a number of subsequent issues, but 
incorporating an additional biomedical angle. The biomedical arguments 
for the potential of AMPs as a new class of antibiotic are laid out, 
followed by an alarming counter-argument.  
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3.2.1. The antibiotic resistance problem, and the potential of AMPs 
as novel therapeutic compounds 
 
After being widely hailed as the greatest innovation of the twentieth 
century, the effectiveness of antibiotics is waning just seventy years after 
they first became widely available (Davies and Davies, 2010). The 
dangers of negligent use of antibiotics was recognised almost from the 
moment of their discovery, hallmarked by Alexander Fleming’s warning 
of the dangers of negligent use of penicillin in his Nobel lecture. Bacteria 
resistant to penicillin were subsequently isolated from the environment 
just years after its commercial introduction (Chambers and DeLeo, 
2009). Highly-resistant strains are now commonplace, and publicly 
prominent ‘superbugs’ that can happily survive in what were formerly 
antibiotics of last resort such as oxicilin or vancomycin (Lipsitch and 
Samore, 2002; Weigel, 2003; Fischbach and Walsh, 2009) are a 
particularly thorny problem for immune-compromised hospital patients. 
Many of these bacteria are resistant to panels of antibiotics, and 
resistance to certain antibiotics can infer cross-resistance to others e.g. 
β-lactam resistance can confer quinolone resistance (Sanders et al., 
1984). There are almost innumerable reviews on the physiology and 
evolution of antibiotic resistance, and it is beyond the scope of this thesis 
to recount this information. 
 
A proposed solution to the problem of antibiotic resistance has been to 
co-opt the antimicrobial peptides used by innate immune systems of, for 
example, frogs (Bechinger et al., 1993) and bees (Bulet et al., 2004), 
and use these therapeutically. This interest was initially motivated by the 
apparent ‘resistance-proof’ nature of these compounds (Hancock, 2000; 
2001; Zasloff, 2002), and it was thought that AMP resistance simply 
could not evolve due to the mechanisms by which AMPs kill bacteria 
(see Chapter 2). However, as demonstrated in Chapter 2 and other 
experimental studies (for example Perron et al., 2006; Pränting et al., 
2008; Habets and Brockhurst, 2012), this is simply not the case. Despite 
the mounting evidence that AMPs are far from resistance-proof, interest 
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continues in ‘AMP therapy’, seeking to use them as bactericidal or 
immunomodulatory drugs (Easton et al., 2009; Yeung et al., 2011). If 
bacteria were to evolve resistance to therapeutic AMPs and thereby 
become cross-resistant to AMPs in their immunological context, the 
consequences for hosts could be dire. 
 
3.2.2. Cross-resistance to antibiotics: Cross-resistance to AMPs? 
 
Cross-resistance is a common trait of antibiotic-resistant bacteria (Levin 
et al., 2000; Cafiso et al., 2010). Cross-resistant strains emerge either 
due to selection from diverse antibiotics in antibiotic-rich environments 
such as hospitals or farms, or because the physiological mechanisms 
conferring resistance to one antibiotic are effective in resisting another. 
The idea that AMPs and antibiotics exert different selective pressures is 
being gradually eroded (Perron et al., 2006; Pränting et al., 2008; 
Habets and Brockhurst, 2012), so the notion that AMP-cross-resistance 
could occur is as credible as for conventional antibiotics. The processes 
that could select for cross-resistance to AMPs are analogous to the 
same processes with antibiotics: resistant strains may emerge in AMP-
rich environments (i.e. hosts), or the range of mechanisms that confer 
resistance to one AMP may exert broad effects (Bell and Gouyon, 2003; 
Peschel and Sahl, 2006). Cross-resistance to AMPs is plausible 
functionally, because the structures of AMPs are highly conserved 
(Zasloff, 2002) and the repertoire of known host resistance mechanisms 
is somewhat limited (Peschel and Sahl, 2006; Gruenheid and Le Moual, 
2012). Since AMPs have been proposed as a novel class of antibiotics 
(Hancock, 2000; Zasloff, 2002; Reddy et al., 2004), it is important for 
public and environmental health to determine whether AMP resistance 
confers cross-resistance in a similar fashion to antibiotic cross-
resistance, due to the risk of AMP therapy selecting strains that are 
highly resistant to AMPs in natural settings. The most alarming potential 
consequence of AMP therapy is selection of bacteria that are better able 
to survive an immune response (Buckling and Brockhurst, 2005).  
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3.2.3. Existing evidence of broad-spectrum AMP resistance  
 
Despite close to a decade’s interest in the notion of universal AMP 
resistance, there has been surprisingly little experimental work that has 
specifically focused on the issue. Older studies showed that cross-AMP-
resistance tended to be limited to structurally similar or closely related 
molecules (Bell and Gouyon, 2003). A recent paper showed that 
Staphylococcus aureus selected to live in high concentrations of 
pexiganan – one of the magainin group of AMPs isolated from the frog 
Xenopus laevis, and the only AMP currently available commercially – 
can also show elevated resistance to the human defensin HNP-1, 
although this effect was not universal across replicate lines (Habets and 
Brockhurst, 2012). This was the first study to show that resistance is not 
necessarily confined to molecules within a given class, and is therefore 
circumstantial evidence that molecular mechanisms of specific AMP 
resistance can be co-opted for defence against AMPs to which the 
resistant bacteria is naïve.  
 
The only study so far that has shown an advantage of AMP resistance in 
a living host model is Pränting et al. (2008), in which one of four 
Salmonella enterica mutants resistant to PR-39 (a porcine AMP) 
survived better than the wild-type strain with which it was co-injected into 
a mouse. This is an interesting result, but the limitations of working with 
vertebrate models mean that the experiment is replicated only once in 
one individual host, and it is possible that host-mediated effects led to 
the greater prevalence of resistant mutants in the mouse. Consequently 
there is ample scope for a broad-reaching study of the effects of AMP 
resistance on bacterial persistence in a host, and the pathology 
associated with infection by AMP-resistant bacteria.  
 
3.2.4. Potential outcomes of infection by AMP-resistant bacteria  
 
There are three basic outcomes in terms of in vivo persistence 
(“persistence outcomes”) for bacteria with a history of exposure to AMPs 
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upon inoculation into a host: the infection can either be more susceptible 
to the immune system, less susceptible, or remain unchanged relative to 
ancestral populations (Figure 3.2.3.1). However these three outcomes 
are products of distinct ecological processes, depending on whether 
previous exposure to AMPs selected for resistance in the population or 
merely stressed it (Figure 3.2.3.1). It is important to define the 
differences between exposure to AMPs; stress, i.e. plastic physiological 
responses to exposure to AMPs leading to sub-optimal cellular function; 
and selection for resistance, i.e. exposure leading to heritable changes 
in traits that allow the bacteria to effectively cope with AMPs in the 
environment.  
 
If bacteria do not become resistant to AMPs after exposure, then the 
persistence outcome should be the same as the ancestor’s. It is also 
possible that bacteria could become more recalcitrant after infection 
without prior AMP resistance evolution if mutations emerge that are 
neutral during the selection process, but are serendipitously beneficial 
after inoculation into a host, such as increased growth rate or antigenic 
modification. This latter process is a backdrop to all the potential 
persistence outcomes that could arise after exposure to AMPs.  
 
Once they are introduced to a host, bacteria that have evolved costly 
AMP resistance are much more interesting than those that were simply 
stressed by exposure during the selection protocol, because the costs 
and benefits of resistance will be amplified in the face of an immune 
response. Benefits will be amplified because in vitro AMP resistance 
may confer systemic immune resistance as predicted in the literature. 
Costs will be amplified because an antibacterial immune response is a 
stressful environment for bacteria, in which cells bearing the greatest net 
benefit after selection are likely to be the most competitive. If the 
benefits of in vitro AMP resistance are outweighed by their cost in vivo 
then an infection will be more susceptible to host immunity, and vice-
versa. It is also possible that the costs and benefits of AMP resistance 
are balanced, or that the costs of in vitro resistance are mitigated by 
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compensatory mutations, in which case there will be no interaction 
between in vitro and in vivo resistance. 
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Figure 3.2.3.1. Potential interactions between responses to in vitro exposure to antimicrobial peptides and inoculation into 
hosts 
Bacteria serially exposed to antimicrobial peptides (AMPs) in vitro can either evolve AMP resistance, or be stressed but evolve no 
resistance (red ovals). When confronted with AMPs as part of a hosts’ immune response, the persistence of formerly AMP-exposed 
strains can be changed relative to that of their ancestor (green boxes). The direction of this change will be determined by the cost: 
benefit ratio of resistance for AMP-resistant strains, or the heritable and epigenetic costs and benefits of stress and random 
mutation for AMP-susceptible strains. 
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3.2.5. Goals of the present study 
 
Experiments described in Chapter 2 generated AMP-resistant bacteria 
with controlled phylogeny and common ancestor. This material presents 
a unique opportunity to compare the effects of AMP resistance on both 
the fitness of the resistant bacteria in hosts, and the fitness of hosts 
infected by the resistant bacteria. The remainder of this chapter 
describes a series of experiments that compare the persistence and 
pathogenicity of AMP-selected, antibiotic-selected and unselected S. 
aureus derived from the selection experiment in Chapter 2. 
Complementary to the benefits of using parasites with a known and 
controlled evolutionary history, these strains are ideal for studies of 
direct clinical relevance since S. aureus is an opportunistic pathogen, 
and the antibiotic (tetracycline) resistance label universal to these 
cultures facilitates controlled recovery of the bacteria from a model host. 
 
The mealworm beetle Tenebrio molitor is a convenient and powerful 
host organism for post-infection survival and bacterial persistence 
experiments (Haine et al., 2008a; Pursall and Rolff, 2011). The ease 
with which several hundred insects can be individually managed means 
that many individuals can be simultaneously treated, as required for 
meaningful survival studies. Additionally, insects gain a distinct 
advantage over vertebrates as models for survival experiments from 
their legal status as lab animals in the UK, which means that it is legal to 
keep infected individuals alive for indeterminate periods after infection. 
T. molitor’s large body size and architecturally simple haemocoel mean it 
is also fairly straightforward to quantitatively measure infection over time. 
In this context it has already been used as a vehicle to study persistence 
of S. aureus. It has been suggested that induced AMPs are a major 
component of T. molitor’s immune response to S. aureus (Haine et al., 
2008a), making investigation of the interaction between AMP resistance, 
pathology and persistence even more attractive in this combination of 
host and parasite. 
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The benefits of long-term in vivo persistence for an opportunistic 
pathogen like S. aureus are obvious. The fitness costs of pathology are 
similarly obvious for a host, and of course host fitness equals zero when 
it is killed by a parasite. A case can also be made that induction of host 
morbidity is adaptive for S. aureus. Pathogenicity (often confusingly 
referred to as ‘virulence’ in the literature, discussed by Alizon et al. 
(2009)) is thought to be adaptive for a parasite if it aids transmission 
(Anderson and May, 1982; but see Ebert and Bull, 2003). S. aureus cells 
are not motile and do not sporulate, and so they can only be transmitted 
by breaching the host’s dermal tissues, which can be achieved by killing 
and putrefying the host. The ability to kill a host can consequently be 
considered a fitness metric for sub-cutaneous S. aureus infection, as 
can – more obviously – the ability to survive a host’s immune response. 
Host mortality can therefore be considered a measure of positive 
microbial fitness in this system, as well as of negative fitness in the host. 
Therefore, understanding the temporal dynamics of infection in relation 
to host mortality creates a clear picture of the fitness of both host and 
parasite, and the dynamic interplay between these two antagonists. 
 
The potential for elevated immuno-resistance and pathogenicity of AMP-
resistant strains are addressed by two experiments described in the 
remainder of in this chapter. The first measured persistence of AMP-
resistant S. aureus (ARSA) in T. molitor up to one week after inoculation, 
as a measure of the ability of ARSA to survive host immunity. In the 
second experiment, survival of ARSA-infected T. molitor was observed, 
which is taken as a measure of the pathology caused by infection with 
these cultures. These experiments were controlled using beetles 
infected with antibiotic-selected or unselected control cultures from the 
previous selection experiment, and with the ancestor of all the selected 
bacteria. Therefore the phylogeny of the infection, the historical intensity 
of selection, and the potential for random evolution of the infectious 
bacteria are all controlled in these experiments. 
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3.3. Materials and methods 
 
3.3.1. T. molitor culture 
 
Final-instar Tenebrio molitor were purchased from a commercial supplier 
(www.livefoods.co.uk), and incubated in rat chow (Harlan Laboratories, 
UK) and apple in an insectary at 26oC ±1 in a 12:12 light/dark cycle. 
Females were sexed as pupae and kept individually in rat chow. 
Eclosion was recorded daily. All beetles were virgins when treated. 
 
3.3.2. S. aureus preparation, storage & culture 
 
S. aureus were revived from glycerol stocks (preparation described in 
Chapter 2.3) by partially thawing one of the two aliquots until enough 
had thawed to pipette 100 !l of the glycerol stock. This volume was 
inoculated into 5ml LB (Sigma L2897-1KG) containing 5 !g ml-1 
tetracycline (Sigma T7660-5G) and 5.6!g ml-1 amphotericin-B (Sigma 
A9528) and grown at 30oC for 24 hours, shaking continuously at 100 
rpm. 
 
A 500!l aliquot of each 24-hour culture was pelleted by 5 minutes 
centrifugation at 4500g. Pellets of bacteria within each treatment were 
then pooled by communal resuspension in 1 ml Tryptic Soy Broth 
(Sigma T8907) with glycerol (80% water: 20% glycerol v/v), and frozen 
at -90oC. Thus a frozen, pooled stock was prepared from each treatment 
in Chapter 2. 
 
Vancomycin- and pgml-selected cultures went extinct at day 14 during 
selection (see Chapter 2.4), so unselected bacteria from day 14 were 
also pooled as an unselected control for these selection lines. 
Pexiganan-selected bacteria from day 14 were also pooled as a selected 
control. Descriptions of pooled bacteria are summarised in Table 3.3.1.  
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Table 3.3.1 – Bacterial populations pooled for T. 
molitor infection 
Culture 
(treatment/timepoint) 
Purpose 
Ancestor, day 0 Pre-selection control 
Iseganan, day 28 AMP-selected 
Melittin, day 28 AMP-selected 
Pexiganan, day 28 AMP-selected 
Unselected, day 28 Unselected day 28 control 
Streptomycin, day 28 Antibiotic-selected 
pgml, day 14 AMP combination-selected 
Vancomycin, day 14 Antibiotic-selected 
Pexiganan, day 14 Selected day 14 control 
Unselected, day 14 Unselected day 14 control 
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Prior to inoculation into T. molitor, pooled bacterial populations were 
revived from glycerol stocks by stabbing a sterile pipette tip approx. 
2mm into the surface of the frozen stock, and dropping this tip into LB 
containing tetracycline and amphotericin-B (5 !g ml-1 and 5.6 !g ml-1 
respectively). This approach was chosen in favour of streaking the 
glycerol stock onto agar and selecting one colony to preserve diversity 
within the culture, which can be important in resistance to bacterial 
stress (Lee et al., 2010). After inoculation, cultures were grown for 24 
hours at 30 oC, shaking continuously at 100rpm. 24-hour cultures were 
pelleted by centrifugation at 4500g for 5 minutes, then washed and re-
suspended in an equal volume of sterile PBS (NaCl 150mM, Na2HPO4 
10mM, pH 6.5).  
 
50!l of each inoculated culture (diluted x 10-5) was plated on with 20 
sterile glass beads on LB 1.5% agar containing tetracycline and 
amphotericin-B, to check for contamination and to quantify density of 
colony forming units (CFU) in the inocula. Plates were incubated for 24 
hours at 37oC, and photographed on a MicroPublisher 3.3 RTV camera 
(QImaging, Burnaby, BC, Canada). CFUs were automatically counted 
using OpenCFU (available at www.sourceforge.net, designed by 
Quentin Geissmann, University of Sheffield). The estimated CFU 
densities of the injected inocula are presented in Appendix 7. 
 
3.3.3. T. molitor inoculation 
 
Injections were performed by first swabbing the ventral surface of the 
abdomen with 80% EtOH, and loading a fine-pulled glass electrode 
(Narishige) with 5!l of the inoculum. A small hole was pierced between 
the third and forth abdominal sternites with a sterile pin. Inocula were 
then injected into the haemocoel by pushing the electrode through this 
hole (Figure 3.3.1) and pneumatically pressurising the sample in the 
electrode. 
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Figure 3.3.1. Inoculating T. molitor with a pulled glass electrode. 
Photo by Richard Naylor 
T. molitor were injected with S. aureus or sterile PBS by loading a glass 
electrode with 5 !l of liquid and injecting it through a hole pierced 
between the third and fourth abdominal sternites.  
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3.3.4. Survival study - Monitoring mortality of infected T. molitor 
 
Females were treated eight days after eclosion (n=50 per treatment), 
and mortality of each individual beetle was checked at least every two 
days. Sterile PBS was injected into controls as a procedural control. 
Mortality was recorded when beetles ceased to move and would not 
respond to mechanical stimulus. These checks were carried out up to 30 
days post-infection.  
 
An accelerated failure time (AFT) model was fitted to the data using a 
Weibull distribution (see Appendix 6 for model selection). 
 
3.3.5. Persistence of selected cultures in T. molitor 
 
3.3.5.1. Persistence study - Recovering inoculated S. aureus by 
perfusion bleeding 
 
Beetles used in this experiment were between seven and ten days old 
when injected. Bacteria were recovered using a ‘perfusion bleed’ assay, 
refined from that of Haine et al. (2008a). See see Appendix 2 for details 
of the refinement of this technique..  
 
Subject T. molitor were washed for 10 seconds in 80% EtOH. Genitalia 
were everted by gently squeezing the abdomen (Figure 3.3.2a), 
swabbed with 80% EtOH, and a small incision was made with a scalpel 
(Figure 3.3.2b). A 30 mm, 30-gauge needle was inserted through the 
plural membrane exposed between the abdomen and thorax on the side 
of the body laterally opposite to the genital incision, and pushed into the 
abdominal haemocoel (Figure 3.3.3a & b). 500!l sterile PBS was 
pushed through the needle, washing haemolymph out of the abdomen 
via the genital incision into a sterile collection tube (Figure 3.3.3c). 
 
Thirty beetles were assigned to each bacterial treatment. Prior to 
inoculation, these beetles were randomly assigned to be bled thirty 
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minutes, twenty-four hours, or seven days after infection, to capture the 
full dynamic range of what is known to date about T. molitor 
antimicrobial immunity (Haine et al., 2008b). Beetles in some treatments 
died between infection and bleeding, so not all timepoints have a full 
complement of ten datapoints, particularly seven days after infection. 
Unfortunate external issues surrounding lab space meant that not all 
experiments could be completed. Consequently the dataset for beetles 
infected with iseganan-selected bacteria is not complete. As inoculations 
had to be completed on different days, fifteen beetles were additionally 
injected with sterile PBS on every day when bacteria were injected as a 
procedural sterility control (see Appendix 2). Five of these PBS-injected 
beetles were bled in parallel to infected beetles every day that bleeds 
were undertaken. 
 
50!l of each perfused haemolymph sample was plated with 20 sterile 
glass beads onto a 950mm LB agar (1.5%) plate, containing tetracycline 
and amphotericin-B (as before). If beetles were bled 30 minutes after 
infection, perfused haemolymph samples were first diluted 10-fold and 
100-fold, and each dilution was plated. The most conservative colony 
forming unit (CFU) estimate from plating these two dilutions was used in 
subsequent analyses. Plates were incubated and colonies counted as 
described in 3.3.2. 
 
3.3.5.2. Persistence study – data analysis 
 
The effect of bleed date on CFU was first analysed to test for any 
systemic contamination specific to a particular day, including data from 
beetles injected with PBS. These data were highly zero-inflated, so a 
zero-hurdle model using a binomial error distribution with a logit link was 
used. 
 
Two subsequent analyses were conducted to assess the interaction of 
AMP resistance and persistence in T. molitor, after excluding the PBS-
treated beetles. First, the reduction of CFU estimates over time by 
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treatment was modelled. Secondly, notable greater variation in CFU 
estimates 24 hours post-infection motivated specific analysis of these 
data. 
 
Non-linear least-squares regression was used to fit a negative 
exponential function of the form 
 !"# !"#!!"#$%&#! !!!! ! ! !"#!!!"#$!!
 
to CFU data over time as linear models on log-log scales. The decay 
rates of the fitted functions (b) are a measure of the ability of inocula to 
persist in the host.  
 
24-hour CFU data were reanalysed separately from the rest of the data. 
A generalized linear model with a quasipoisson error distribution was 
fitted to the data, with treatment as a predictor variable. Initially 
inoculated CFU and date of treatment were non-significant factors of the 
maximal model and were excluded. To simplify the model, treatment 
groups showing significant differences from the intercept were grouped 
one-by one, with the end result that all ARSA strains (i.e. significantly 
different from the intercept) with the exception of pexiganan day 28 were 
grouped into one term of the model (ARSA). This process generated one 
group of equal statistical difference from the other inputs to the model.  
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Figure 3.3.2. Preparing T. molitor for perfusion bleeding. Photos by Richard Naylor. 
Beetles were prepared for perfusion bleeding by everting the genitalia and make a small incision on its side 
!" #"
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Figure 3.3.3. Perfusion bleeding T. molitor. Photos by Richard Naylor. 
Needles were inserted into plural membrane exposed between the abdomen and thorax (a, b) and used to flush 500 !l sterile PBS 
through the haemocoel, removing infectious bacteria. Perfusions escaped via an incision on the beetles’ posteriors and were 
collected in sterile centrifuge tubes, prior to plating on agar to quantify densities of viable bacteria in the haemocoel. 
!"" #"
$"
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3.4 Results 
 
3.4.1. Survival of S. aureus-infected T. molitor 
 
There were strong effects of treatment group on beetle survival (Figure 
3.4.1.1). Relative to the ancestral (day 0) control bacteria, pexiganan-
selected (day 28), streptomycin-selected (day 28), and unselected (day 
28) bacteria were significantly more pathogenic (Table 3.4.1.1.) Beetles 
inoculated with iseganan-selected (day 28), pexiganan-selected (day 
28), and pgml-selected (day 14) S. aureus all died significantly slower 
than ancestor-infected control beetles. Survival of beetles inoculated 
with unselected (day 14), melittin-selected (day 14), vancomycin-
selected (day 14) S. aureus or PBS did not significantly deviate from that 
of ancestor-treated beetles.  
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Figure 3.4.1.1. Post-infection survival of T. molitor infected with 
selected and unselected S. aureus 
T. molitor were infected on day 0 with S. aureus with a history of 
exposure to a range of antimicrobial peptides and antibiotics, and the 
ancestor of these strains. Survival of beetles within each treatment 
group was subsequently monitored up to 30 days after infection. 
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Table 3.4.1.1. Survival of T. molitor infected with selected bacteria: 
Accelerated failure time model (Weibull distribution). Significant 
differences from ancestral bacteria highlighted in blue (better survival) 
and red (worse survival) 
Treatment Coefficient Standard error Wald statistic p 
Intercept (Ancestor) 2.9330 0.0754 38.91 <0.0001 
Iseganan (d28) 0.3054 0.1115 2.74 0.0062 
Pexiganan (d14) 0.2438 0.1105 2.21 0.0273 
pgml (d14) 0.2328 0.1097 2.12 0.0339 
Vancomycin (d14) 0.1634 0.1089 1.50 0.1337 
Melittin (d28) -0.0386 0.1039 -0.37 0.7102 
PBS 0.0988 0.1063 0.93 0.3528 
Unselected (d14) 0.0774 0.1121 0.69 0.4902 
Pexiganan (d28) -0.3203 0.1029 -3.11 0.0019 
Unselected (d28) -0.3565 0.1039 -3.43 0.0006 
Streptomycin (d28) -0.2591 0.1075 -2.41 0.0159 
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3.4.2. Persistence of selected bacteria in T. molitor 
 
Bacterial treatment affected CFU recovered from infected beetles. Log-
10 CFU data are presented in Figure 3.4.2.1. 
 
There was some bacterial growth from samples derived from PBS-
injected beetles. This was centred on perfusion bleeds conducted one 
particular day. However there was no significant effect of day on CFU in 
infected individuals (Zero hurdle model, binomial error distribution with 
logit link, p>0.05), so PBS data were discounted from subsequent 
analyses. 
 
There is some variation between treatments in decay rates of CFU over 
time (summarised in Figure 3.4.2.2). However, in common with the 
results from the survival study, this does not map directly onto the 
evolutionary history of the inocula. CFU of streptomycin-selected S. 
aureus has the flattest response to time, and its confidence interval does 
not overlap with that of the ancestor, suggesting it has evolved to be a 
more persistent parasite than its ancestor. The difference between 
streptomycin-selected cultures and other cultures grown up to 28 days 
suggests that this is an effect of selection for streptomycin resistance 
rather than a function of time in serial culture during selection (Chapter 
2). By contrast, persistence of vancomycin-selected S. aureus has 
apparently not evolved at all relative to the ancestor. CFU of both 
unselected and AMP-selected S. aureus (at both days 14 and 28) 
evolved moderately slower decay rates in the host than the ancestor, but 
this change was not significant. Decay rate of the vancomycin-selected 
culture was indistinguishable from the ancestor. The fitted models are 
plotted in Appendix 3. 
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Figure 3.4.2.1. Persistence of selected S. aureus in T. molitor by treatment and time. 
T. molitor were infected on day 0 with S. aureus with a history of exposure to a range of antimicrobial peptides and antibiotics, and 
the ancestor of these strains. These bacteria were recovered 30 minutes, 24 hours and 7 days post-infection and plated on agar to 
quantify the densities of viable cells (CFU) in vivo. Top and bottom error bars show the 95th and 5th percentile, respectively. 
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Figures 3.4.2.2. Decay rates of log CFU estimates (selected S. aureus) in T. molitor, ±95% confidence intervals 
T. molitor were infected on day 0 with S. aureus with a history of exposure to a range of antimicrobial peptides and antibiotics, and 
the ancestor of these strains. These bacteria were recovered 30 minutes, 24 hours and 7 days post-infection and plated on agar to 
quantify the densities of viable cells (CFU) in vivo. Negative exponential functions were fitted to the data to estimate the rate of 
decline of each bacterial treatment in the host. These rates are plotted with 95% confidence intervals to show the variation in the 
ability of these strains to survive host immunity.  
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3.4.2.3. Comparison of 24h infection titers 
 
Although persistence of infection over seven days was the main trait of 
interest, Figure 3.4.2.1 suggested that an interesting and somewhat 
distinct phenomenon was occurring 24 hours post-infection, and that 
AMP-selected bacteria were surviving at a greater density than 
antibiotic-selected or unselected cultures, contrary to the prediction that 
such differences would manifest most in the later phases of a persistent 
infection.  
 
With the exception of pexiganan-selected (day 28) S. aureus, all AMP-
selected cultures survived to a higher density 24-hours post infection 
than other cultures, independent of CFU 30 minutes or seven days after 
infection (Generalised Linear Model with quasipoisson family, t=4.258, 
df=100, p<0.001) There was also a marginal effect of streptomycin 
resistance (p=0.08). The data are presented in Figure 3.4.2.4 as they 
were entered into this simplified model. 
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Figures 3.4.2.4. Persistence of grouped AMP-resistant S. aureus (ARSA) and other selected cultures 24 hours post-
infection 
 
T. molitor were infected with S. aureus with a history of exposure to a range of antimicrobial peptides and antibiotics, and the 
ancestor of these strains. All antimicrobial peptide-resistant S. aureus (ARSA) - with the exception of those exposed to pexiganan 
for 28 days - showed significantly better survival in the host than other cultures 24 hours post-infection. ARSA data are grouped to 
reflect statistical model simplifications. Top and bottom error bars show the 95th and 5th percentile, respectively. 
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3.5. Discussion 
 
This experiment was designed to test if AMP resistance is beneficial or 
deleterious in a host. Understanding this interaction is informative in 
either direction: either the rarity of AMP resistance (Chapter 2) can be 
explained by costs of evolving AMP resistance outweighing benefit in 
terms of survival in a host; or AMP-resistant bacteria persist better than 
non-resistant populations, and therefore using AMPs as drugs could 
select for more pathogenic bacteria. These data show that the 
relationships between S. aureus resistance to specific compounds, in 
vivo persistence and pathogenicity are complicated. This complexity is 
likely to be enhanced by the experimental evolution approach used to 
raise resistance in the inocula, which provides opportunity for random 
evolution of traits that would be neutral in the in vitro selection protocol, 
but advantageous in a host. There are, however, some striking trends in 
the data, despite the potential for confounding variation. I will first 
discuss the in vivo density of ARSA 24 hours post-infection, followed by 
the pathogenicity and long-term persistence of these strains in the host. 
 
Barring cultures that were exposed to pexiganan for 28 days, all S. 
aureus that were exposed to AMPs in the selection protocol survived 24 
hours in T. molitor much better than other cultures (Figure 3.4.2.4). This 
is the first evidence from a living host organism that providing scope for 
bacteria to evolve resistance to AMPs ‘arms the enemy’ with resistance 
to host immunity (Bell and Gouyon, 2003; Buckling and Brockhurst, 
2005), and a stark and compelling warning of dangers associated with 
‘AMP therapy’. Furthermore, it directly complements recent work 
showing that pexiganan resistance can lead to in vitro cross-resistance 
(Habets and Brockhurst, 2012).  
 
The implications of the interaction between a history of exposure to 
AMPs and 24-hour persistence are manifold, in terms of both our 
functional understanding of immunity and the biomedical implications of 
‘AMP therapy’. Regarding immunity first, the interaction between AMP 
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resistance and persistence corroborates previous evidence that AMPs 
are genuinely antimicrobial in immune responses (Andreu and Rivas, 
1998; Bulet et al., 2004; Charroux and Royet, 2010), contrary to the 
proposition in the introduction to Chapter 2. This effect is only apparent 
24 hours after infection, which is coincident with a temporal peak in 
expression of T. molitor AMPs (P. Johnston & J. Rolff, in prep). This is 
the one of the few organisms, if not the only organism, in which the 
evolutionary consequences of the temporal dynamics of immunity are 
being studied (Haine et al., 2008b). Understanding the timing of 
immunity in this organism could be an important first step in 
understanding how temporal dynamics of immunity regulate micro- and 
macro-evolution of bacterial parasites. The data presented in this 
chapter suggest that AMPs may well be very important in these 
processes (Haine et al., 2008a).  
 
There are clear differences between the pathogenicity of the selected 
bacteria, although the trends in these data are less clear with respect to 
AMP resistance. The elevated pathogenicity (relative to the ancestral 
culture) of 28-day streptomycin-selected, pexiganan-selected and 
unselected bacteria suggests that pathogenicity in this experiment is to 
some extent a function of time in serial culture. However this effect was 
not mirrored in cultures that had been selected for melittin and iseganan 
resistance for 28 days, thus indicating that other processes are at work. 
Perhaps in vitro AMP resistance in these lines is not beneficial in vivo, or 
associated trade-offs negatively regulate pathogenicity. 
 
The results of the beetle survival experiment are particularly surprising 
with respect to the pexiganan-selected (day 28) culture, because the 
parent cultures performed poorly during selection (Chapter 2), and 
showed no signs of persisting better than the other AMP-selected 
cultures either in terms of decay rate or absolute CFU: rather, this was 
the only AMP-selected culture to not persist significantly better than non-
AMP-resistant cultures 24 hours after infection, although it showed more 
variation in seven-day CFU than any other treatment. It may be that the 
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level of in vitro resistance or tolerance these cultures evolved is optimal 
in the host beyond but not before seven days after infection. Perhaps 
these cultures evolved traits during the selection protocol that aid in 
long-term in vivo survival but not in vitro. For example, a low metabolic 
rate and an ability to evade the immune system in tissues would allow 
persistent cells to maintain a low level of latent infection until in vivo 
conditions became permissive for re-growth. The fact that mortality of T. 
molitor infected with these pexiganan-selected bacteria occurred mostly 
after day seven is consistent with such an infection dynamic. 
Unfortunately it is impossible to quantify such processes over a longer 
time frame because bacteria killing the host would lead to a self-
selecting sample of hosts without a resurgent infection.  
 
It is also remarkable that streptomycin-selected S. aureus were so much 
fitter by all metrics than cultures exposed to other treatments, and were 
more pathogenic than most treatments. This strain clearly persists better 
than any other over the first week after infection, significantly more so 
than the ancestor (Figure 3.4.2.3). This result defies all expectations 
from the start of the experiment, as streptomycin was included as a ‘soft-
selection’ control in the selection protocol. Nevertheless, S. aureus 
exposed to this antibiotic showed the quickest evolution of dose-
response in Chapter 2, and the most stable dose-response curve 
subsequently, i.e. evolutionary innovation was rapid, and there was 
ample time thereafter for refinement. As mentioned in Chapter 2, these 
cultures may have had a head-start in evolving resistance to their 
stressor: the ancestor uses a rapid efflux pump to resist tetracycline (A. 
Williams & S. Foster, Pers Comm; Hillen and Berens, 1994), which 
suggests that these cultures might have co-opted and developed their 
ancestral tetracycline resistance machinery for streptomycin resistance 
in a way that cultures exposed to other stressors could not. Likewise, it 
is eminently conceivable that these cultures’ mechanisms of antibiotic 
resistance endow them with a degree of resistance to innate immunity, 
although a recent assay of these streptomycin-selected populations did 
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not detect any cross resistance to AMPs in vitro (J. Purves, Pers. 
Comm.).  
 
Whatever the mechanisms underpinning the pathogenesis of 
streptomycin- and pexiganan-selected cultures may be, these results 
should be a stark warning to biomedical scientists with designs on 
developing components of innate immune responses as novel 
therapeutic antimicrobials (Hancock, 2000; Zasloff, 2002). Supporting 
earlier studies (Torella et al., 2010), I demonstrate that the evolutionary 
processes governing interactions between in vitro and in vivo microbial 
resistance are complex and unpredictable. My experiments show a 
marked increase in the pathogenicity of S. aureus that were selected for 
resistance to a supposedly benign antibiotic (streptomycin), allowed to 
drift in evolutionary space for around 2000 generations, or selected for 
resistance to a supposed wonder-drug (pexiganan); despite the low 
fitness of the latter in vitro. Moreover, the pathogenesis of lines grown in 
pexiganan for 28 days powerfully supports the hypothesis that using 
AMPs as drugs may ‘arm the enemy’ (Bell and Gouyon, 2003; Buckling 
and Brockhurst, 2005), and demonstrates that in vitro experiments 
should not be considered a reliable predictor of what will happen in 
dramatically different and variable in vivo conditions. 
 
In contrast to the pathogenic and unpredictable pexiganan- and 
streptomycin-selected cultures, the pathogenicity of other selection lines 
scaled well with their performance during the preceding real-time 
evolution experiment (Chapter 2). Vancomycin-selected cultures showed 
little response to selection and, correspondingly, there were no 
differences between vancomycin-selected cultures and the ancestor in 
T. molitor. It is difficult to account for why there should be no difference 
between survival of beetles infected with melittin-selected bacteria and 
the ancestor, apart from to suggest that the benefits of melittin 
resistance outweigh its costs in vitro, but that the sum is closer to zero in 
vivo. Also, the results of the AFT model suggest that there was no 
difference between the sterile procedural control (PBS) and pathogenic 
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ancestral bacterial culture, which is cause for minor concern, but the 
data (Figure 3.4.1.1) suggest that this is likely an artefact of 
imperfections inherent in any statistical model: the proportion of beetles 
surviving after injection with PBS is consistently greater than that of 
infected individuals, and importantly it is around 0.2 greater than that of 
beetles inoculated with the ancestral bacteria, until around day 22 after 
treatment, when only 30% of the original PBS-treated group survive, 
followed by a reversal of the trend between the ancestor- and PBS-
treated groups. Thus the AFT analysis is likely skewed by only 15 
individuals, but unfortunately it is difficult to model these data more 
precisely. 
 
S. aureus exposed to pexiganan for 14 days, iseganan for 28 days, or 
the 50:50 combination of pexiganan and melittin killed T. molitor 
significantly more slowly than their ancestor. This is an interesting result 
for several reasons. Crucially, it suggests that therapeutic use of AMPs 
as antibiotics does not always necessarily lead to the evolution of more 
pathogenic infection, although the reverse effect in the pexiganan-
selected (day 28) cultures, discussed earlier, should strongly discourage 
any attempts to draw generalisations about AMP-mediated selection 
from these data. Once again, the disparity between in vitro and in vivo 
results may be explained by a different balance of costs and benefits of 
resistance in these environments. However, this does not appear to be 
the case for pgml-selected cultures. It seems that this combination 
treatment of bacteria in the selection protocol, which was intended to be 
a step closer to the natural environment, has blocked evolution of traits 
that would be favoured in both the in vivo or in vitro environment (with 
the caveat that there was some effect of treatment in terms of 24-hour 
survival in T. molitor, although this was the weakest significant effect), 
consistent with theoretical predictions (Chait and Craney, 2007; 
Fischbach, 2011). These cultures showed little response to exposure to 
a combination of AMPs measured by in vitro assays, nor did they report 
any benefit from this in vitro history when exposed to a natural panel of 
stressors in vivo. This further substantiates the conclusion reached in 
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Chapter 2, that the concurrent deployment of multiple AMPs during 
immune responses likely slows the evolution of infectious bacteria and 
constrains the evolution of AMP resistance.  The environment of multiple 
AMPs, rather than selecting for generalist resistance with an additional 
associated cost of a slower response to selection, appears to have 
blocked selection for any traits that could be beneficial in either in vitro or 
in vivo environments, apart from, in these experiments, 24 hours after 
infection. Finally it is intriguing that cultures grown for 14 days in 
pexiganan should be less pathogenic than their 28-day counterparts, 
despite appearing to be somewhat more persistent in T. molitor. These 
disparities are strongly consistent with the suggestion that the in vitro 
strategy for cultures exposed to pexiganan in the selection protocol 
switched from resistance to tolerance around day 14, and that this has 
knock-on consequences for these strains in vivo, where they are 
opposite in every trait measured.  
 
In conclusion, these data show that ARSA are not fundamentally weaker 
than antibiotic-selected or unselected S. aureus when injected into T. 
molitor. On the contrary, there is no systemic difference between AMP-
selected and other cultures by survival and persistence metrics, which in 
conjunction with the observations of the evolution of these strains 
suggests that AMPs are not the ‘wonder drugs’ they were thought to be 
in an evolutionary theatre. The only systemic difference that could be 
detected between ARSA and other strains was that ARSA survived the 
first twenty-four hours after infection far better than other strains. 
Although this did not manifest in differences in persistence rates or host 
morbidity in this study, it demonstrate scope for these processes, since 
long-term persistence - and thereby pathology and morbidity – are 
functions of the early survival of an infection.  
 
The biomedical implications of the interaction between historical 
exposure to AMPs and 24-hour persistence are fundamental if AMP 
therapy is to become a reality (Yeung et al., 2011). Microbial 
contributions to host pathology are likely to be determined by infectious 
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cells that survive initial immune responses and persist. Such persistence 
is a function of earlier bacterial densities, so there is more scope for 
damaging infection when the inoculum survives the initial few hours or 
days of the immune response. Although the experiments in the present 
study did not detect any differences between treatments in 7-day 
infection titers, late-infection persistence is a function of the early density 
of the infection. Therefore, the elevated ability of AMP-resistant bacteria 
to survive 24 hours in a host provides more scope for long-lasting, 
damaging infection, even if that was not detected in these experiments. 
Thus, these results run absolutely contrary to the notion that 
“antimicrobial peptides have clear and obvious therapeutic potential” 
(Hancock, 2000). On the contrary, “large-scale use of chemotherapeutic 
AMPs may ultimately help pathogenic bacteria colonise!animals and 
plants that were previously off-limits to them” (Buckling and Brockhurst, 
2005), and medicinal use of AMPs could have important evolutionary 
effects on the evolution of pathogenic bacteria, with potentially dire 
consequences for patients. 
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Summary of Chapters 2 and 3 
 
Chapters 2 & 3 demonstrate that there are evolutionary costs of being 
selected in vitro for resistance to components of host immunity – 
specifically antimicrobial peptides (AMPs) – which manifest as weaker 
growth in pristine environments and specific adaptation to grow at high 
concentrations of these stressors. These costs are to some extent 
alleviated in a host animal, when exposure to the stressors against 
which resistance has been acquired facilitates better survival of the 
infection at certain times after inoculation. Furthermore, I have shown 
that an improved ability to survive in a host need not be related to 
specific selection from immune effectors, and that selection from other 
stressors can also improve persistence in vivo. Critically the data show 
that development of AMPs as clinical antibiotic drugs could select for 
more persistent pathogens. 
 
However, I have not shown any fundamental difference in the costs 
experienced by bacteria exposed to AMPs and those exposed to 
antibiotics. There must therefore be another reason that AMP resistance 
has not been commonly reported in environmental isolates of bacteria, 
and the data constitute the first experimental evidence that this 
phenomenon could be mediated by the multiplicity of AMPs that are 
simultaneously produced by infected hosts. 
 
These first two Chapters show that resistance in an opportunistically 
pathogenic bacterium is regulated by benefits in some environments, 
which are offset by costs in others. In short, resistance may not always 
be the optimal strategy for a parasite.  
 
Chapters 4 & 5 seek to develop the reciprocal of this framework. The 
core question motivating these Chapters is “why do hosts not always 
resist their parasites?” Since the outcome of infection is determined by 
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the balance of a parasite’s evolutionary resistance to a host and the 
host’s ecological resistance to a parasite, presumably there are 
endogenous factors that constrain a host’s ability to clear parasitic 
infection. Chapter 4 seeks to measure the cost of an immunological 
resistance response to simulated microbial infection, by measuring a 
fitness cost of the immune challenge and demonstrating immunological 
self-harm to host tissue. Chapter 5 develops this framework by 
investigating the transcriptomic basis of immunological resistance, which 
shows that numerous mRNAs transcribed after an infection are 
predicted to have self-damaging secondary functions. 
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Chapter Four 
 
Costs of immunological resistance: 
Could autopathology generate 
negative immunological feedbacks?  
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4.1. Abstract 
 
Tolerance is quickly emerging as an important force in animal host and 
parasite evolution. Although tolerance has been recognised 
phenomenologically, very little is known about its causes or 
mechanisms. A case can be made that the optimal immunological 
strategy for an infected host shifts from resistance to tolerance over time 
after infection, because constitutive immunity is predicted to be self-
harming (immunopathology), and cumulative costs of immunopathology 
will eventually outweigh the benefits of completely killing a dwindling 
infection. Tenebrio molitor infected with live or dead Staphylococcus 
aureus show no difference in survival, suggesting that endogenous 
pathology associated with the response to microbial immune elicitors is 
a major component of total pathology. Inoculating T. molitor with dead S. 
aureus also led to wanton haemocoelic melanin deposition, suggesting a 
link between this constitutive immune effector and self-damage. Since a 
host cannot continuously invest in traits that will eventually kill it, a link 
can be tentatively made between immunopathological constitutive 
defences and eventual tolerance. 
 
4.2. Introduction 
 
4.2.1. Pathology and persistent infection are the produce of 
microbial and host traits. 
 
From the moment of association, the fates of an infected host and its 
infecting parasites are locked together (Little et al., 2010), and the 
fitness of each protagonist is dependent upon phenotypes expressed by 
both (Long and Graham, 2011). A host's "decision" to express a given 
immune effector of parasite resistance is determined by the benefit of 
expression relative to the endogenous costs, and the same logic holds 
for a parasite's expression of any costly "virulence factor" that aids 
survival in the host. Therefore, activity of individual immune effectors 
should be modulated as the marginal benefit of its use diminishes, for 
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example as  parasite densities decrease. Consequently, the costs to a 
host of expressing a certain immune phenotype will have knock-on 
effects on parasites, because endogenous host costs form a negative 
feedback on the host's ability to invest in that trait. This cost: benefit of 
resistance framework forms the basis of classical ecological immunology 
theory (Sheldon and Verhulst, 1996; Rolff and Siva-Jothy, 2003). In the 
light of the recent recognition of parasite tolerance in animals as an 
alternative immunological strategy to resistance, I propose that the cost-
benefit framework could generate negative feedbacks that will lead to 
host-parasite coexistence. These interdependencies generate a vast 
and varied array of potential feedbacks and outcomes, the exciting 
potential for which has only recently been recognised. 
 
The causes and consequences of pathogen-driven persistence are well 
characterised (see Chapter 1). However it has recently been recognised 
that an infection not dying in animal hosts can be host-driven, i.e. the 
host tolerates the infection (Raberg et al., 2007). Theory suggests that 
tolerance is an important outcome, both in terms of short-term selection 
on individual hosts and parasites, and long-term host-parasite 
coevolution (Råberg et al., 2008; Little et al., 2010). However, to date it 
has been studied mainly on a phenomenological and theoretical level 
(e.g. Ayres and Schneider, 2008; Schneider and Ayres, 2008; Schneider 
and Chambers, 2008, Best et al., 2010; Long and Boots, 2011). 
Consequently, there is a pressing need to study the causes and 
mechanisms of tolerance. This chapter is concerned with understanding 
why parasite tolerance is induced. 
 
There is an explicit but apparently unrecognised conceptual connection 
between tolerance and auto-reactivity caused by a host's immune 
system: "virulence" (total damage to a host) is defined as the sum of 
host self-damage and parasite-mediated damage (Long and Graham, 
2011). Tolerance is defined as the inverse of virulence (Baucom and de 
Roode, 2010; Schneider, 2011), i.e. hosts remain healthy independent of 
parasite burden, and are isolated from damage associated with infection. 
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In other words, tolerance is coincident with low immunopathology. 
Individual hosts cannot modulate the costs of evolving an immune 
response because they are fixed, but they can modulate investment into 
resisting infection. By doing so they modulate the inducible costs of 
resistance, the negative effects of which are life-history trade-offs and 
immunopathology (Graham et al., 2010; Schmid-Hempel, 2011). There 
is therefore a strong conceptual connection between hosts avoiding the 
immunopathological costs of resistance, and the induction of tolerance. 
 
Theory and empirical studies show that, when considered as life-long 
strategies, resistance and tolerance are negatively correlated (Raberg et 
al., 2007). Tolerance, resistance and virulence are not lasting states, 
and expression of immunity is modulated in response to infection. 
Consequently, rather than considering them as stable strategies 
throughout a host's lifetime, one must consider their dynamic 
relationship. Could the induction of resistance and tolerance also be 
negatively correlated over the lifespan of an individual host? I propose 
that tolerance should be dynamically induced after immunopathological 
resistance, because this process leads to increasing net cost and 
decreasing gain, particularly as parasite densities decrease. The 
mechanistic basis of this argument is that the collateral physiological and 
structural damage caused by resistance mechanisms negatively feeds 
back on a host’s ability to invest in resistance, and so less autotoxic 
immune effectors are deployed. In short, there is an upper limit on how 
long and how intensively a host can continue investing in a process that 
damages it. A ‘black-box’ evolutionary ecology argument - in terms of 
temporal patterns of investment and negative feedbacks - and a 
mechanistic biochemical argument of physiological damage and 
biochemical interactions are outlined separately below. 
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4.2.2. The ‘black box’ evolutionary ecology argument for 
immunopathology driving tolerance 
 
Immunopathology should only be maintained when its benefits (fitness 
retained by parasite killing) outweigh its costs (collateral self-damage). 
One can therefore assume that autopathological immune responses 
have been tuned by natural selection to minimise the ratio of 
autopathology to parasite killing, i.e. to minimise the secondary cost of 
parasite resistance, and make the trade-off between these two traits as 
favourable as possible. One can consequently assume that 
immunopathology is proportional to parasite killing. The rate of 
investment into immunopathological resistance traits therefore ought to 
decrease as net immunopathology increases over time. At this point a 
host must employ less autoreactive immune effectors to prevent further 
growth of the infection. If the antiparasitic effect of an immune effector is 
positively related to its autoreactivity, then an initial rapid initial burst of 
autopathology should diminish over time, associated with an observed 
outcome eventually consistent with tolerance (Figure 4.2.1). Fitness loss 
is therefore minimised by trading future unpredictable pathogenic 
damage for current predictable immunopathological damage.  
 
It might be argued that, rather than optimizing tolerance, 
immunopathology should promote more specific resistance responses. 
The counterargument is that, unfortunately for hosts, the most potent 
resistance responses are probably also autotoxic, because these attack 
the most fundamental features of parasites. In this case, 
immunopathology is a secondary effect of the requirement for potent 
resistance responses. It is therefore possible that resistance responses 
are universally autotoxic to some extent.   
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Fig 4.2.1. Shifting optimality of resistance and tolerance in 
response to immunopathology. 
If activation of constitutive resistance responses causes proportional 
damage to host and parasite, then the host’s ability to invest in 
resistance has an upper limit. Accumulation of immunopathological 
damage constrains rate of investment in immunopathological processes. 
Hosts approaching this limit must reduce investment in autotoxic 
responses, with a subsequent decline in rates of parasite killing. This 
leads to a continuous switch from parasite resistance to tolerance. 
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4.2.3. The biochemical argument for immunopathology as a cause 
of tolerance 
 
The proposal that tolerance is a concession to avoiding 
immunopathology associated with resistance is predicated on the 
assumption that resistance should be more autopathological than 
tolerance. I propose that constitutive immune defences are by definition 
resistance responses, and that constitutive defences are selected for an 
ability to attack fundamental and conserved traits, with the secondary 
drawback of immunopathology. 
 
As discussed in Chapter 1, constitutive defences are activated 
immediately upon detection of parasites. Such defences are therefore 
under strong selection for generalism in their efficacy, capable of killing 
or neutralising the phylogenetically diverse array of parasites that a host 
may encounter. As such, they are also under selection to be largely non-
specific. Their effectiveness must also be stable over evolutionary time. 
Finally, constitutive defences must be rapid and potent in order to 
minimise colonization of the host by the parasite. I predict that selection 
for these functions favours constitutive immune effectors that attack 
highly-conserved physiological, cytological or histological traits. The 
downside of the generalist power of such effectors is that the conserved 
traits they attack are likely to be shared by both the parasites they attack 
and the hosts they protect. Consequently, there is an evolutionary-
biochemical argument that immunopathology should be associated with 
constitutive immune defences when these defences are involved in 
resisting a parasite.  
 
4.2.4 The putative biochemistry of tolerance 
 
Our understanding of the mechanistic bases of tolerance is thus far 
weak (Baucom and de Roode, 2010). Arguably, the dual phenomena of 
a long-lasting induced humoral immune response and coincident 
persistent infection in Tenebrio molitor (Haine et al., 2008a) is the only 
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study which makes a link between a particular functional group of 
immune effectors (i.e. unidentified soluble antimicrobial compounds, 
possibly AMPs) and a persistent sepsis: these phenomena are also 
consistent with tolerance. A complementary result from a recent study is 
that an insect AMP is required for control and maintenance of a 
symbiotic bacterium (Haag et al., 2011; Login et al., 2011). These results 
are significant for the current discussion because AMPs should not be 
toxic to metazoa (see thesis introduction), and so their putative role in 
tolerance responses is consistent with induced tolerance as a less costly 
alternative to resistance. Interestingly, there is biochemical evidence 
from the moth Manduca sexta that an inducible defence (lysozyme) 
inhibits autotoxic catalysis of prophenoloxidase, suggesting selection for 
induced defences to dampen the action of constitutive defences (Rao et 
al., 2010). 
 
4.2.5. Melanisation and immunopathology. 
 
It can be argued that any organism with an un-compartmentalised body 
cavity is selected for particularly potent constitutive defences. This is 
because any infection has the potential to become rapidly systemic, 
rather than being spatially confined by physical structures. This Bauplan 
also means that the autopathological effects of immune responses 
should manifest at an organismal level as toxins and reactive molecules 
are circulated around all tissues. As discussed in Chapter 1, melanin 
and the biochemical cascades involved in its production have been 
frequently used as metrics of invertebrate immune function (Rolff and 
Siva-Jothy, 2003; Eleftherianos et al., 2007; 2007; Pauwels et al., 2011; 
Laughton et al., 2011b) but also see (Cerenius et al., 2008). The 
antimicrobial killing power of melanisation is thought to be mediated by 
the production of highly toxic intermediates such as oxidized phenols, 
quinones and reactive oxygen species, anoxia induced by melanin 
deposition on cell surfaces (Nappi and Ottaviani, 2000; Zhao et al., 
2007), and externalising phagocytosed microbes by coating aggregated 
nodules of phagocytes in sclerotized melanic tissue. These cascades 
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are strong candidates as immune effectors with autopathological side-
effects, because these processes do not discriminate between 
prokaryotic and eukaryotic cells and are undertaken in the presence of 
both within the haemocoel (Figure 4.2.2). Furthermore, it ought to 
produce an easily measurable phenotype in the form of indiscriminate 
blackening of host tissues. 
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Figure 4.2.2. The potential of melanisation and melanin-producing 
cascades to act as an immunological “double-edged sword” 
Activation of melanin producing-pathways in response to infection leads 
to wanton melanin deposition and release of toxic by-products. These 
combat infection but can circulate freely in the open haemocoel, 
secondarily damaging to host tissue.  
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With specific reference to the system in hand, there is some 
circumstantial evidence that melanisation is associated with self-harm in 
Tenebrio, although it has rarely been framed as such and explicit 
experiments are scarce. The most direct example (Sadd and Siva-Jothy, 
2006) showed an association between melanisation of a nylon implant 
and decreased malpighian tubule function. Notably, this damage was not 
systemic, but that may have been because the nylon filament implant 
used to stimulate melanisation was spatially discrete. More recently, a 
strain-specific positive relationship has been demonstrated between 
Tenebrio mortality, PO activity and melanisation after infection with 
Aeromonas hydrophilia (Noonin et al., 2010), although it is impossible to 
form conclusions about causality in this case since there was no direct 
manipulation of PO. A more direct link between PO and fitness is given 
by a recent study showing an association between elevated larval PO 
activity stimulated by non-infectious material and reduced adult lifespan 
(Pursall, 2010; Pursall and Rolff, 2011), although these results are also 
correlative. The only experimental manipulation of Tenebrio melanisation 
activity to date showed that RNAi knockdown of a protein with a role in 
the negative regulation of melanisation was associated with rapid tissue 
melanisation and mortality (Zhao et al., 2005), but unfortunately this 
study did not address the interaction with pathogen resistance or 
tolerance. Armitage & Siva-Jothy (2005) showed that T. molitor selected 
for more melanic cuticle were both more immunocompetent and were 
better able to retain fitness after activation of melanin-producing 
pathways, suggesting variation in ability to cope with coincident self-
damage after melanisation. Perhaps the most compelling evidence that 
melanisation plays a role in determining resistance outcomes comes 
from an organism in which PO and melanin-associated immunity is 
understudied: a single mutation in a signaling protease involved in 
Drosophila’s melanisation response had dramatic and microbe-specific 
effects on resistance and tolerance (Ayres and Schneider, 2008). 
 
This chapter details a series of studies to test the hypothesis that 
immunopathology is a major cost of resistance responses. This is 
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intended to pave the way to understanding if autopathological immune 
processes drive the induction of tolerance. This is achieved by two 
experiments. The first aimed to measure what proportion of post-
infection fitness loss (virulence) is driven by immunopathology, by 
monitoring survival of beetles inoculated with a range of dead or live 
bacterial (S. aureus) challenges. Doses were varied because 
immunopathology is predicted to be proportional to dose, so variation in 
virulence after infection with dead cellular material can be attributed to 
self-damage. Insects are ideal models to address these questions 
because their open haemocoel means each individual is effectively a 
model abscess, and so infection and immunity are manifested at an 
organismal level with measurable fitness consequences. The second 
experiment consisted of dissecting beetles that had been inoculated with 
dead S. aureus and looking for morphological evidence of self-harm, 
specifically melanisation. 
 
4.3. Materials and methods 
 
4.3.1. Quantifying the contribution of immunopathology to host 
mortality 
 
A beetle survival study was performed to assess how much post-
infection fitness can be attributed to T. molitor’s reaction to dead 
bacterial cellular material (i.e. endogenous damage only), and how much 
to live bacteria at the same dose. Beetles were prepared for these 
studies exactly as in Chapter 3, with the following differences: 
 
1. Beetles were injected with bacteria grown from a single colony 
of S. aureus JLA513 (SH1000 background), grown in LB media with 
tetracycline at 5 !g ml-1 and amphotericin-B at 5.6 !g ml-1. In the 
preliminary study, S. aureus were cultured for 48h to allow time for them 
to enter stationary phase and deplete their media of nutrients. Since any 
immunopathological effects on post-infection fitness are predicted to be 
dose-dependent, three concentrations were used. Concentrations were 
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varied by aliquoting and centrifuging (5 minutes at 4500 rpm) the starting 
culture, then resuspending the pellets in 75%, 100% or 125% of the 
starting volume of supernatant. An aliquot of the supernatant was also 
taken. The resuspended cultures were split again, and one aliquot of 
each was killed by heat shock (12 minutes at 65c in a water bath). This 
created six aliquots of bacteria (Table 4.3.1.): live-high dose (LH), live-
medium dose (LM), live-low dose (LL), dead-high dose (DH), dead-
medium dose (DM) and dead-low dose (DL). In addition beetles were 
treated with supernatant (SN) to control for the effect of toxins released 
into the growth medium by S. aureus during growth. It was thought 
necessary to suspend the pelleted bacteria in this growth medium 
because live S. aureus will produce extracellular toxins in the host but 
dead bacteria will not. Suspending bacteria in toxic supernatant makes 
this problem systemic, and any difference between the survival of 
bacteria injected with the same dose of live or dead bacteria can 
therefore be attributed to variation in toxins. The difference between 
beetles treated with bacterial material and beetles treated with 
supernatant can be attributed to the presence or absence of cellular 
material. The treatments for this first survival study are listed in table 
4.3.1. 
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Table 4.3.1. S. aureus preparations inoculated into T. molitor 
before monitoring beetle survival 
Abbreviation Description CFU x 10-5 
DH Dead bacteria, high dose 550 (dead) 
DM Dead bacteria, medium dose 263 (dead) 
DL Dead bacteria, low dose 154 (dead) 
LH Live bacteria, high dose 550 
LM Live bacteria, medium dose 263 
LL Live bacteria, low dose 154 
SN Supernatant: S. aureus toxins 0 
PBS Sterile PBS: wounding control n/a 
C Untreated controls n/a 
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2. All beetles used in these experiments were sexed and 
individually isolated as pupae from long-term stocks at the University of 
Sheffield. All beetles were treated seven days after imaginal eclosion, 
and 25 individuals were used per treatment. Shortly after the experiment 
was completed it became apparent that this stock of beetles was 
infected with microsporidia, and it is possible that this infection was 
present in the beetles used in the survival study. 
  
4.3.2. Assessment of self-melanisation after live and dead bacterial 
challenges 
 
To assess beetle-driven blackening of self-tissues after inoculation with 
bacteria, 10 adult virgin T. molitor were injected with 5!l dead (heat-
shocked by 12 minutes at 65c in a water bath) 24h culture of S. aureus 
JLA 513 (c. 107 cells) as described above and in Chapter 3. These cells 
were pelleted from washed and suspended in a volume of sterile PBS 
equal to the volume of growth medium the culture was grown in. The 
inviability of heat-killed bacteria was confirmed by spreading a 
suspension of these bacteria on LB agar (1.5%). 10 controls were 
injected with 5!l of sterile PBS. 
 
Observations of melanisation were conducted by dissecting Tenebrio 
elytra and wings and entering the abdomen through the exposed plural 
membrane. These dissections were conducted 36-48h after infection. 
Beetles were preserved for up to a week in 100% absolute EtOH before 
dissection. Images were taken on a MicroPublisher 3.3 RTV camera 
(QImaging, Burnaby, BC, Canada) attached to either a Leica dissecting 
stereoscope or Leitz Diaplan compound microscope (Wetzlar, Hessen, 
Germany). 
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4.4. Results  
 
4.4.1. Comparing survival of T. molitor inoculated with dead or 
living S. aureus 
 
Survival curves of treated beetles are presented in Figure 5.4.1.1a. 
Beetles treated with live or dead S. aureus or S. aureus culture 
supernatant died quicker than untreated or PBS-treated controls over 
the first seven days after treatment (figure 5.4.1.1b). Over these first few 
days all beetles treated with S. aureus cellular material died at a greater 
rate than those treated with supernatant toxins, PBS, or untreated 
controls; apart from those given a low dose of dead cells. However, 
supernatant also negatively affected beetle survival.  
 
A Cox’s proportional hazards model was fitted to these data, which 
suggested an increase in mortality hazard (relative to untreated controls) 
of beetles treated with live or dead S. aureus cellular material (excluding 
a low dose of live cells), which is marginally not but significantly greater 
in magnitude than the risk of mortality of supernatant-treated beetles 
(Table 5.4.1, Figures 4.4.1.2. & 4.4.1.3). Hazard ratios from the model 
are presented in Figure 4.3.1.4. 
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Figure 4.4.1.1. Survival of T. molitor infected with varied doses of dead and live S. aureus, showing (A) all data to day 60 
and (B) the initial ten days after inoculation 
T. molitor were injected with varied doses of dead and live S. aureus and their survival was monitored daily, to assess the relative 
contributions of microbe and host to virulence. 
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Table 4.4.1. Survival of T. molitor after inoculation with dead and live S. 
aureus: Cox’s proportional hazards model output 
Treatment Coefficient 
(Intercept = 
untreated 
controls) 
Wald statistic Z-statistic Pr(>|z|) 
DH 0.8835 0.3061 2.89 0.0039 
DL 0.8350 0.3065 2.72 0.0064 
DM 0.9567 0.3117 3.07 0.0021 
LH 1.5004 0.3215 4.67 <0.0001 
LL 0.4617 0.3108 1.49 0.1375 
LM 0.9749 0.3064 3.18 0.0015 
PBS 0.0552 0.3067 0.18 0.8572 
SN 0.6876 0.3148 2.18 0.0290 
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Figure 4.4.1.2. Survival study - mortality hazard functions (Cox’s 
proportional hazards model) 
T. molitor were inoculated with varied doses of dead (red) and live 
(black) S. aureus, to assess the relative contributions of host and 
microbial pathology to host survival. There was a greater but non-
significant hazard of mortality for beetles injected with dead bacteria 
than those injected with the solvent in which the dead bacteria were 
suspended, suggesting that endogenous pathology negatively impacts 
on host survival. See Table 4.3.1 for treatment key. 
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Figure 4.4.1.3. Factoral change in risk of mortality of T. molitor 
injected with dead (red) and live (black) bacterial challenges, and 
treatment controls (PBS and S. aureus toxins; dark and light blue 
respectively) 
T. molitor were inoculated with varied doses of dead and live S. aureus 
and a Cox’s proportional hazards model was fitted to the data. 
Exponentiating the coefficients of the model give the change in risk of 
mortality relative to the intercept (untreated controls). See Table 4.3.1 for 
treatment key. 
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Figure 4.3.1.4. Hazard ratios of T. molitor infected with dead and 
live S. aureus. 
T. molitor were injected with varied doses of dead and live S. aureus and 
a Cox’s proportional hazards model was fit to the survival data. This 
figure shows the hazard coefficients and confidence intervals from the 
model. The dashed line represents the survival coefficient of dead/high 
(DH) dose-treated beetles. See Table 4.3.1 for treatment key.  
Hazard Ratio
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
trt - C:DH
trt - DL:DH
trt - DM:DH
0.9
9 0.9 0.7 0.8 0.9
5
trt - LH:DH
trt - LL:DH
trt - LM:DH
trt - PBS:DH
trt - SN:DH
! 133 
4.4.2. Observations of self-melanisation after inoculation with dead 
and live bacteria 
 
PBS-injected beetles had clear, white fat body tissue that showed no 
apparent discolouration (examples in Figure 4.4.2.1a) In contrast, 
beetles injected with cellular suspensions developed melanised nodules 
throughout the abdominal haemocoel (Figure 4.4.2.1b). There were no 
qualitative differences between beetles treated with either live or dead 
bacteria. Blackening of the dorsoventral area of the pleural membrane in 
the downstream region of the dorsal vessel was commonly observed. 
These observations demonstrate systemic self-melanisation after a 
simulated bacterial challenge. 
 
Interestingly, fine dissection of tissue nodules and blackened 
membranes revealed that microsporidia-like cells were commonly 
associated with melanic deposits (Figure 4.4.2.4). These cells were not 
associated with melanic deposits in PBS-injected beetles (Figure 
4.4.2.3).  !! !
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Figure 4.4.2.1. Exemplar dorsal views of T. molitor abdomens 72 
hour after injection with sterile PBS (A) or dead S. aureus (B).  
T. molitor were injected with dead bacteria to stimulate an immune 
response, and the abdomens of inoculated animals was compared to 
those of healthy individuals injected with sterile saline, after elytra and 
wings were removed. Injection of dead bacterial matter stimulates and 
immune response in the absence of prolonged pathology from the 
inoculum. The profound blackening and wasting of tissues shown in 
panel B can therefore be attributed to endogenous host processes. 
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Figure 4.4.2.2. Dissected T. molitor fat body, 72 hours after 
infection with dead S. aureus. 
T. molitor were injected with dead bacteria to stimulate an immune 
response in the absence of prolonged pathology from the inoculum. This 
micrograph shows dark melanised deposits on dissected fat body tissue, 
deposited by the host in response to injection of dead bacteria. Such 
deposits were found throughout the haemocoels of immune-challenged 
beetles. 
 
  
!""#$%
! 136 
 
 
 
Figure 4.4.2.3. Phase-contrast micrograph, showing dissected 
microsporidia-like cells attached the inner surface of the pleural 
membrane of PBS-injected T. molitor 
 
When microsporidia-like cells were found in T. molitor whose immune 
systems had not been activated by injection with dead bacterial matter, 
they were not associated with melanic deposits. 
!"#$%#
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Figure 4.4.2.4. Melanic deposits on microsporidia-like cells from T. molitor infected with dead S. aureus, dissected from 
the inner surface of the abdominal plural membrane.  
Melanin is associated with microsporidia-like cells in T. molitor only after the beetle is injected with dead bacterial matter: (A) Plan 
view of dissected melanic spots. (B) Phase-contrast micrograph, showing a close magnification of melanised microsporidia-like 
cells.!
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#$"%&"#$$"%&"
'"
! 138 
4.5. Discussion 
 
The two experiments described were designed with the goal of 
assessing what proportion of virulence in T. molitor can be attributed to 
immunopathology, and whether there is morphological evidence of 
attacks on self-tissue after infection. Some inference can be drawn from 
the results, particularly in light of published literature about the functions 
of PO, melanin and immunopathology in a wider sense. However results 
from the survival study should be treated with care due to the potentially 
confounding effect of suspending bacterial preparations in culture 
supernatant. There are clear negative effects of being injected with 
supernatant, which may mask the fitness effects of inoculation with 
bacterial material. 
 
Survival of beetles treated with dead or live S. aureus (Figure 4.4.1.1) 
ranks as predicted, with a consistently greater risk of mortality in beetles 
treated with bacterial cellular material (apart from treatment LL) than in 
beetles treated with toxins (Figure 4.4.1.3 & Table 4.4.1). Notably, 
Figure 4.4.1.1b suggests that the differences between groups arose 
mostly over the first week after treatment, consistent with the proposition 
that the initial phases of immune responses are responsible for fitness 
loss. However the differences between the groups treated with 
supernatant and cellular material were not significant, so the toxic effects 
of the supernatant solvent cannot be separated from effects caused by 
immunopathology. The lack of significance in these data is likely 
accentuated by the relatively small sample sizes (25 per group).  
 
These observations suggest that a further study with a larger sample 
size and bacterial preparations suspended in a non-toxic solvent might 
yield stronger positive results, particularly if a different analytical 
approach were used to compartmentalize mortality over discrete periods 
of the survival curve. There would be particular value in focusing on the 
first ten days after inoculation, because this appears is when the majority 
of fitness is lost in beetles treated with bacterial cellular material, 
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because this is when constitutive defences are most active, and 
because this period is most relevant for fitness in the wild. Although I 
attempted such a study, uncontrollable factors led to the failure of that 
particular experiment (see Appendix 4), and it could not be repeated due 
to time constraints. However it is of course also possible that survival is 
not a suitable proxy for immunopathological damage – indeed the idea 
that investment in immunopathological effectors is condition-dependent 
to some extent predicts this – or that the hypothesis is simply void. The 
numerous autocorrelations between harmful processes during the initial 
days after inoculation (wounding, pathogen-derived toxicity, 
immunopathology, and potentially tolerance) mean that a successful 
iteration of this experiment should ideally incorporate mechanistic 
manipulations, e.g. RNAi knockdown of proPO or melanin-inhibitory 
protein, which should respectively restore or further compromise survival 
after inoculation with dead bacteria if immunopathology does indeed 
compromise survival. 
 
The observation of systemic melanisation of the haemocoel tissues in 
response to inoculation with dead bacteria is important for two reasons. 
First, it provides a new piece of circumstantial evidence that melanin and 
sclerotisation are important antibacterial immune effectors in insects. 
This accords with a growing body of more quantitative experimental data 
demonstrating an important role in resistance responses (Zhao et al., 
2007; Cerenius et al., 2008; Pauwels et al., 2011). If this is taken as 
granted, then the second implication of these results is that the 
observations of self-melanisation and blackened microsporidia suggest 
that constitutive defences have been selected for nondiscriminatory 
attacks on biological material: providing a link between a modulated and 
easily quantified defence effector, the benefits of antimicrobial defence, 
and the costs of immunopathological collateral damage (Sadd and Siva-
Jothy, 2006). A worthwhile sequel to these qualitative observations 
would be to quantify accrual of melanised tissue over a week after 
inoculation with dead and live bacteria, and measuring the temporal 
dynamics of PO and proPO over the week after inoculation would be 
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informative. If auto-melanisation is self-damaging and necessitates 
investment in alternative routes to infection management, and then PO 
activity should be coincident with intensive infection, and should 
negatively correlate induced antimicrobial activity. proPO should be 
depleted over time, in order to cut off the supply of immunological tools 
with which the host could further damage itself. 
 
Should the principles outlined in this chapter withstand further testing, 
then the dominant paradigm of invertebrate immunology would be 
refined. The recent recognition of tolerance in animal systems has 
expanded the conception of what animal immune systems can actually 
do, showing that they are subtler than just blunt instruments for the 
elimination of parasites. Clearly there are situations when it is more 
advantageous for a host to allow parasites to live in its tissues than to 
remove them, and I suggest that avoiding immunopathology is 
intrinsically linked to these situations. Parasites are by definition not 
cost-neutral, suggesting that they should only be tolerated if the costs of 
their removal are greater than those of their tolerance. Since many of the 
costs of immunity are fixed overheads (Schmid-Hempel, 2011), 
autopathological immune effectors are strong candidates for tipping the 
scales of cost and benefit sufficiently to alter the optimum immunological 
strategy from resistance to tolerance.  
 
To summarise, hosts’ constitutive defences will be selected for functions 
that will make them secondarily autotoxic. If immune responses and 
therefore their constituent effectors are graded on a continuum between 
resistance and tolerance responses, then we predict that resistance 
responses will be immunopathological, because resistance should be 
the optimal strategy when an infection is established, and constitutive 
defences are used to control the first phase of an infection. However the 
optimality of resistance will change as the cumulative costs of resistance 
reach a threshold value and parasite densities are diminished. At this 
point less autotoxic immune effectors should be transcribed, with the 
tradeoff that they are less potently antimicrobial. There are no published 
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studies on how immunological transcriptomes change over time after 
bacterial infection, but a shifting assemblage of immune effectors from 
autoreactive and nonspecifically toxic molecules to specific disruptors of 
microbial physiology would be consistent with a switch from resistance 
to tolerance.  
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Chapter Five 
 
Identification of immuno-modulated 
expressed sequence tags in 
Tenebrio molitor by suppressive 
subtractive hybridization 
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5.1. Abstract 
 
Tenebrio molitor is constrained as a study system by a lack of molecular 
sequence data to complement physiological studies of immunity. A 
deeper understanding of the mechanistic bases of T. molitor responses 
to S. aureus infection could support the principle that immunopathology 
is important in determining the dynamics of infection and host mortality 
in this organism. It would also be a boon for future researchers using this 
beetle as a study system, for example in studies of its long-lasting 
immunity. Consequently T. molitor were infected with S. aureus, and 
immunomodulated expressed sequence tags (ESTs) were cloned and 
sequenced by Suppressive Subtractive Hybridisation. The output 
sequence data were assigned Gene Ontologies using Blast2GO, to 
predict functions. The data suggest that infected T. molitor produce 
enzymes with potential to harm both microbial parasites and the host, 
and therefore that immunopathology could be a strong determinant of 
immunity in this system. 
 
5.2. Introduction 
 
5.2.1. Why sequence T. molitor? 
 
Tenebrio molitor is an emerging model study system. The primary 
scientific reasons for its use are that its large body permits extraction of 
relatively large volumes of haemolymph (up to around 10!l can be easily 
extracted) giving it a distinct edge over Drosophila. These volumes 
facilitate physiological assays (e.g. Barnes and Siva-Jothy, 2000) or 
biochemical studies (e.g. Zhao et al., 2005). In combination with 
Staphylococcus aureus it provides an ideal system to study persistent 
infection in insects (Haine et al., 2008a). T. molitor’s main drawback as 
an immunological study system is the paucity of genomic and 
transcriptomic sequence data to describe its immune response, and 
functional manipulations are not possible on the same scale as in other 
insects, e.g. Tribolium castaneum (Bucher et al., 2002; Knorr et al., 
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2009), Drosophila (Ayres and Schneider, 2008). Our knowledge of the 
mechanisms of T. molitor immunity is based on biochemical studies 
(Moon et al., 1994a; Zhao et al., 2005; Fabrick et al., 2009; Jiang et al., 
2011), or circumstantial inference (Haine et al., 2008a), which would be 
well-complemented by molecular sequence data. 
 
It is also useful to begin to develop an understanding of the 
transcriptional changes in T. molitor specifically in response to 
Staphylococcus aureus, to begin to fill in the mechanistic blanks in on-
going projects using this beetle as a model organism. In terms of work 
included so far in this thesis, it would be informative to know whether 
mRNAs for enzymes with potential to cause autopathology are 
abundantly transcribed shortly after detection of S. aureus. Such a 
finding would be consistent with the hypothesis that self-damaging 
immune effectors have not been selected against because generalist 
toxicity is a fundamental requirement of resistance to microbial infection. 
With transcriptomic information, future research could test this idea 
through loss-of-function studies. Transcriptomic data could also be used 
to test the proposal that long-lasting induced humoral immunity has 
evolved in T. molitor as a mechanism to control persistent infection 
(Haine et al., 2008a). This goal could be achieved by monitoring 
transcription of specific compounds along the time course of the long-
lasting immune response, followed by specific knockdown of constituent 
effectors of long-lasting immunity. Such investigations of long-lasting T. 
molitor immunity would be a step towards pinning functions in parasite 
tolerance to specific immune effectors. 
 
5.2.2. Suppressive subtractive hybridisation: an overview, and 
application in this study 
 
Modern high-throughput ‘next-gen’ molecular sequencing technology is 
rapidly producing a massive edifice of data, by capturing the full diversity 
of RNA or DNA of the organisms it is used to sequence. These 
techniques permit thorough and rigorous analysis of the full diversity of 
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nucleic acids in a sample, which hugely enriches our insight into how 
organisms and evolution work. Additionally, full transcriptome analysis, 
for example using RNA-seq technology, allows creation of contigs that 
can be paired with proteomic data. These approaches are hugely 
valuable, but are not always the best fit for purpose. If, for example, a 
researcher is interested in responses to a specific treatment, next-gen 
technology will provide a thorough answer, but it will often be buried in 
volumes of extraneous data that can only be removed with time-
consuming bioinformatic analysis. The present study requires a 
qualitative assessment of a targeted subset of T. molitor’s transcriptome 
in response to S. aureus infection, for which next-gen sequencing would 
be overkill.  
 
Suppressive subtractive hybridisation (SSH) is a means to a handle on 
the transcriptome of S. aureus-infected T. molitor, although it has now 
largely been superseded by next-gen sequencing technology. It is a 
selective PCR-based transcriptomic method used to amplify and clone 
cDNAs that are differentially expressed in two samples. It can be used to 
detect transcriptional differences between “driver” cDNA from treated 
experimental subjects and controls, by hybridising and removing 
equimolar cDNAs, leaving only cDNAs over-expressed in the driver 
population. Also, because SSH randomly samples mRNAs from the full 
diversity of the transcriptome, the probability of transcripts associated 
with a certain gene being returned in the final analysis is related to the 
abundance of transcripts of that gene. It is therefore a semi-quantitative 
approach to transcriptomic sequencing. It lacks the depth and breadth of 
next-gen technologies like 454 and Illumina, but it is a cheaper, less 
labour-intensive approach to revealing qualitative differences in 
expression.  
 
The output of SSH is a collection of expressed sequences tags (ESTs) – 
mRNA sequences between around 0.1 – 1 mb long that can then be 
used in subsequent expression studies. Here, SSH is used to 
characterise expressed sequence tags (ESTs) from T. molitor infected 
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with S. aureus. Output ESTs were mapped with Gene Ontologies (GOs) 
(Conesa et al., 2005). GOs are useful new tools for molecular biologists, 
facilitating classification of genes using a standardised syntax. They 
allow classification of genes based on the cellular component in which 
they occur, the molecular function of the product, and the functional 
biological significance of the product. Once sequences had been 
mapped to GOs, upregulation of output from the SSH was validated by 
quantitative real-time PCR.!
 
5.3. Materials and methods 
 
All experimental work was conducted at the Institute of Phytopathology 
and Applied Zoology, Justus-Liebig-Universität Gießen, Germany. 
Sequencing was outsourced to GATC (Konstanz, Germany). Further 
confirmation of immune responses and sequence data by qPCR was 
conducted at the University of Sheffield. 
 
5.3.1. Larval and bacterial culture 
 
T. molitor larvae used to generate cDNA for SSH were purchased from a 
commercial supplier (Fressnapf, Germany) and maintained in ground 
meal with apple at 28oC in the dark. For qPCR analyses, larvae from 
long-term cultures maintained at the University of Sheffield were raised 
on ground rat chow (Harlan Laboratories, UK) and apple in an insectary 
at 26oC ±1 in a 12:12 light/dark cycle. Bacteria were grown by 
inoculating a single colony of S. aureus (SH1000 tetracycline-resistant 
strain JLA513, kindly supplied by Simon Foster, University of Sheffield) 
into Luria-Bertani (LB) medium supplemented with 5 !g ml-1 tetracycline 
and 5.6 !g ml-1 amphotericin-B. This preparation was grown for 48 hours 
at 30oC, allowing the culture to reach stationary phase in accordance 
with previous Tenebrio infection studies (Haine et al., 2008a). 
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5.3.2. Infection and RNA extraction 
 
For creation of a cDNA library larval Tenebrio were used rather than 
imagoes for their large fat body and subsequently higher mRNA yields, 
and to circumvent diluting the source pool of mRNA with heavily 
transcribed sex-related genes in adults. 
 
Fourteen final-instar larvae were chilled on ice for 15 minutes, and then 
a small patch of the dorso-posterior surface of the animals was swabbed 
with 80% EtOH. A sterile pin was used to pierce between the third and 
fourth body segments, through which 6.3 x 104 CFU of S. aureus culture 
suspended in 5 !l LB was injected via a sterilised glass needle. Fourteen 
controls were injected with sterile PBS. 
 
RNA was extracted eight hours post-infection, since previous studies 
have shown strong transcription at this interval post-infection in insects 
(Altincicek et al., 2008b; Vogel et al., 2011b). Larvae were homogenized 
in liquid nitrogen, and stored at -80oC.  
 
RNA was isolated from homogenate by phenol-chloroform extraction. 
Around 10 mg of frozen homogenate was suspended in 1 ml Triazol 
(Molecular Research Center, TR-118) and vortexed, before adding 150 
!l 1-Bromo-3-chloropropane (Sigma B9673). This preparation was 
vortexed and allowed to stand two minutes at room temperature, then 
five minutes on ice. It was centrifuged (10 minutes at 4oC, 16000 g), 
before adding the transparent phase to 550 !l isopropanol and 
incubating this mixture at 4oC for 24 hours. The incubated preparations 
were centrifuged (30 minutes, 4oC, 16000 g), and the supernatants 
removed. 80% ethanol was added to the pellets, which were then spun 
again (10 minutes, 4oC, 16000 g) to precipitate RNA. The supernatants 
were removed and the pellets dried for 10 minutes on ice. Pellets were 
then dissolved in RNA storage solution (Ambion, AM7000) and stored at 
-20oC. 
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5.3.3. Constructing a subtracted cDNA library 
 
cDNA was constructed from extracted RNA using a SMART PCR cDNA 
Synthesis Kit (Clontech, 634902). Sequences over-expressed in “driver” 
cDNA (derived from experimental animals) relative to controls were 
isolated using the PCR-select cDNA subtraction kit (Clontech, 120911). 
Both kits were used according the protocols described by Altincicek & 
Vilcinskas (2007). 
 
5.3.4. Cloning and sequencing 
 
cDNA probes were transformed into competent E. coli supplied with a 
pGEM-t-Easy kit (Promega A1360). These cells were plated on LB 1% 
agar, and 288 clones were randomly selected and inoculated into soft 
agar on three 96-well plates. These plates were incubated overnight at 
37oC, and then sent to a commercial sequencing provider (GATC, 
Konstanz, Germany). 
 
5.3.5. Bioinformatic analyses 
 
Vector sequences were removed using seqtrim 
(http://www.scbi.uma.es/cgi-bin/seqtrim/seqtrim_login.cgi, (Falgueras et 
al., 2010) and trimmed sequences were searched against the NCBI non-
redundant protein database using BLAST2GO (http://www.blast2go.org, 
(Conesa et al., 2005). Trimmed sequences were assembled using cap3 
(95% sequence identity, 30 bp overlap). Sequences retrieving a BLASTx 
hit with an e-value of <10-3 were mapped for gene ontologies (GOs) and 
annotated. 82 of the 189 BLAST-searched sequences were annotated 
with GOs. Further analyses were only performed on annotated 
sequences.  
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5.3.6. Quantitative PCR 
 
q-PCR was performed on an Applied Biosystems StepOnePlus platform, 
using iTaq SYBR Green Supermix With ROX (BioRad 172-5851) with 5 
ng of cDNA per 15 !l reaction, according to the instructions of the 
manufacturer.  
 
Primers were designed for sequences aligned with known immune 
effectors (Table 5.1) using Primer3 (http://frodo.wi.mit.edu/primer3) 
according to the parameters described in Appendix 8. Primers that 
annealed to secondary target sequence structures predicted by the 
mfold web app (http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-
Form; (Zuker, 2003), or that exhibited self-complementarity (predicted by 
OligoCalc: http://www.basic.northwestern.edu/biotools/oligocalc.html; 
(Kibbe, 2007) were excluded. Since qPCR was performed to validate the 
SSH (i.e. to ensure that S. aureus infection of Tenebrio induces an 
immune response) expression of the previously sequenced Tenebrio 
immunological genes Tenecin-1 (Moon et al., 1994a) and pro-
phenoloxidase (NCBI accession number AB020738.1) were also 
included in the qPCR analysis. Confirming the up-regulation of these 
sequences would constitute a confirmed panel of immune effector 
sequences available for future studies. I used a ribosomal protein 
(rpl27a, NCBI accession number X99204.1) as an internal control 
because this gene should be constitutively expressed. Relative 
expression was calculated as the exponent of the CT value of the control 
gene minus that of the target genes. 
 
cDNA from the original SSH experiment was unavailable for qPCR 
confirmation. Therefore qPCR of these sequences was performed on 
pooled cDNA from Tenebrio larvae drawn from long-term stocks at the 
University of Sheffield that were treated exactly as the animals used to 
generate cDNA for the initial SSH (13 individuals injected with S. aureus, 
13 with PBS). This opens these experiments to the possibility of 
confounding inter-population differences in the specifics of immunity, but 
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a broad pattern of up-regulation of immunoresponsive genes suggests 
effective treatment. RNA extraction was replicated twice and both 
samples were run used in the assay, replicated twice for each gene of 
interest, generating four CT values per gene per treatment or control 
larvae. The most conservative CT value was used. 
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Table 5.3.1. Primers used for qPCR 
Alignment NCBI 
accession 
number 
Left primer 5’-3’ Right primer 5’-3’ 
Multicopper oxidase n/a GTGACATCTCGTGGTCCTCTC CAGGCTACTGGTTGTTCCACT 
Tyrosine hydroxylase n/a TTCACGACTCCGCTTTCTTT AATTGGACTTGCTTCACTTGG 
Ferritin n/a GGGTCGGTCTTGATTTCTTGT AAGGCAATAGTCGCATCCA 
Attacin 2 n/a TCCACCTTCCATTTCGTTTC ATTCACCTCTTTGGCGTTTG 
Tenecin 1 D17670.1 GGAAGCGGCAACAGCTGAAGAAAT AACGCAGACCCTCTTTCCGTTACA 
ProPO AB020738.1 GCACGAGCTGGAATTGTGT GGTCGAACAACAGGAGGATG 
Ribosomal protein L27a X99204.1 
 
GCATGGCAAACACAGAAAGCATC ATGACAGGTTGGTTAGGCAGGC 
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5.4. Results & discussion 
 
The SSH analysis produced a clutch of positive reads from sequencing 
of pooled subtracted mRNA from T. molitor larvae eight hours post-
infection. Many of these sequences aligned strongly with sequences of 
known immunological relevance from other species, including a number 
of proteins with known auto-reactive functions. Sequences with 
promising immunological alignments are discussed below, categorised 
by functional group.  
 
5.4.1. Subtracted cDNA library sequencing & predicted functions 
 
Blast2GO revealed that 82 of the 288 clones produced by the SSH 
yielded ESTs showing ontologies with known genes (Appendix 5). These 
were primarily with other insect species and 55 further unknown 
sequences, including 5 contigs.  
 
Figures 5.3.1 and 5.3.2 respectively show the breakdown of GOs in 
molecular and biological function at GO level 3. ESTs with known 
ontologies are discussed in detail below. 
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Fig 2. Gene ontologies: Biological process (Ontology level 3) !
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Fig 1. Gene ontologies: Molecular function (Ontology level 3) !
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Figure 5.3.1. Annotated SSH results: Molecular function GOs (level 3) 
Sequences produced by SSH analysis were annotated with gene ontologies (GOs) to putatively assign them functions 
based on those of homologous sequences. The detail of these proposed functions is based on the “level” of ontologies, 
which determines how many connections are made between each sequence and functions of homologs. This figure shows 
GOs for molecular function at level 3. 
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!"#$%&'()*)+)',"-.-#"/0.'1%-/&22'342'534'.&6&.'*7'Figure 5.3.2. Annotated SSH results: Biological processes GOs (level 3) 
Sequences produced by SSH analysis were annotated with gene ontologies (GOs) to putatively assign them functions 
based on those of homologous sequences. The detail of these proposed functions is based on the “level” of ontologies, 
which determines how many connections are made between each sequence and functions of homologs. This figure shows 
GOs for biological processes at level 3. 
! 155 
5.4.1.1a. Immune defence - signalling 
 
Once an infection has breached an insect’s dermal tissues, the first step 
of an immune response is the detection of invading microbes. Molecules 
for this purpose can be crudely categorised as receptors known as 
pattern recognition-receptors (PRRs) that specifically bind microbe-
associated molecular patterns, or pro-enzymes that are activated upon 
incubation with microbes. The SSH returned an mRNA sequence hit 
aligning with a beta-glucan recognition protein. Beta-glucans are 
fundamental carbohydrate components of bacterial cell walls, making 
them suitable targets for PRRs such as the beta-glucan recognition 
protein returned by the SSH (Jiang et al., 2004).  
 
5.4.1.1b. Immune defence – Enzymatic defences 
 
The SSH revealed numerous oxidative and reductive enzymes, 
hydrolases, and proteases (Figures 5.3.1 & 5.3.2). Such enzymes are 
implicated in enzymatic cascades associated with melanin production 
(Zhao et al., 2007; Dittmer and Kanost, 2010; Prasain et al., 2012), in 
agreement with previous work showing that melanin production is 
important in fighting bacterial infection. These include a laccase, tyrosine 
hydroxylase, multicopper oxidase, dopa decarboxylase, and quinone 
oxidoreductase. Interestingly I did not detect differential expression of 
any prophenoloxidases (proPOs), suggesting that the frequent 
measurement of proPOs as a metric of investment in immunity may be 
misleading (consistent with Christensen et al., 2005), and that the roles 
of other enzymes in melanin production and invertebrate immunity ought 
to be considered more thoroughly and frequently.  
 
22 ESTs associated with such oxidative enzymes were present in the 
pool (Appendix 5). Since SSH is a semi-quantitative process, the 
prevalence of these transcripts in the SSH output suggests that these 
enzymes are important mediators of immunity. Finding mRNAs for such 
oxidative enzymes is particularly important in light of the ideas proposed 
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in Chapter 4.  Such oxidative enzymes produce toxic secondary 
products that can damage both host and parasite (reviewed in Gillespie 
et al., 1997; and chapters in Rolff and Reynolds, 2009).  
 
5.4.1.1c. Immune defence – Iron scavengers 
 
The SSH output contained 25 molecular function GOs for ion binding 
(Figure 1), largely comprising transferrins and ferritins. These enzymes 
scavenge iron (Beasley et al., 2011), thereby impairing microbial 
metabolism and increasing stress (Hammer and Skaar, 2011). For 
Staphylococci in particular, iron is a an important nutrient: iron-starved S. 
aureus struggle to grow in its absence, and iron paucity promotes biofilm 
formation as a stress response in vitro (Johnson et al., 2005). Bacteria in 
biofilms switch to persistence phenotypes and grow more slowly than in 
ideal culture conditions (Lewis, 2001; Balaban, 2004; Lewis, 2005). It is 
conceivable that reduced host tissue iron content could slow growth of 
infection as a tolerance strategy, by stimulating infectious bacteria to 
activate pathways normally associated with stressed phenotypes, 
consistent with predictions about the ultimate function of long-lasting 
immune responses (Schneider and Chambers, 2008). The ability to 
acquire iron has been shown to be crucial for virulence of the 
entomopathogenic bacterium Photorhabdus luminescens (Watson et al., 
2010), substantiating the idea of selection for hosts to deprive infectious 
bacteria of iron. However, by upsetting iron homeostasis these defences 
also likely incur physiological costs of use. 
 
5.4.1.1.d. Immune defence – Antimicrobial peptides 
 
The SSH yielded ESTs that aligned with two antimicrobial peptides. 
BLAST2GO aligned one EST with an antimicrobial peptide from 
Tribolium castaneum (Coleoptericin). A second aligned with a predicted 
AMP (cp1) from the T. castaneum genome (NCBI reference sequence: 
XM_001809585.1), which is thought to be an attacin and has recently 
been discovered by a parallel SSH analysis in the burying beetle 
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Nicrophorus vespiloides (Vogel et al., 2011b). Interestingly, attacins are 
active only against growing gram-negative bacteria (Carlsson et al., 
1991; 1998). The expression of this AMP in response to stationary-
phase gram-positive bacteria suggests that the transcription of a range 
of AMPs is conjoined regardless of whether the products are effective 
against the infection, substantiating the suggestion that AMPs may 
interact in yet-unknown ways in vivo (Chapter 2).  
 
5.4.1.2. Stress-associated proteins 
 
Immune responses are often associated with the transcription of stress-
associated genes (Altincicek et al., 2008b; Vogel et al., 2011a). T. 
molitor expressed cytochrome p450, known for a role in detoxification 
post-infection (Chahine and O'Donnell, 2011; Chung et al., 2011). One 
sequence in particular, aligned with stress-induced phosphoprotein 1, 
showed ontologies with various aspects of stress management, 
development and immune function.  
 
5.4.1.3 Other GO-annotated sequences 
 
In addition to detecting ESTs directly involved in the immune response, it 
is likely that the SSH process has detected ESTs associated with 
second order effects of immune challenge, which are involved in other 
metabolic, physiological and transcriptional processes. Based on the 
scheme of Altincicek et al (2008b) these transcripts are classified by 
involvement in metabolism, protein biogenesis and transcription, and 
development. There were also a number of sequences for which it was 
impossible to propose a classification. This study is concerned with 
finding effectors of immunity for future functional studies. Therefore, 
although transcription of these ESTs with functions other than parasite 
management must be modulated by infection in order for the SSH to 
detect them, they are not directly relevant to the present study, and so 
are listed separately in Appendix 5. 
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5.4.2. qPCR confirmation of immune responses 
 
qPCR was used to validate the SSH technique by confirming that 
infecting larvae with S. aureus had indeed caused up-regulation of the 
ESTs returned by the SSH and caused an immune response. 
Attacin/cp1, Tenecin 1, and tyrosine hydroxylase showed strongly up-
regulated expression after immune challenge, and multicopper oxidase 
and pro-phenoloxidase showed marginally up-regulated expression 
(Figure 5.4.1). This confirms both that the outputs from the SSH are up-
regulated after infecting T. molitor larvae with S. aureus, and that this 
treatment causes an immune response. 
 
Although qPCR showed a broad pattern of up-regulation of the target 
genes, infection was not associated with stronger expression of ferritin. 
This result was surprising, since the high frequency of ferritin reads in 
the pool of 288 sequences suggests that this mRNA was abundant. The 
strong expression of ferritin in the qPCR control group suggested that it 
is constitutively highly expressed regardless of treatment, and that 
redundant cDNAs have caused a false positive in the SSH. However this 
is a potential issue with any transcriptomic experiment. It is also possible 
that this discrepancy is due to the use of different larval populations to 
generate cDNA for the SSH and qPCR analyses.  
 
With the exception of ferritin, the broad up-regulation of the target 
immune effectors in infected larvae suggests that the sequence data 
produced by the SSH are reliable, and up-regulated in response to S. 
aureus infection. This affirms the validity of the SSH methodology.   
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Figure 5.4.1. Expression of immunomodulated sequences identified 
by SSH, relative to ribosomal control gene rpl27a. 
Expression of genes of interest was measured by qPCR to affirm up-
regulation of immunomodulated T. molitor genes after S. aureus 
infection. Expression of each gene of interest was calculated relative to 
a ribosomal control gene by exponentiating the difference between CT 
values produced by target genes and control genes. 
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5.5. Summary and perspective 
 
This experiment has revealed that a great diversity of mRNAs are 
detectable in T. molitor after infection with S. aureus. Many of these 
mRNAs align with others from databases that code for proteins with 
known immunological functions. A subset of these effectors - such as 
laccases, tyrosine hydroxylases, multicopper oxidases and quinone 
oxidoreductase – are involved in production of toxins that would be toxic 
to both the beetle and S. aureus infection when they are circulated 
around the haemocoel. These data are not proof of the essential role of 
generalist toxicity in resistance responses suggested in Chapter 4, but 
they are strongly consistent with this hypothesis. It would be informative 
to quantify expression of immune effectors with predicted autotoxic side-
effects over the time-course of T. molitor’s immune response, and to see 
if their knockdown reduces self-melanisation and post-infection mortality. 
Similar approaches could also be used to probe ultimate function of 
long-lasting T. molitor immunity. 
 
This study has contributed sequence data that can now be used in 
answering a range of questions regarding the evolution of immunity in T. 
molitor in conjunction with the expanding wealth of biochemical, 
physiological and ecological methods that have previously been used in 
this organism. These mRNA sequence data will help to understand the 
biology of this emerging study system, and through doing so can be 
used in answering key questions that have begun to be addressed in T. 
molitor.  
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Chapter Six 
 
Synthesis & general discussion 
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6.1. Summary of findings 
 
The results presented in the preceding four Chapters complement 
existing data on the costs and benefits to bacteria of evolving resistance 
to host immunity; and the costs and mechanisms of inducing a host 
resistance response to infection. These findings are recapitulated in the 
table on the following page, before a discussion of the broader 
implications of a synthesis of these results. 
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Table 6.1. Key findings presented in this thesis 
Chapter 2 • For the major human pathogen Staphylococcus 
aureus, the costs of genetic trade-offs caused by the 
evolution of resistance to antimicrobial peptides are not 
greater than those of evolving resistance to stressful 
antibiotics. 
• The evolutionary response to selection from a 
combination of antimicrobial peptides is weaker than the 
response to the constituents of the combination. 
 
Chapter 3 • Populations of antimicrobial peptide-resistant S. 
aureus survive the initial twenty-four hours after 
inoculation into the mealworm beetle Tenebrio molitor 
significantly better than antibiotic-selected populations, 
unselected populations, and the ancestor of all these 
populations. 
• When T. molitor are infected with S. aureus, there is 
no effect of antimicrobial peptide resistance in the inocula 
on beetle survival. 
 
Chapter 4 • Simulating an antibacterial immune response in T. 
molitor causes damage to self-tissue that has previously 
been shown to be associated with a decline in 
physiological function. 
• T. molitor's response to simulated bacterial infection 
causes secondary damage to another microbe in the 
haemocoel. 
 
Chapter 5 • T. molitor's antibacterial immune response is 
mediated by a diversity of molecular mechanisms. A 
number of these are strongly reactive and could cause 
pathological self-harm when released into the haemocoel. 
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6.2. Costs and benefits of the evolution of antimicrobial peptide 
resistance 
 
According to the experiment presented in Chapter 2, the costs of 
antimicrobial peptide (AMP) resistance are in the same range as costs of 
resistance to conventional antibiotics. As expected, Staphylococcus 
aureus exposed to the antibiotic streptomycin rapidly evolved resistance 
to this stressor, and cultures exposed to vancomycin showed very little 
response to selection. Cultures exposed to AMPs showed a response 
slower than that to streptomycin, but in contrast to vancomycin there 
was still a response. Vancomycin exerts its bactericidal action on the cell 
wall, and AMPs damage the cell membrane, so resistance to both is 
likely to involve costly change in fundamental structural traits. 
Vancomycin resistance has previously evolved in environmental S. 
aureus (Weigel, 2003; Wright, 2007) and was more costly than AMP 
resistance in my experimental protocol, therefore I have falsified the idea 
that AMP resistance is constrained by its inherent cost. Nevertheless 
there clearly are costs of AMP resistance, expressed as a depression of 
r0 in low concentrations of AMP and un-supplemented media, but 
mitigation of these costs was also observed. 
 
The costs of AMP resistance appear, however, to be somewhat 
mitigated when the resistant bacteria are inoculated into T. molitor. 
Recent unpublished transcriptomic data (P. Johnston & J. Rolff, Pers. 
Comm.) show that AMPs are most strongly expressed by T. molitor over 
the first twenty-four hours after bacterial infection, and accordingly 
significantly more AMP-resistant S. aureus were recovered from the 
beetle twenty-four hours after infection. This shows that fitness of strains 
that have endured selection for resistance is environmentally 
determined, and that the outcome of infection is in part determined by 
the genetic costs and benefits of parasite traits. AMP-resistant strains 
can better survive immunity, and so have a greater chance of persisting, 
growing to escape the haemocoel and being transmitted, and are 
therefore fitter in a host. Importantly, this is a significant biomedical 
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finding, as it suggests that using AMPs as therapeutic antimicrobials 
could be a profoundly bad idea (Bell and Gouyon, 2003; Habets and 
Brockhurst, 2012). If "AMP therapy" becomes a medical reality, my data 
show that the resistant strains that will probably consequently evolve will 
cause more persistent and more pathogenic infection. 
 
6.3. Evolutionary conservation of self-harming immunity 
 
My work in this thesis was also concerned with the costs of host 
resistance to infection, and whether these costs can be implicated as 
causes of tolerance. I presented data in Chapter 4 that are consistent 
with a connection between self-melanisation and resistance to bacterial 
infection in T. molitor (Zhao et al., 2007). Although I unfortunately could 
not measure a fitness cost coincident with this self-melanisation, 
previous work (Sadd and Siva-Jothy, 2006) showed that this 
phenomenon compromises fundamental physiological function. Chapter 
5 shows that T. molitor's immune response to S. aureus infection is 
mediated in part by reactive enzymes that produce by-products toxic to 
fundamental conserved cellular traits (Zhao et al., 2007). When these 
products are released into the open haemocoel they will harm infectious 
bacteria, with the secondary effect of systemic self-damage.  Although 
melanisation may not necessarily be a downstream effect of these 
processes (Leclerc et al., 2006), it can be considered an indicator of 
them. I suggest that the release of such nonspecific toxins has been 
conserved as part of the immune system precisely because they will 
damage a wide range of living cells, and they are therefore potent and 
versatile components of constitutive immune defence. In short, I propose 
that intrinsically costly immunopathology has been conserved because 
broad-spectrum toxicity is a fundamental requirement of immune 
systems, which must act quickly and decisively against potential 
infection by organisms from any taxonomic kingdom. 
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6.4. Reciprocal costs of resistance define host-parasite 
associations 
 
I suggest that applying the same intellectual framework to hosts and 
their infections could be extremely constructive in building our 
understanding of how these protagonists coevolve. The concept of costs 
of immunity is well-established, and the evolutionary immunology 
framework has been used to study the determinants of parasite 
resistance for nearly twenty years (Sheldon and Verhulst, 1996). The 
concept of cost is not quite so pervasive in microbiology and pathogen 
literature, largely because researchers in these fields are 
understandably more concerned with how microbes harm hosts than 
why. Nevertheless there are clear genetic costs associated with evolving 
resistance to chemical stressors, and costly trade-offs to expressing the 
phenotypes used to survive host immunity. I propose that there is scope 
to expand the framework developed in evolutionary immunology beyond 
just the host to include parasites as well, because the costs to parasites 
of resisting immunity will determine the outcome of infection just as 
strongly as the costs to the host of resisting the parasite.  
 
Ultimately, hosts and the organisms that inhabit them are each simply 
components of the other's environment that can facultatively cause 
stress, and from this perspective both are governed by the same 
evolutionary rules when it comes to resisting these stresses. In their 
most reduced form, the interactions between hosts and infections are 
reciprocal responses of each party to chemicals associated with the 
other, and these responses are frequently resistant. Both are subject to 
evolutionary and deployment costs of resistance, benefits of resistance, 
endogenous negative feedbacks on resistance, and usually antagonism 
from the other in expressing resistance. Applying this framework 
simultaneously to both host and infection is likely to yield a much more 
complete picture of how hosts and parasites coevolve. An additional 
benefit of such a conceptual framework is that it will aid integration 
between host-parasite and mutualism research, by building a single 
! 168 
system by which the costs and benefits of any symbiotic association can 
be assessed. Since mutualistic associations have parasitic origins, the 
proposed integrative conceptual framework could well allow us to better 
understand what determines the positions of microbes on the continuum 
between pathogen and mutualist (Douglas, 2010; Lazzaro and Rolff, 
2011). I view my work in this thesis, particularly Chapter 3, as a case 
study in this approach.  
 
6.5. Is tolerance a low-cost alternative to resistance? 
 
Although I have presented no work explicitly studying tolerance, there 
are numerous theoretical connections between the costs of resistance 
and parasite tolerance. Considering the recent surge of academic 
interest in this formerly under-appreciated aspect of immunity (Schneider 
and Ayres, 2008), it is worthwhile discussing how the results presented 
herein and their more general context could be related to the evolution 
and activation of tolerance.  
 
Theory predicts that resistance and tolerance are negatively correlated 
(Roy and Kirchner, 2000), which has been demonstrated empirically 
both in animals (Raberg et al., 2007) and plants (Koskela et al., 2002; 
Rodenburg et al., 2006; Rowntree et al., 2011a). Also, it is generally 
accepted that resistance and tolerance are not discrete phenotypes, and 
that host responses range continuously between the two (Graham et al., 
2010; Rowntree et al., 2011a). These observations suggest that the 
optimality of each strategy is determined by a continuous variable. 
Prevalence of tolerance can be defined as the inverse of the prevalence 
of pathology (Rowntree et al., 2011a). Pathology is an expression of the 
cost of damage caused by the infection and the cost of immunity i.e. 
resistance. If tolerance and resistance are successful, then the host is 
isolated from the cost of damage caused by infection and the benefits of 
each strategy are equal, so these variables can be removed. On this 
basis, the prevalence of tolerance is inversely related to the costs of 
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resistance. Synthesising these principles suggests that tolerance is less 
endogenously costly than resistance. 
 
If tolerance is less inherently costly than resistance, why should 
resistance ever evolve? There are two likely reasons. First, that the 
machinery of tolerance, whatever it might be, will be governed by 
tradeoffs and therefore be imperfect, just like resistance. This being so, 
a tolerant host will still suffer some diminished costs of parasitism. 
Secondly, as long as the parasite lives in the host there is a risk that it 
will evolve means to subvert the host's expression of tolerance. Since a 
parasite should only harm its host if it aids transmission (Anderson and 
May, 1982) and tolerance by definition prevents this, one can predict 
that selection to subvert tolerance is strong. 
 
There is some empirical evidence that is supportive of these ideas. 
Recent work has shown that protein nutrition affects antimicrobial 
peptide expression (i.e. resistance genes) in Drosophila melanogaster 
(Fellous and Lazzaro, 2010), and the ability to resist viral infection in the 
Indian mealmoth Plodia interpunctella (Boots, 2011). Resource 
availability is a strong determinant of condition, so resistance and 
condition are positively correlated. Combined with the aforementioned 
idea that tolerance is less costly than resistance, I suggest that 
resistance is optimal when the host is in sufficiently good condition to 
mount a resistance response. If the cost of resistance is independent of 
condition, then the marginal gains from resistance are diminished as 
condition declines. However marginal gains can be rescued by 
increased investment in tolerance if the associated costs are less than 
costs of resistance, but at the risk of future parasitism and damage. The 
optimality of each strategy is therefore determined by cost, and can be 
written as: !"#$%&'$#(!!"!!"#$"%&' !! !"#$%&%"# ! !"#$!!"!!"#$"%&' ! !"#$!!"!!"#"$%!!"#"$%!!"!!!!!!"#"$%&' 
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If an infected organism can "calculate" this for tolerance and resistance, 
then the ratio of the optimalities of each separate strategy should 
determine the ratio of investment into each process: 
 !"#$%&'$#(!!"!!"#$#%&'("!!!"#$%&'$#(!!"!!"#$%&'($ !  !"#$%&'$"&!!"!!"#$#%&'("!!!"#$%&'$"&!!"!!"#$%&'($ 
 
Thus I suggest that costs of resistance play an important role in the 
evolution and induction of tolerance. In this context it is significant that 
tolerance and resistance to microbial infection in D. melanogaster can 
be altered by mutation in a single gene critical for melanisation, a 
mediator of costly antimicrobial resistance (Ayres and Schneider, 2008). 
If it is accepted that the conceptual framework governing resistance in 
host-parasite systems can work reciprocally, then the reasoning applied 
to host tolerance of parasites should also determine whether infection is 
host-resistant and pathological, or host-tolerant and benign. 
 
6.6. Synthesis and future directions 
 
There is a diverse range of experiments that could follow those 
described in Chapters 2 - 5, with implications for the specific topics 
covered in each individual Chapter and for the broader proposed 
framework. 
 
6.6.1. Further assessments of the costs of AMP resistance 
 
Although a genetic cost of evolving AMP resistance has been shown, it 
would be ideal to quantify competitiveness of the selected strains 
against one another, particularly for those exposed to the combination of 
pexiganan and melittin. Ideally this experiment would be fully reciprocal 
and involve all the selected cultures. This would constitute powerful 
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evidence to show whether or not the apparent rarity of natural AMP 
resistance is driven by reduced competitiveness of resistant mutants 
when they arise in vivo. To complete such an experiment with the strains 
evolved in Chapter 2 would require transformation of the cultures with 
distinctive markers.  
 
6.6.2. Mechanisms of AMP resistance 
 
Functional studies would allow a deeper understanding of how AMP 
resistance is mediated. Although mechanisms of AMP resistance are 
already known (Peschel and Sahl, 2006; Gruenheid and Le Moual, 
2012), this would be the first time they have been shown in 
experimentally evolved cultures. The known mechanisms of AMP 
resistance could be elucidated using an array of phenotypic assays, for 
example by measuring extracellular protease activity. Relating the 
fitness of each strain to specific mechanisms, and particularly to the 
induction of specific mechanisms, would build understanding of the costs 
of activating these resistance mechanisms, thereby applying the 
evolutionary immunology cost framework to bacteria. Understanding the 
costs that bacteria stand by activating such mechanisms is also likely to 
aid our understanding of how host control of the evolution of infection is 
mediated via bacterial physiology.  
 
6.6.3. Phylogeny of AMP-resistant cultures 
 
Implicitly, the genomes of populations that have to overcome greater 
evolutionary hurdles must change more than those of populations that 
have easily overcome stresses. On this basis, sequencing and 
phylogeny of the cultures that evolved in Chapter 2 show how 
parsimonious evolution under selection from each stressor was. This 
would test the prediction that the cultures that went extinct under 
selection are reasonably close to the ancestor, whereas those that 
showed a more pronounced response to selection will have moved 
further through evolutionary space. 
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6.6.4. Inhibiting autopathological immunity 
 
Inhibiting mechanisms of autopathological immunity will help to clarify 
whether the costs of resistance drive the induction of tolerance. However 
inference from such functional studies must made carefully. As 
discussed in Chapters 1 & 4, it is possible that the antimicrobial and self-
damaging effects coincident with melanin production are mediated by 
upstream compounds, and so inhibition of prophenoloxidase, for 
instance, may not mediate any effect on either antimicrobial activity or 
self-damage. Furthermore, the results of Chapter 5 show that a diverse 
range of reactive enzymes and therefore toxins are produced after 
infection, so selective knock-down or mutation of select mechanisms 
may not cause any measurable fitness effect. These problems 
notwithstanding, if a thorough buffer can be imposed on autopathological 
immunity, it could test if this phenomenon has been maintained because 
of the necessity for constitutive defence to be effective against a 
diversity of potential infections. 
 
6.6.5. Resource manipulation of infected T. molitor 
 
If host investment into resistance and tolerance is affected by condition 
as proposed in Section 6.5, then manipulating nutritional quality should 
generate predictable outcomes in infection titers: reduced nutritional 
quality should yield elevated tolerance of infection. Such experiments 
could be particularly informative about the dynamic balance between 
resistance and tolerance if they were 2-factoral, and incorporated 
different parasites that varied in their ability to resist host immunity, such 
as the AMP-resistant lines evolved the experiment described in Chapter 
2. This would constitute an experiment that fully embraces the idea that 
hosts and infections are governed by the same processes, with the 
same evolutionary and ecological outcomes. 
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6.6.6. Outlook 
 
Resistance is costly, and this principle extends to diverse and disparate 
organisms. Applying it to associated organisms is useful in developing 
our understanding of the benefits, costs and feedbacks that govern their 
coevolution, and creating generalisations that can be extended to all 
organisms. 
 
I believe that future experiments should better consider the 
interconnectedness of the costs experienced by hosts and parasites as 
they each try to resist the other, because these will lead to feedbacks 
that will strongly determine the outcome of infection. More fundamentally 
the parallels in the evolutionary ecology of both parties are manifold and 
profound, and the same framework can be applied to them. An 
integrative framework that applies the same logic to both partners in 
interspecific associations could be useful in understanding the full 
spectrum of interactions from pathogen to mutualist. As emphasised by 
Graham et al. (2010), we must consider the fitness of host and parasite 
as completely interconnected, and measuring the fitness of both and the 
strength of the interaction is vital in understanding coevolution. This 
thesis has discussed the dual notions of costs of bacterial resistance to 
immunity, and costs of host resistance to parasites; which is a case 
study in trying to think about hosts and parasites in the same way. As 
technological advances and novel approaches like deep sequencing, 
meta-genomics and new analytical tools allow us to fathom greater 
depths of the complexity of life at all levels of organisation, it will become 
increasingly possible to use unified conceptual approaches to 
understand infection, immunity, and ultimately probe what drives 
coevolution. 
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vii. Appendices  
 
 
Appendix 1. Issues with dose-response and r0max estimates 
 
Practical constraints meant it was impossible to control the number of 
cells entering the dose-response assays. This may have knock-on 
effects on the apparent growth of cultures in the dose-response assay 
for three reasons: 
 
1. Bacterial cultures grow roughly exponentially. Variation in the 
number of cells which is exponentiated will correspond with variation in 
the consequent slopes. 
2. Bacteria in different phases of growth will also be in different 
physiological states, which may alter susceptibility to a stressor.  
3. The molarity of a stressor per individual bacterial cell will depend 
on the number of cells entering the assay if the concentration of the 
stressor required for its effectiveness is not exceeded, since (y/x) = 2 
(y/2x). 
 
The assays and subsequent analyses were designed to buffer against 
this possibility:  
 
1. 18h growth in unsupplemented media between leaving the 
selection protocol and entering the dose-response allowed time for 
exponential growth in stress-free conditions across all treatments 
2. Six hours (the duration of the dose-response assay) is a 
sufficient window of opportunity for S. aureus to reach its maximal 
growth rate, and only the maximal possible r0 value is used in the 
analyses. 
3. The calculation of a rate (r0) in place of a raw dN/dT figure 
ought to control confounding effects of starting OD on metrics of growth. 
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Appendix 2. Controlling contamination in perfusion bleed 
techniques 
 
Chapter 3 makes use of "perfusion bleed" techniques originally 
developed by (Haine et al., 2008a) to hydraulically flush infectious 
bacteria from T. molitor's haemocoel. Before embarking on the 
experiments described in Chapter 3 it became evident that there was 
room to improve the original protocol.  
 
The essence of the perfusion bleed technique (Chapter 3, Figures 3.3.2 
& 3.3.3) is to inject tetracycline-resistant S. aureus into T. molitor’s 
abdomen and then flush the abdomen with a relatively large volume of 
PBS. A sub-sample of this solution is then spread with beads on an agar 
plate. This plate contains tetracycline and amphotericin-B, on the 
assumption that these antimicrobials will control for microbial 
contamination. The advantages of this assay over plating a diluted 
sample of neat haemolymph are that it reduces the potential for 
stochastic effects on the final number of CFU detected on the agar plate 
- for example caused by small localized abscesses acting as reservoirs 
of infection, that may not be detected by without forcing bacteria from 
the tissue with a pressurised solvent like PBS. Reflection on extensive 
experience of the assay (including generating part of the original (Haine 
et al., 2008a) dataset) revealed potential flaws that had to be addressed 
before the assay or the data used by (Haine et al., 2008a) could be 
regarded confidently. These flaws are described below: 
 
1. Experimental control. 
(Haine et al., 2008a) present no evidence of procedural control (i.e. 
perfusion bleeds of beetles injected with sterile liquid), negative control 
(i.e. to check for contamination of PBS or agar), or untreated control (i.e. 
perfusion bleeds of un-injected beetles). These flaws are fundamental 
and could profoundly alter the apparent dynamics of persistent infection 
in the T. molitor / S. aureus system if any contamination is present. 
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2. Sensitivity to contamination. 
The perfusion bleed technique relies on the assumption that T. molitor’s 
resident bacteria are filtered out of the final assay by tetracycline 
dissolved in agar. However environmental microbes are commonly 
antibiotic resistant or indifferent (see Chapter 1 and Chapter 3). Thus 
there is potential for contamination of T. molitor with tetracycline-
resistant environmental bacteria. 
 
3. Potential for contamination. 
There are three potential routes for any tetracycline-resistant bacteria 
that may be present in experimental beetles to enter the experimental 
sample. Such bacteria could be a) washed off the cuticle of experimental 
animals by PBS that leaks from where the hypodermic needle is inserted 
into the beetle and fall into the collection tube; b) endemic to 
haemolymph; or c) released from the gut into the haemocoel if the 
hypodermic needle pierces into the gut lumen.  
 
I investigated the potential for these issues to confound the results of 
(Haine et al., 2008a), and thereby develop adequate control protocols for 
my own subsequent experiments in Chapter 3. I checked for potential 
contamination when negative controls were employed, refined the 
protocol, repeated part of (Haine et al., 2008a)'s study into the dynamics 
of persistent infection with a negative control and refined protocol, and 
checked the presence of S. aureus from frozen stocks of the samples 
generated by (Haine et al., 2008a). 
 
For to test for potential contamination, I infected 10 beetles from long-
term stocks at the University of Sheffield with S. aureus JLA 513 (a 
tetracycline-resistant clone that was integral in all subsequent 
experiments in Chapters 2-5, and the clone used by (Haine et al., 
2008a)). Beetles were infected as described in Chapter 3, except that 
bacteria were unwashed and suspended in their growth medium. One 
colony of S. aureus was inoculated into 5 ml LB containing 5 "g ml-1 
tetracycline and 5.6 "g ml-1 amphotericin B. Bacteria were grown for 48h 
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at 30oC, shaking at 100 rpm. I injected a further 10 beetles with un-
inoculated growth medium, and another 10 were untreated. These 
beetles were perfusion bled with sterile PBS 5h after treatment as 
described in Chapter 3, and 5"l of the bleed was plated onto LB agar 
using sterile glass beads. The plates were incubated overnight at 30oC. 
CFU were counted manually. The resultant CFU data are plotted in 
Figure A2.1. 
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Figure A2.1. Quantifying contamination from perfusion bleeding T. 
molitor 
Bacterial CFU from perfusion bleeds of T. molitor that were not injected 
with anything, injected with 5"l of an overnight culture of S. aureus JLA 
513 (tetracycline resistant), or injected with sterile bacterial growth 
medium. 5"l of the perfusions were plated on LB agar containing 5 "g 
ml-1 tetracycline and 5.6 "g ml-1 amphotericin-B. These data show that 
the perfusion bleed assay used by (Haine et al., 2008a) is sensitive to 
contamination and would benefit from refinement. 
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The data in Figure A.2.1. demonstrated that the assay required further 
development to ensure sterility, and that bacteria capable of growing on 
tetracycline and amphotericin-B were present in T. molitor. 
 
To localize the source of the contamination, I sampled the cuticle and 
haemolymph of beetles (ten per group). Pure haemolymph was 
extracted by piercing a hole in the beetle's plural membrane between the 
abdomen and thorax with a sterile pin, and pipetting the exuded 
haemolymph. This was mixed with sterile PBS in a 1:10 ratio, 
approximating the mixture of haemolymph and PBS in a perfusion bleed. 
To sample the cuticle, beetles were washed in sterile PBS by dunking 
each individual beetle in PBS in a centrifuge tube and vortexing briefly. I 
also perfusion bled ten uninfected beetles as before, but first washed 
them for ten seconds in 80% ethanol. 5 "l of the resulting samples were 
plated as before. To test whether the contamination shown in A2.1 was 
introduced during the plating process, beads were spread over plates 
with no beetle sample (n=3). PBS was drawn from the same tube when 
refilling the syringe between bleeding individual beetles, so to test if this 
could be contaminated during the bleeding procedure, a 50"l sample of 
the PBS was plated before and after bleeding (n=3). To test whether the 
contamination could be airborne, plates were also left open in the 
laminair flow cabinet in which the samples were plated (n=3). Plates 
were incubated and CFU were quantified as previously. The percentage 
of plates showing growth are plotted in Figure A.2.2. The CFU counts 
from samples of beetles that were washed in EtOH are presented in 
Figure A.2.3, compared to the data from untreated beetles (using the 
same data as A.2.1). 
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Figure A.2.2. Localising contamination in the perfusion bleed 
technique: percentage of plates showing positive growth. 
Pure samples of beetle haemolymph, perfusion bled haemolymph 
(Untreated), PBS exposed to the cuticle (Cuticle PBS), and perfusion-
bled haemolymph from beetles that were first washed in 80% EtOH 
(EtOH wash) were plated on LB containing tetracycline (5 "g ml-1) and 
amphotericin-B (5.6 "g ml-1). No colonies grew from pure haemolymph. 
Plating samples from perfusion-bled beetles or cuticular washes led to 
positive growth from 90% of samples in each treatment, suggesting that 
the contamination was cuticular. Washing the beetle's cuticle with EtOH 
before perfusion bleeding reduced the number of plates showing positive 
growth to 30%.  
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Figure A.2.3. CFU from perfusion bled beetles with and without 
EtOH washing. 
Uninfected beetles were perfusion bled as by (Haine et al., 2008a), or 
after washing the beetle cuticle in ethanol for 10 seconds before 
bleeding. Washing with ethanol stopped growth in 70% of cases, and 
reduced it below that of the uninfected beetles in a further 10% (n=10 
per treatment). 
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These data show that it is sensible to briefly wash all beetles in an 
experiment before perfusion bleeding. It also shows that an uninfected 
control is essential in studies using this procedure. Although the assay is 
not perfect, using this slightly refined protocol and including controls 
ensures that any contamination is systemic. If CFU counts from 
uninfected controls are significantly less than those from infected 
beetles, then the procedure is reasonably sound. If, however, CFU 
counts from uninfected controls are not significantly different from those 
of infected beetles, then it is possible if not likely that the measurement 
of infection in the infected beetles is not the injected bacteria, but rather 
background contamination. Comparisons should be made between 
uninfected beetles and infected beetles based on the day that the 
beetles were bled, since this is when cuticular contamination is 
controlled for with EtOH washing. Although plating neat haemolymph 
would from some perspectives be preferable because there was no 
evidence of contamination when beetles were bled this way (Figure A. 
2.2), it seems likely that this method is open to stochastic because S. 
aureus infection in the beetle is likely to be localised in abscesses, and 
cells from such abscesses would not be washed from beetle tissues 
without the hydraulic pressure applied by the perfusion bleed technique. 
 
The experiment in Chapter 3 detailing persistence of S. aureus in T. 
molitor incorporated all the above procedures into the experiment and 
analysis. Every day that beetles were infected for these experiments, a 
subset (15-30 individuals) was injected with sterile PBS in parallel to 
those injected with bacteria. Some (5-10) of these sterility controls were 
bled in parallel to their infected counterparts. This revealed that there 
was some background contamination on some specific bleed days, but 
the numbers of bacteria recovered from the uninfected controls were 
always significantly less than the infected beetles, showing that the CFU 
data reported were true positives. 
 
I was concerned that a high-profile study (Haine et al., 2008a) may have 
reported an erroneous result. Therefore I tested whether the results 
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reported could have been false positives. Fortunately, Haine et al left 
frozen stocks of the pooled S. aureus they recovered from T. molitor at 
the University of Sheffield, which I had access to. Therefore I plated 
these samples on Mannitol salt phenol red agar (Sigma, 63567-500G-F). 
This is a selective high-salt medium, commonly used for diagnostic tests 
of Staphylococci. The contaminating cells recovered by perfusion 
bleeding (above) appeared Staphylococcal, likely S. epidermis. Mannitol 
salt phenol red agar is a commonly used diagnostic test that 
distinguishes between S. aureus and other Staphylococci by testing for 
the ability to ferment mannitol, which is indicated by a clear yellow halo 
around mannitol-fermenting cells. Bacteria left by (Haine et al., 2008a) 
fermented mannitol (Figure A.2.4), shows that S. aureus were present in 
some of these samples, showing that (Haine et al., 2008a) did manage 
to establish persistent S. aureus infection, but the accuracy of their 
assay is a little dubious. However I could not recover any living cells at 
all from the "28 days" timepoint reported previously. It may be that any 
Staphylococcal cells that were present did not survive freezing, or that 
those reported were false positives. It has also since been confirmed 
that, in agreement with (Haine et al., 2008a; 2008b), T. molitor induce 
long-lasting antimicrobial haemolymph activity in response to S. aureus 
infection (P. Johnston, Pers. comm.).  
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Figure A.2.4. Assaying presence of S. aureus in frozen samples 
from (Haine et al., 2008a) 
(Haine et al., 2008a) claim to have infected T. molitor with S. aureus and 
recovered cells up to 28 days after infection, and that samples from 
replicate beetles at each time point were pooled and frozen at -90oC. 
Subsequent concerns about methodology motivated re-plating these 
samples to test for the presence of S. aureus. Plating frozen samples of 
bacteria extracted from T. molitor up to 28 days after infection on 
Mannitol salt phenol red agar revealed that persistent S. aureus infection 
was established. Each scrape on each plate represents a different 
replicate frozen stock labeled as derived from that respective time-point. 
6 replicate stocks were available for each 3 days, 14 days and 21 days. 
5 were available for 1 minute, and 3 for 28 days. Golden halos around 
bacterial scrapes indicates the presence of S. aureus. No bacteria could 
be recovered from the sample of bacteria labeled to indicate that it 
contained bacteria extracted 28 days after T. molitor infection, which 
may indicate that either no S. aureus were present at this point, or that 
the cells did not survive freezing. 
 
1 minute 3 days 7 days 
14 days 21 days 28 days 
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To further test (Haine et al., 2008a) and the applicability of perfusion 
bleeding T. molitor to assay for S. aureus persistence, part of their study 
was repeated, to check the validity of the previous results and the assay. 
Specifically, 70 beetles were injected with sterile PBS as a 
contamination control, and a further 70 were injected with washed S. 
aureus JLA 513, as described in Chapter 3. Beetles were perfusion bled 
and samples were plated as described in Chapter 3. Beetles were bled 1 
minute after injection (samples diluted x 10-3 ), 30 minutes after (samples 
diluted x 10-2), 6 hours after, 3 days after, 7 days after, 14 days after, 
and 28 days after. Some beetles that were designated to be bled at later 
time-points died before they could be bled. The results (Figure A.2.5) 
show that this protocol established repeatable S. aureus infection. There 
was some contamination in some PBS-injected beetles, but most 
samples from sterility controls were clean. This shows that the approach 
used by (Haine et al., 2008a) was not perfect, but that modification by 
including a proper control and surface-sterilising beetles by washing 
them in ethanol before perfusion bleeding allows quantitative measure of 
infection and exclusion of most contamination. 
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Figure A.2.5. Testing the application of perfusion bleeding 
techniques to persistent S. aureus infection of T. molitor. 
Beetles were infected and perfusion bled as previously (Haine et al., 
2008a), with the modification of a sterile procedural control (red), and 
beetles were washed in ethanol before perfusion bleeding. This 
approach removes most systemic contamination across the full range of 
time points, as shown by the consistently greater CFU counts from S. 
aureus-infected beetles (black).  
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Appendix 3. Nonlinear least squares regression of selected S. 
aureus CFU in T. molitor 
 
In analysis of data contributing to Chapter 3, nonlinear least-squares 
regression was used to fit a model of the form 
 !"# !"#!!"#$%&#! !!!! ! ! !"#!!!"#$! 
 
to the CFU estimates of selected bacteria extracted from infected T. 
molitor 30 minutes, 24 hours and 7 days after infection. The b parameter 
of this model describes the decay of the model (presented in Figure 
3.4.2.2). The data from each bacterial treatment are plotted below in 
Figures A.3a on a normal time scale, with the fitted model modified 
appropriately. 
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Figures A.3a. Ancestral S. aureus (day 0) persistence in T. molitor   
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Figures A.3b. Melittin-selected S. aureus (day 28) persistence in T. 
molitor   
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Figures A.3c. Pexiganan-selected S. aureus (day 14) persistence in 
T. molitor   
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Figures A.3d. Pexiganan-selected S. aureus (day 28) persistence in 
T. molitor   
0 50 100 150
0
5
10
15
Pexiganan (d28)
time post-infection (hours)
lo
g 
C
FU
 e
st
im
at
e
! 215 
 
Figures A.3e. pgml-selected S. aureus (day 14) persistence in T. 
molitor   
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Figures A.3f. Unselected-selected S. aureus (day 14) persistence in 
T. molitor   
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Figures A.3g. Unselected-selected S. aureus (day 28) persistence in 
T. molitor   
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Figures A.3h. Streptomycin-selected S. aureus (day 28) persistence 
in T. molitor   
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Figures A.3i. Unselected-selected S. aureus (day 14) persistence in 
T. molitor 
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Appendix 4. Second attempt to measure costs of autopathological 
immunity in T. molitor 
 
The results of the survival experiment presented in Chapter 4 were 
weakened by the effect of suspending bacterial cellular material in 
supernatant. This experiment was attempted a second time, but after 
washing the bacterial cultures and re-suspending them in an equal 
volume of sterile PBS. Dosage was not varied in this second experiment. 
Beetles were reared from the same stock as in Chapter 4, in which a 
microsporidian infection had previously been noted (see Figure 4.4.2.3). 
Survival curves of the beetles in this second experiment are presented in 
Figure A.4.1. 
 
Unfortunately survival in all treatment groups was decreased relative to 
those in the first experiment. Pupal mass of the beetles that went into 
the repeated experiment was much diminished relative to the masses of 
the beetles used for the original experiment (Figure A.4.2), indicating 
poor general condition. No attempt was made to quantify microsporidia 
at either point, but it is plausible that the infection had worsened in the 
second experiment, which would account for poor condition of the 
beetles. 
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Figure A.4.1. Survival curves of T. molitor inoculated with equal 
doses of dead and live S. aureus 
Beetles were inoculated with dead (heat-shocked) and live S. aureus, 
which had been washed and re-suspended in a volume of PBS equal to 
the volume of growth medium they grew in. Maximum beetle survival in 
all groups was much less than T. molitor's the normal expected lifespan, 
suggesting poor condition.  
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Figure A.4.2. Comparison of beetle pupal masses used for two 
post-immunopathology survival experiments  
Pupal masses of beetles used for survival study 1 (Chapter 4, Figure 
4.4.1.1) were considerably greater than the masses of those used for 
survival 2 (Figure A.4.1), consistent with poor general beetle condition. 
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Appendix 5. Full list of immune-induced mRNA sequences 
identified by SSH in Tenebrio molitor larvae after infection with 
Staphylococcus aureus JLA 513 
 
The SSH transcriptomic analysis produced numerous BLAST hits that 
were assigned gene ontologies (Conesa et al., 2005). Gene ontologies 
(GOs) and each sequence's most significant BLASTx hit were used to 
classify the sequences by proposed function. The classification 
categories are based on those of (Altincicek et al., 2008a). The full list of 
BLASTx alignments are presented in Table A.5 with GOs. 
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Table A.5. Transcriptomic (SSH) characterisation of T. molitor's immune response to S.  aureus 
infection: Gene Ontologies (GOs). Sequences are assigned to a certain proposed group based 
on what is known of their best BLAST hit and GO descriptions. GOs are automatically classified 
as biological process (BP), molecular function (MF) or cellular component (CC) 
Proposed group Best BLAST hit GO group GO description 
Immune defence 
and effectors 
laccase 1 BP oxidation reduction 
  BP iron ion transport 
  MF copper ion binding 
  MF iron ion transmembrane 
transporter activity 
  MF oxidoreductase activity 
Immune defence 
and effectors 
transferrin BP cellular iron ion 
homeostasis 
  BP iron ion transport 
  CC extracellular region 
  MF ferric iron binding 
Immune defence 
and effectors 
tyrosine hydroxylase BP catecholamine 
biosynthetic process 
  BP oxidation reduction 
  BP tyrosine metabolic 
process 
  MF tyrosine 3-
monooxygenase activity 
  MF iron ion binding 
Immune defence 
and effectors 
tyrosine hydroxylase BP developmental 
pigmentation 
  BP adult locomotory behavior 
  BP regulation of dopamine 
metabolic process 
  BP male courtship behavior 
  BP oxidation reduction 
  BP dopamine biosynthetic 
process 
  BP tyrosine metabolic 
process 
  MF tyrosine 3-
monooxygenase activity 
  MF iron ion binding 
Immune defence 
and effectors 
dopa decarboxylase BP catecholamine 
biosynthetic process 
  BP histidine metabolic 
process 
  BP L-phenylalanine metabolic 
process 
  BP tryptophan metabolic 
process 
  BP tyrosine metabolic 
process 
  BP alkaloid biosynthetic 
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process 
  BP indole biosynthetic 
process 
  MF pyridoxal phosphate 
binding 
  MF aromatic-L-amino-acid 
decarboxylase activity 
Immune defence 
and effectors 
multicopper oxidase BP oxidation reduction 
  BP iron ion transport 
  MF copper ion binding 
  MF iron ion transmembrane 
transporter activity 
  MF oxidoreductase activity 
Immune defence 
and effectors 
transferrin BP cellular iron ion 
homeostasis 
  BP iron ion transport 
  CC extracellular region 
  MF ferric iron binding 
Immune defence 
and effectors 
beta- -glucan recognition protein 
2 
BP regulation of innate 
immune response 
  CC extracellular region 
  MF bacterial cell surface 
binding 
Immune defence 
and effectors 
multicopper oxidase BP oxidation reduction 
  MF oxidoreductase activity 
  MF copper ion binding 
Immune defence 
and effectors 
phenylalanine hydroxylase BP oxidation reduction 
  BP L-phenylalanine catabolic 
process 
  BP tryptophan biosynthetic 
process 
  BP tyrosine biosynthetic 
process 
  BP L-phenylalanine 
biosynthetic process 
  MF phenylalanine 4-
monooxygenase activity 
  MF iron ion binding 
  MF amino acid binding 
Immune defence 
and effectors 
antibacterial peptide CC extracellular region 
Immune defence 
and effectors 
Coleoptericin (antimicrobial 
peptide) 
BP defense response to 
bacterium 
  BP innate immune response 
  CC extracellular region 
Immune defence 
and effectors / stress 
stress-induced-phosphoprotein 1 BP encapsulation of foreign 
target 
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  BP compound eye 
photoreceptor cell 
differentiation 
  BP protein folding 
  BP tyrosine phosphorylation 
of STAT protein 
  BP periodic partitioning 
  BP hindgut morphogenesis 
  BP open tracheal system 
development 
  BP humoral immune 
response 
  BP equator specification 
  BP germ-line stem cell 
division 
  BP ovarian follicle cell stalk 
formation 
  BP defense response to virus 
  BP Regulation of haemocyte 
differentiation 
  BP stem cell maintenance 
  BP somatic stem cell division 
  BP lamellocyte differentiation 
  BP primary sex determination 
  BP eye-antennal disc 
morphogenesis 
  BP imaginal disc-derived leg 
morphogenesis 
  BP Haemocyte proliferation 
  BP border follicle cell 
migration 
  BP STAT protein nuclear 
translocation 
  BP imaginal disc-derived wing 
morphogenesis 
  BP ommatidial rotation 
  BP cytokinesis 
  BP cellular defense response 
  BP signal transduction 
  CC Golgi apparatus 
  CC nucleus 
  MF Janus kinase activity 
  MF protein binding 
  MF non-membrane spanning 
protein tyrosine kinase 
activity 
Immune defence 
and effectors 
transferrin BP cellular iron ion 
homeostasis 
  BP iron ion transport 
  CC extracellular region 
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  MF ferric iron binding 
Immune defence 
and effectors 
transferrin BP cellular iron ion 
homeostasis 
  BP iron ion transport 
  CC extracellular region 
  MF ferric iron binding 
Immune defence 
and effectors 
ferritin heavy chain BP cellular iron ion 
homeostasis 
  BP oxidation reduction 
  BP iron ion transport 
  CC Golgi apparatus 
  CC intracellular ferritin 
complex 
  MF ferrous iron binding 
  MF oxidoreductase activity 
  MF ferric iron binding 
Immune defence 
and effectors 
laccase 1 BP oxidation reduction 
  MF oxidoreductase activity 
  MF copper ion binding 
Immune defence 
and effectors 
multicopper oxidase BP oxidation reduction 
  BP electron transport 
  BP iron ion transport 
  MF laccase activity 
  MF copper ion binding 
  MF iron ion transmembrane 
transporter activity 
Immune defence 
and effectors 
transferrin BP cellular iron ion 
homeostasis 
  BP iron ion transport 
  CC extracellular region 
  MF ferric iron binding 
Immune defence 
and effectors 
tyrosine hydroxylase BP cellular amino acid and 
derivative metabolic 
process 
  BP cellular aromatic 
compound metabolic 
process 
  BP cellular amine metabolic 
process 
  MF "oxidoreductase activity 
Immune defence 
and effectors 
tyrosine hydroxylase BP catecholamine 
biosynthetic process 
  BP oxidation reduction 
  BP tyrosine metabolic 
process 
  MF tyrosine 3-
monooxygenase activity 
  MF iron ion binding 
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Immune defence 
and effectors 
tyrosine hydroxylase BP catecholamine 
biosynthetic process 
  BP oxidation reduction 
  BP tyrosine metabolic 
process 
  MF tyrosine 3-
monooxygenase activity 
  MF iron ion binding 
Immune defence 
and effectors 
tyrosine hydroxylase BP catecholamine 
biosynthetic process 
  BP oxidation reduction 
  BP tyrosine metabolic 
process 
  MF tyrosine 3-
monooxygenase activity 
  MF iron ion binding 
Proteases masquerade-like serine 
proteinase homologue 
BP proteolysis 
  MF serine-type 
endopeptidase activity 
Proteases hemolymph proteinase 5 MF serine-type peptidase 
activity 
 hemolymph proteinase 5 MF peptidase activity 
Proteases trypsin-like proteinase BP proteolysis 
  MF serine-type 
endopeptidase activity 
Proteases bleomycin hydrolase BP proteolysis 
  MF cysteine-type 
endopeptidase activity 
Proteases clipa6 protein BP proteolysis 
  MF serine-type 
endopeptidase activity 
Proteases proprotein convertase subtilisin 
kexin type furin 
BP proteolysis 
  CC Golgi stack 
  CC plasma membrane 
  CC integral to Golgi 
membrane 
  MF serine-type 
endopeptidase activity 
Proteases serine protease BP proteolysis 
  MF serine-type 
endopeptidase activity 
Catabolism fatty acyl- reductase 1 MF catalytic activity 
Metabolism amp dependent ligase BP transport 
  BP acyl-carrier-protein 
biosynthetic process 
  MF cofactor binding 
  MF ligase activity 
  MF acyl carrier activity 
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Metabolism nad beta subunit BP metabolic process 
  CC membrane 
  MF binding 
  MF NAD(P) transhydrogenase 
activity 
Metabolism carnitine o-acyltransferase BP fatty acid metabolic 
process 
  BP acyl-carrier-protein 
biosynthetic process 
  BP glycerolipid metabolic 
process 
  MF carnitine O-
palmitoyltransferase 
activity 
 synaptosomal-associated protein 
29 
MF protein binding 
Metabolism fatty acyl- reductase 1 BP lipid metabolic process 
  CC peroxisome 
  CC membrane 
  MF binding 
  MF oxidoreductase activity 
Metabolism sphingolipid delta 4 desaturase c-
4 hydroxylase protein des2 
BP spermatogenesis 
  BP fatty acid biosynthetic 
process 
  BP oxidation reduction 
  CC plasma membrane 
  CC integral to membrane 
  CC mitochondrion 
  MF stearoyl-CoA 9-
desaturase activity 
  MF sphingolipid delta-4 
desaturase activity 
Metabolism quinone oxidoreductase BP oxidation reduction 
  BP electron transport 
  MF zinc ion binding 
  MF NADPH:quinone 
reductase activity 
Metabolism fatty acyl- reductase cg5065-like BP metabolic process 
  MF binding 
  MF catalytic activity 
Metabolism amp dependent ligase BP metabolic process 
  MF catalytic activity 
Metabolism nadh-ubiquinone oxidoreductase 
24 kDa 
BP "mitochondrial electron 
transport 
  BP electron transport 
  CC mitochondrial respiratory 
chain complex I 
  MF NAD or NADH binding 
  MF NADH dehydrogenase 
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activity 
Metabolism phosphoglyceromutase BP glycolysis 
  MF "2 
Ribosomal protein 60s acidic ribosomal protein p2 BP translational elongation 
  BP ribosome biogenesis 
  CC ribosome 
  MF structural constituent of 
ribosome 
Signaling lung seven transmembrane 
receptor 
BP signal transduction 
  CC integral to membrane 
  MF receptor activity 
Stress-associated 
proteins 
cytochrome p450 MF metal ion binding 
Stress-associated 
proteins 
protein vac14 homolog BP response to osmotic 
stress 
  BP signal transduction 
  BP interspecies interaction 
between organisms 
  CC microsome 
  CC vacuolar membrane 
  CC endoplasmic reticulum 
  CC endosome membrane 
  MF receptor activity 
  MF kinase activator activity 
  MF protein binding 
Transcription and 
protein biogenesis 
transcription initiation factor tfiid 
subunit 2 
MF zinc ion binding 
  MF metallopeptidase activity 
Transcription and 
protein biogenesis 
-like protein subfamily b member 
11 
BP protein folding 
  MF heat shock protein binding 
  MF unfolded protein binding 
Transcription and 
protein biogenesis 
tbc1 domain family member 19 BP regulation of Rab GTPase 
activity 
  CC intracellular 
  MF Rab GTPase activator 
activity 
Transcription and 
protein biogenesis 
eukaryotic translation initiation 
factor 3 subunit b 
BP regulation of translational 
initiation 
  CC eukaryotic translation 
initiation factor 3 complex 
  CC ribosome 
  MF RNA binding 
  MF translation initiation factor 
activity 
  MF nucleotide binding 
Transcription and 
protein biogenesis 
nuclear rna export factor 1 BP mRNA transport 
  CC nucleus 
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Transcription and 
protein biogenesis 
translation elongation factor 2 BP regulation of translational 
elongation 
  CC ribosome 
  MF translation elongation 
factor activity 
  MF GTP binding 
  MF protein binding 
  MF GTPase activity 
Transcription and 
protein biogenesis 
histone transcription regulator BP chromatin modification 
  BP gastrulation 
  BP "regulation of transcription 
  CC nuclear chromatin 
  MF transcription regulator 
activity 
  MF protein binding 
  MF chromatin binding 
Transcription and 
protein biogenesis 
piwi MF nucleic acid binding 
Transcription and 
protein biogenesis 
arylsulfatase b BP metabolic process 
  MF sulfuric ester hydrolase 
activity 
Transcription and 
protein biogenesis 
transposable element p 
transposase (p-element 
transposase) 
MF nucleic acid binding 
Transcription and 
protein biogenesis 
microphthalmia-associated 
transcription factor 
BP compound eye 
morphogenesis 
  BP regulation of transcription 
  CC nucleus 
  MF transcription regulator 
activity 
Transcription and 
protein biogenesis 
dolichyl-
diphosphooligosaccharide protein 
glycotransferase 
BP protein amino acid N-
linked glycosylation 
  CC lipid particle 
  MF transferase activity 
Transport proteins nadh dehydrogenase subunit 4l BP "mitochondrial electron 
transport NADH to 
ubiquinone" 
  BP ubiquinone biosynthetic 
process 
  BP sodium ion transport 
  BP proton transport 
  CC respiratory chain 
  CC mitochondrion 
  MF NADH dehydrogenase 
(ubiquinone) activity 
Transport proteins organic cation BP transmembrane transport 
Transport proteins amino acid transporter BP amino acid transport 
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  CC integral to membrane 
Transport proteins pleckstrin homology domain 
family f (with fyve domain) 
member 2 
CC transport vesicle 
  MF zinc ion binding 
Transport proteins amp dependent ligase BP transport 
  BP acyl-carrier-protein 
biosynthetic process 
  MF cofactor binding 
  MF ligase activity 
  MF acyl carrier activity 
No proposed group peroxisome biogenesis factor 1 BP microtubule-based 
peroxisome localization 
  BP auxin biosynthetic process 
  BP protein import into 
peroxisome matrix 
  BP regulation of transcription 
  BP multicellular organismal 
development 
  CC cytosol 
  CC peroxisomal membrane 
  CC nucleus 
  MF zinc ion binding 
  MF "ATPase activity 
  MF protein C-terminus binding 
  MF protein complex binding 
  MF lipid binding 
  MF DNA binding 
  MF ATP binding 
No proposed group serine threonine-protein 
phosphatase 4 regulatory subunit 
2 
BP mitotic cell cycle 
  CC protein phosphatase 4 
complex 
  MF protein phosphatase 
regulator activity 
No proposed group gtp cyclohydrolase i isoform b BP tetrahydrofolate 
biosynthetic process 
  BP compound eye 
pigmentation 
  BP embryonic pattern 
specification 
  BP tetrahydrobiopterin 
biosynthetic process 
  BP pteridine biosynthetic 
process 
  BP cuticle pigmentation 
  BP one-carbon metabolic 
process 
  BP preblastoderm mitotic cell 
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cycle 
  BP larval chitin-based cuticle 
development 
  BP folic acid biosynthetic 
process 
  CC cytoplasm 
  MF GTP cyclohydrolase I 
activity 
No proposed group -like protein subfamily c member 
22 
BP "liquid clearance 
  BP "regulation of tube length 
  BP extracellular matrix 
organization 
  BP endocytosis 
  CC early endosome 
  CC plasma membrane 
  CC cytoplasmic vesicle 
  MF heat shock protein binding 
No proposed group chaperone protein dnaj BP spermatogenesis 
  BP protein folding 
  BP "DNA damage response 
  BP androgen receptor 
signaling pathway 
  BP sperm motility 
  BP response to heat 
  BP signal transduction 
  CC cytoplasm 
  CC membrane 
  MF metal ion binding 
  MF low-density lipoprotein 
receptor binding 
  MF heat shock protein binding 
  MF ATP binding 
  MF unfolded protein binding 
No proposed group ubiquitin c BP axon guidance 
  BP ER-associated protein 
catabolic process 
  BP positive regulation of 
transcription 
  BP regulation of synaptic 
plasticity 
  BP induction of apoptosis by 
extracellular signals 
  BP anti-apoptosis 
  BP positive regulation of 
ubiquitin-protein ligase 
activity during mitotic cell 
cycle 
  BP long-term strengthening of 
neuromuscular junction 
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  BP anaphase-promoting 
complex-dependent 
proteasomal ubiquitin-
dependent protein 
catabolic process 
  BP negative regulation of 
ubiquitin-protein ligase 
activity during mitotic cell 
cycle 
  BP ribosome biogenesis 
  CC nucleoplasm 
  CC endosome membrane 
  CC cytosolic small ribosomal 
subunit 
  MF transcription regulator 
activity 
  MF protein binding 
  MF structural constituent of 
ribosome 
No proposed group gtp cyclohydrolase i BP tetrahydrofolate 
biosynthetic process 
  BP compound eye 
pigmentation 
  BP embryonic pattern 
specification 
  BP tetrahydrobiopterin 
biosynthetic process 
  BP pteridine biosynthetic 
process 
  BP cuticle pigmentation 
  BP one-carbon metabolic 
process 
  BP preblastoderm mitotic cell 
cycle 
  BP larval chitin-based cuticle 
development 
  BP folic acid biosynthetic 
process 
  CC cytoplasm 
  MF GTP cyclohydrolase I 
activity 
No proposed group rab gdp-dissociation inhibitor BP neurotransmitter secretion 
  BP regulation of GTPase 
activity 
  BP vesicle-mediated transport 
  BP protein transport 
  CC synaptic vesicle 
  MF Rab GDP-dissociation 
inhibitor activity 
No proposed group serine threonine-protein kinase BP auxin biosynthetic process 
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tao1 
  BP protein amino acid 
phosphorylation 
  BP apoptosis 
  BP transmembrane receptor 
protein serine/threonine 
kinase signaling pathway 
  BP serine family amino acid 
metabolic process 
  MF receptor signaling protein 
serine/threonine kinase 
activity 
  MF ATP binding 
No proposed group anopheles stephensi BP oxidation reduction 
  MF oxidoreductase activity 
  MF copper ion binding 
No proposed group maternal expression at isoform b BP auxin biosynthetic process 
  BP cytoplasmic mRNA 
processing body 
assembly 
  BP "nucleobase 
  CC cytoplasmic mRNA 
processing body 
  MF SUMO binding 
  MF ATP-dependent RNA 
helicase activity 
  MF RNA binding 
  MF ATP binding !!
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Appendix 6. Model selection for survival analysis (accelerated 
failure time model) 
 
A range of models were fitted to the survival data presented in Chapter 
3. The models with their respective residuals are presented in Figure 
A.6. The Weibull distribution was chosen as the best fit based on 
Akaike's information criterion. 
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Figure A.6. Model selection for accelerated failure time analysis, showing fitted model (black lines) and residuals 
(coloured lines). The Weibull distribution was chosen as the best-fitting model (Akaike's information criterion values: Weibull = 
3328.198, logistic = 3416.745, exponential = 3566.084, gaussian = 3412.853, lognormal = 3445.279, loglogistic = 3377.702; 
Equivalent degrees of freedom for all treatments = 12)
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Appendix 7. Estimated densities of S. aureus injected into T. 
molitor (Chapter 3) 
 
T. molitor were injected with bacteria that had been selected for AMP 
resistance, antibiotic resistance, unselected serially cultured controls, or 
the ancestor of all these strains. There was some variation in the 
injected densities of these bacteria, shown in the tables below. Table 
A.7.1 shows the densities of S. aureus injected to beetles whose survival 
was monitored. Table A.7.2 shows the densities of S. aureus injected 
into T. molitor before monitoring persistence in the beetle. 
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Table A.7.1. Injected CFU estimates of S. aureus strains 
injected into T. molitor for survival study (Chapter 3) 
Strain Injected CFU estimate 
Ancestor !"#$%&'$(
Iseganan 28 )"'*%&'$(
Melittin )"!+%&'+(
Pexiganan 14 !"!,%&'$(
Pexiganan 28 !"!#$%&'(
pgml 14 !"-.%&'$(
Unselected 14 !"-.%&'$(
Unselected 28 !"!)$%&'(
Streptomycin *"#.%&'$(
Vancomycin !")!%&'$(
Table A.7.2. Injected CFU estimates of S. aureus strains 
injected into T. molitor for persistence study (Chapter 3) 
Strain Injected CFU estimate 
Ancestor (2 separate days) 7.20E+06 
1.67E+07 
Iseganan 28 4.64E+07 
Melittin 7.00E+06 
Pexiganan 14 4.70E+08 
Pexiganan 28 9.40E+06 
pgml 14 1.17E+07 
Unselected 14 2.08E+08 
Unselected 28 1.16E+07 
Streptomycin 1.28E+07 
Vancomycin 1.11E+07 
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Appendix 8. Stipulations of qPCR primer design. 
 
qPCR primers were designed using the standard Primer3 input, with the 
following stipulations: 
• 90-110 bps product 
• Minimum primer tm = 59c, optimum tm = 60c, maximum tm = 61c 
• Maximum self-complimentarity = 4 
• Maximum 3’ complimentarity = 1 
• Return >20 sequences 
 
 
